{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 11316, "items": [{"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T12:36:08Z", "timestamp": 1574858168667}, "reference-count": 63, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 10, 1]], "date-time": "2018-10-01T00:00:00Z", "timestamp": 1538352000000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100000054", "name": "National Cancer Institute", "doi-asserted-by": "crossref", "award": []}, {"DOI": "10.13039/100000002", "name": "National Institutes of Health", "doi-asserted-by": "crossref", "award": []}, {"DOI": "10.13039/100000016", "name": "U.S. Department of Health and Human Services", "doi-asserted-by": "crossref", "award": []}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "theclinics.com", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Hematology/Oncology Clinics of North America"], "published-print": {"date-parts": [[2018, 10]]}, "DOI": "10.1016/j.hoc.2018.05.006", "type": "journal-article", "created": {"date-parts": [[2018, 7, 26]], "date-time": "2018-07-26T05:49:59Z", "timestamp": 1532584199000}, "page": "787-809", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Familial Waldenstr\u00f6m Macroglobulinemia"], "prefix": "10.1016", "volume": "32", "author": [{"given": "Mary L.", "family": "McMaster", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Hematology/Oncology Clinics of North America"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0889858818307329?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0889858818307329?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 6]], "date-time": "2018-12-06T14:53:13Z", "timestamp": 1544107993000}, "score": 43.232998, "issued": {"date-parts": [[2018, 10]]}, "references-count": 63, "journal-issue": {"published-print": {"date-parts": [[2018, 10]]}, "issue": "5"}, "alternative-id": ["S0889858818307329"], "URL": "http://dx.doi.org/10.1016/j.hoc.2018.05.006", "ISSN": ["0889-8588"], "issn-type": [{"value": "0889-8588", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Familial Waldenstr\u00f6m Macroglobulinemia", "name": "articletitle", "label": "Article Title"}, {"value": "Hematology/Oncology Clinics of North America", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.hoc.2018.05.006", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Published by Elsevier Inc.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T18:13:05Z", "timestamp": 1574705585088}, "publisher-location": "Cham", "reference-count": 72, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319225838", "type": "print"}, {"value": "9783319225845", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 10, 7]], "date-time": "2016-10-07T00:00:00Z", "timestamp": 1475798400000}, "delay-in-days": 0, "content-version": "unspecified"}, {"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 10, 7]], "date-time": "2016-10-07T00:00:00Z", "timestamp": 1475798400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2017]]}, "DOI": "10.1007/978-3-319-22584-5_10", "type": "book-chapter", "created": {"date-parts": [[2016, 10, 6]], "date-time": "2016-10-06T06:25:38Z", "timestamp": 1475735138000}, "page": "111-141", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Genetic Predisposition to Waldenstr\u00f6m Macroglobulinemia"], "prefix": "10.1007", "author": [{"given": "Mary L.", "family": "McMaster", "sequence": "first", "affiliation": []}, {"given": "Helga M.", "family": "\u00d6gmundsd\u00f3ttir", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 10, 7]]}, "reference": [{"key": "10_CR1", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/0268-960X(94)90073-Q", "volume": "8", "author": "RA Kyle", "year": "1994", "unstructured": "Kyle RA. Monoclonal gammopathy of undetermined significance. Blood Rev. 1994;8:135\u201341.", "journal-title": "Blood Rev"}, {"issue": "10", "key": "10_CR2", "doi-asserted-by": "crossref", "first-page": "3759", "DOI": "10.1182/blood-2003-03-0801", "volume": "102", "author": "RA Kyle", "year": "2003", "unstructured": "Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, Plevak MF, Melton III LJ. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood. 2003;102(10):3759\u201364.", "journal-title": "Blood"}, {"key": "10_CR3", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1038/196176b0", "volume": "196", "author": "R Massari", "year": "1962", "unstructured": "Massari R, Fine JM, Metais R. Waldenstr\u00f6m\u2019s macroglobulin\u00e6mia observed in two brothers. Nature. 1962;196:176\u20138.", "journal-title": "Nature"}, {"key": "10_CR4", "doi-asserted-by": "crossref", "first-page": "830", "DOI": "10.7326/0003-4819-93-6-830", "volume": "93", "author": "WA Blattner", "year": "1980", "unstructured": "Blattner WA, Garber JE, Mann DL, McKeen EA, Henson R, McGuire DB, Fisher WB, Bauman AW, Goldin LR, Fraumeni Jr JF. Waldenstr\u00f6m\u2019s macroglobulinemia and autoimmune disease in a family. Ann Intern Med. 1980;93:830\u20132.", "journal-title": "Ann Intern Med"}, {"key": "10_CR5", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1111/j.0954-6820.1982.tb01935.x", "volume": "211", "author": "JM Fine", "year": "1982", "unstructured": "Fine JM, Lambin P, Massari M, Leroux P. Malignant evolution of asymptomatic monoclonal IgM after seven and fifteen years in two siblings of a patient with Waldenstr\u00f6m\u2019s macroglobulinemia. Acta Med Scand. 1982;211:237\u20139.", "journal-title": "Acta Med Scand"}, {"issue": "4", "key": "10_CR6", "doi-asserted-by": "crossref", "first-page": "369", "DOI": "10.1111/j.0954-6820.1986.tb02780.x", "volume": "220", "author": "JM Fine", "year": "1986", "unstructured": "Fine JM, Muller JY, Rochu D, Marneux M, Gorin NC, Fine A, Lambin P. Waldenstr\u00f6m\u2019s macroglobulinemia in monozygotic twins. Acta Med Scand. 1986;220(4):369\u201373.", "journal-title": "Acta Med Scand"}, {"key": "10_CR7", "first-page": "891", "volume": "51", "author": "EP G\u00e9taz", "year": "1977", "unstructured": "G\u00e9taz EP, Staples WG. Familial Waldenstr\u00f6m\u2019s macroglobulinaemia: a case report. S Afr Med J. 1977;51:891\u20132.", "journal-title": "S Afr Med J"}, {"issue": "7", "key": "10_CR8", "doi-asserted-by": "crossref", "first-page": "1554", "DOI": "10.1002/1097-0142(19891001)64:7<1554::AID-CNCR2820640734>3.0.CO;2-3", "volume": "64", "author": "G Renier", "year": "1989", "unstructured": "Renier G, Ifrah N, Chevailler A, Saint-Andre JP, Boasson M, Hurez D. Four brothers with Waldenstrom\u2019s macroglobulinemia. Cancer. 1989;64(7):1554\u20139.", "journal-title": "Cancer"}, {"issue": "6", "key": "10_CR9", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.3109/02841869109092443", "volume": "30", "author": "N Taleb", "year": "1991", "unstructured": "Taleb N, Tohme A, Abi JD, Kattan J, Salloum E. Familial macroglobulinemia in a Lebanese family with two sisters presenting Waldenstr\u00f6m\u2019s disease. Acta Oncol. 1991;30(6):703\u20135.", "journal-title": "Acta Oncol"}, {"issue": "4", "key": "10_CR10", "first-page": "226", "volume": "28", "author": "P Youinou", "year": "1978", "unstructured": "Youinou P, Le Goff P, Saleun JP, Rivat L, Morin JF, Fauchier C, le Menn G. Familial occurrence of monoclonal gammapathies. Biomedicine. 1978;28(4):226\u201332.", "journal-title": "Biomedicine"}, {"key": "10_CR11", "first-page": "37", "volume": "31", "author": "F Coste", "year": "1964", "unstructured": "Coste F, Massais P, Menkes C. Un cas de macroglobulinemia. Rev Rhumat. 1964;31:37\u20139.", "journal-title": "Rev Rhumat"}, {"issue": "17", "key": "10_CR12", "doi-asserted-by": "crossref", "first-page": "5063", "DOI": "10.1158/1078-0432.CCR-07-0299", "volume": "13", "author": "ML McMaster", "year": "2007", "unstructured": "McMaster ML, Csako G, Giambarresi TR, Vasquez L, Berg M, Saddlemire S, Hulley B, Tucker MA. Long-term evaluation of three multiple-case Waldenstr\u00f6m macroglobulinemia families. Clin Cancer Res. 2007;13(17):5063\u20139.", "journal-title": "Clin Cancer Res"}, {"issue": "S445", "key": "10_CR13", "doi-asserted-by": "crossref", "first-page": "140", "DOI": "10.1111/j.0954-6820.1966.tb02353.x", "volume": "179", "author": "M Seligmann", "year": "1966", "unstructured": "Seligmann M. A genetic predisposition to Waldenstrom\u2019s macroglobulinaemia. Acta Med Scand. 1966;179(S445):140\u20136.", "journal-title": "Acta Med Scand"}, {"issue": "1", "key": "10_CR14", "doi-asserted-by": "crossref", "first-page": "66", "DOI": "10.1016/0002-9343(67)90149-0", "volume": "43", "author": "M Seligmann", "year": "1967", "unstructured": "Seligmann M, Danon F, Mihaesco C, Fudenberg HH. Immunoglobulin abnormalities in families of patients with Waldenstr\u00f6m\u2019s macroglobulinemia. Am J Med. 1967;43(1):66\u201383.", "journal-title": "Am J Med"}, {"key": "10_CR15", "first-page": "1744", "volume": "93", "author": "A Vannotti", "year": "1963", "unstructured": "Vannotti A. Etude clinique dun cas de macroglobulinemia de Waldenstrom a caractere familial, associe a des trouble endocriniens. Schweiz Med Wochenschr. 1963;93:1744\u20136.", "journal-title": "Schweiz Med Wochenschr"}, {"issue": "4", "key": "10_CR16", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1016/S0372-1248(66)80150-9", "volume": "9", "author": "JM Fine", "year": "1966", "unstructured": "Fine JM, Massari R, Boffa GA, Lambin P. Macroglobulin\u00e9mie \u00e0 caract\u00e8re familial pr\u00e9sente chez trois sujets d\u2019une m\u00eame fratrie. Transfusion (Paris). 1966;9(4):333\u201341.", "journal-title": "Transfusion (Paris)"}, {"issue": "3", "key": "10_CR17", "doi-asserted-by": "crossref", "first-page": "696", "DOI": "10.1046/j.1365-2141.1998.01061.x", "volume": "103", "author": "HA Deshpande", "year": "1998", "unstructured": "Deshpande HA, Hu XP, Marino P, Jan NA, Wiernik PH. Anticipation in familial plasma cell dyscrasias. Br J Haematol. 1998;103(3):696\u2013703.", "journal-title": "Br J Haematol"}, {"key": "10_CR18", "first-page": "208", "volume": "3", "author": "GA Spengler", "year": "1966", "unstructured": "Spengler GA, Butler R, Fischer CH, Ryssel HJ, Schmid E, Siebner H. On the question of familial occurrence of paraproteinemia. Helv Med Acta. 1966;3:208\u201319.", "journal-title": "Helv Med Acta"}, {"issue": "5", "key": "10_CR19", "first-page": "479", "volume": "5", "author": "MW Kalff", "year": "1969", "unstructured": "Kalff MW, Hijmans W. Immunoglobulin analysis in families of macroglobulinaemia patients. Clin Exp Immunol. 1969;5(5):479\u201398.", "journal-title": "Clin Exp Immunol"}, {"issue": "9", "key": "10_CR20", "first-page": "1363", "volume": "7", "author": "MS Linet", "year": "1993", "unstructured": "Linet MS, Humphrey RL, Mehl ES, Brown LM, Pottern LM, Bias WB, McCaffrey L. A case-control and family study of Waldenstrom\u2019s macroglobulinemia. Leukemia. 1993;7(9):1363\u20139.", "journal-title": "Leukemia"}, {"key": "10_CR21", "first-page": "484", "volume": "80", "author": "P Custodi", "year": "1995", "unstructured": "Custodi P, Cerutti A, Cassani P, Perazzi C, Ravanini P, Fortina G. Familial occurrence of IgMk gammopathy: no role of HCV infection. Haematology. 1995;80:484\u20135.", "journal-title": "Haematology"}, {"issue": "5", "key": "10_CR22", "doi-asserted-by": "crossref", "first-page": "740", "DOI": "10.1001/archneur.57.5.740", "volume": "57", "author": "SM Manschot", "year": "2000", "unstructured": "Manschot SM, Notermans NC, van den Berg LH, Verschuuren JJGM, Lokhorst HM. Three families with polyneuropathy associated with monoclonal gammopathy. Arch Neurol. 2000;57(5):740\u20132.", "journal-title": "Arch Neurol"}, {"issue": "1", "key": "10_CR23", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1016/0002-9343(75)90333-2", "volume": "59", "author": "JF Fraumeni", "year": "1975", "unstructured": "Fraumeni JF, Wertelecki W, Blattner WA, Jensen RD, Leventhal BG. Varied manifestations of a familial lymphoproliferative disorder. Am J Med. 1975;59(1):145\u201351.", "journal-title": "Am J Med"}, {"issue": "4", "key": "10_CR24", "first-page": "283", "volume": "203", "author": "OG Bj\u0151rnsson", "year": "1978", "unstructured": "Bj\u0151rnsson OG, Arnason A, Gudmunosson S, Jensson O, Olafsson S, Valimarsson H. Macroglobulinaemia in an Icelandic family. Acta Med Scand. 1978;203(4):283\u20138.", "journal-title": "Acta Med Scand"}, {"issue": "5", "key": "10_CR25", "doi-asserted-by": "crossref", "first-page": "396", "DOI": "10.1111/j.1600-0609.2011.01593.x", "volume": "86", "author": "H Steingrimsd\u00f3ttir", "year": "2011", "unstructured": "Steingrimsd\u00f3ttir H, Einarsd\u00f3ttir HK, Haraldsd\u00f3ttir V, Ogmundsd\u00f3ttir HM. Familial monoclonal gammopathy: hyper-responsive B cells in unaffected family members. Eur J Haematol. 2011;86(5):396\u2013404.", "journal-title": "Eur J Haematol"}, {"issue": "2", "key": "10_CR26", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.7326/0003-4819-67-2-309", "volume": "67", "author": "RC Williams Jr", "year": "1967", "unstructured": "Williams Jr RC, Erickson JL, Polesky HF, Swaim WR. Studies of monoclonal immunoglobulins (M-components) in various kindreds. Ann Intern Med. 1967;67(2):309\u201327.", "journal-title": "Ann Intern Med"}, {"key": "10_CR27", "doi-asserted-by": "crossref", "first-page": "2094", "DOI": "10.1002/1097-0142(197711)40:5<2094::AID-CNCR2820400518>3.0.CO;2-5", "volume": "40", "author": "ZA Zawadzki", "year": "1977", "unstructured": "Zawadzki ZA, Yoshiharu A, Kraj MA, Haradin AR, Fisher B. Familial immunopathies: report of nine families and survey of literature. Cancer. 1977;40:2094\u2013101.", "journal-title": "Cancer"}, {"key": "10_CR28", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1212/WNL.35.5.679", "volume": "35", "author": "NA Busis", "year": "1985", "unstructured": "Busis NA, Halperin JJ, Stefansson K, Kwiatkowski DJ, Sagar SM, Schiff SR, Logigian EL. Peripheral neuropathy, high serum IgM, and paraproteinemia in mother and son. Neurology. 1985;35:679\u201383.", "journal-title": "Neurology"}, {"issue": "10", "key": "10_CR29", "doi-asserted-by": "crossref", "first-page": "1308", "DOI": "10.1136/jnnp.51.10.1308", "volume": "51", "author": "TS Jensen", "year": "1988", "unstructured": "Jensen TS, Schroder HD, Jonsson V, Ernerudh J, Stigsby B, Kamieniecka Z, Hippe E, Trojaborg W. IgM monoclonal gammopathy and neuropathy in two siblings. J Neurol Neurosurg Psych. 1988;51(10):1308\u201315.", "journal-title": "J Neurol Neurosurg Psych"}, {"issue": "2", "key": "10_CR30", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1111/j.1365-3083.1994.tb03450.x", "volume": "40", "author": "HM \u00d6gmundsd\u00f3ttir", "year": "1994", "unstructured": "\u00d6gmundsd\u00f3ttir HM, J\u00f3hannesson GM, Sveinsd\u00f3ttir S, Einarsd\u00f3ttir S, Hegeman A, Jensson O. Familial macroglobulinaemia: hyperactive B-cells but normal natural killer function. Scand J Immunol. 1994;40(2):195\u2013200.", "journal-title": "Scand J Immunol"}, {"issue": "2", "key": "10_CR31", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1053/sonc.2003.50063", "volume": "30", "author": "ML McMaster", "year": "2003", "unstructured": "McMaster ML. Familial Waldenstrom\u2019s macroglobulinemia. Semin Oncol. 2003;30(2):146\u201352.", "journal-title": "Semin Oncol"}, {"issue": "12", "key": "10_CR32", "doi-asserted-by": "crossref", "first-page": "2342", "DOI": "10.1038/sj.leu.2403991", "volume": "19", "author": "A Altieri", "year": "2005", "unstructured": "Altieri A, Bermejo JL, Hemminki K. Familial aggregation of lymphoplasmacytic lymphoma with non-Hodgkin lymphoma and other neoplasms. Leukemia. 2005;19(12):2342\u20133.", "journal-title": "Leukemia"}, {"issue": "8", "key": "10_CR33", "doi-asserted-by": "crossref", "first-page": "3052", "DOI": "10.1182/blood-2008-06-162768", "volume": "112", "author": "SY Kristinsson", "year": "2008", "unstructured": "Kristinsson SY, Bj\u00f6rkholm M, Goldin LR, McMaster ML, Turesson I, Landgren O. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden. Blood. 2008;112(8):3052\u20136.", "journal-title": "Blood"}, {"key": "10_CR34", "doi-asserted-by": "crossref", "first-page": "1581", "DOI": "10.3324/haematol.2009.008979", "volume": "94", "author": "SY Kristinsson", "year": "2009", "unstructured": "Kristinsson SY, Goldin LR, Bj\u00f6rkholm M, Koshiol J, Turesson I, Landgren O. Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies. Haematologica. 2009;94:1581\u20139.", "journal-title": "Haematologica"}, {"key": "10_CR35", "doi-asserted-by": "crossref", "first-page": "627", "DOI": "10.1038/leu.2015.279", "volume": "30", "author": "C Frank", "year": "2016", "unstructured": "Frank C, Fallah M, Chen T, Mai EK, Sundquist J, F\u00f6rsti A, Hemminki K. Search for familial clustering of multiple myeloma with any cancer. Leukemia. 2016;30:627\u201332.", "journal-title": "Leukemia"}, {"issue": "1", "key": "10_CR36", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.3109/0284186X.2015.1096019", "volume": "55", "author": "L Brandfors", "year": "2016", "unstructured": "Brandfors L, Kimby E, Lundqvist K, Melin B, Lindh J. Familial Waldenstrom\u2019s macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies - a population-based study from northern Sweden. Acta Oncol. 2016;55(1):91\u20138.", "journal-title": "Acta Oncol"}, {"issue": "48", "key": "10_CR37", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1093/jncimonographs/lgu002", "volume": "2014", "author": "CM Vajdic", "year": "2014", "unstructured": "Vajdic CM, Landgren O, McMaster ML, Slager SL, Brooks-Wilson A, Smith A, Staines A, Dogan A, Ansell SM, Sampson JN, Morton LM, Linet MS. Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenstr\u00f6m\u2019s macroglobulinemia: the InterLymph Non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr. 2014;2014(48):87\u201397.", "journal-title": "J Natl Cancer Inst Monogr"}, {"issue": "3", "key": "10_CR38", "doi-asserted-by": "crossref", "first-page": "488", "DOI": "10.1093/annonc/mdj111", "volume": "17", "author": "SP Treon", "year": "2006", "unstructured": "Treon SP, Hunter ZR, Aggarwal A, Ewen EP, Masota S, Lee C, Santos DD, Hatjiharissi E, Xu L, Leleu X, Tournihac O, Patterson CJ, Manning R, Branagan AR, Morton CC. Characterization of familial Waldenstrom\u2019s macroglobulinemia. Ann Oncol. 2006;17(3):488\u201394.", "journal-title": "Ann Oncol"}, {"issue": "1", "key": "10_CR39", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.3816/CLML.2011.n.016", "volume": "11", "author": "C Hanzis", "year": "2011", "unstructured": "Hanzis C, Ojha RP, Hunter Z, Manning R, Lewicki M, Brodsky P, Ioakimidis L, Tripsas C, Patterson CJ, Sheehy P, Treon SP. Associated malignancies in patients with Waldenstrom\u2019s macroglobulinemia and their kin. Clin Lymphoma Myeloma Leuk. 2011;11(1):88\u201392.", "journal-title": "Clin Lymphoma Myeloma Leuk"}, {"issue": "3", "key": "10_CR40", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.1016/j.canep.2011.10.010", "volume": "36", "author": "RP Ojha", "year": "2012", "unstructured": "Ojha RP, Hanzis CA, Hunter ZR, Greenland S, Offutt-Powell TN, Manning RJ, Lewicki M, Brodsky PS, Ioakimidis L, Tripsas CK, Patterson CJ, Sheehy P, Singh KP, Treon SP. Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: a preliminary study. Cancer Epidemiol. 2012;36(3):294\u20137.", "journal-title": "Cancer Epidemiol"}, {"key": "10_CR41", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1159/000335618", "volume": "127", "author": "SY Kristinsson", "year": "2012", "unstructured": "Kristinsson SY, Goldin LR, Turesson I, Bj\u00f6rkholm M, Landgren O. Familial aggregation of lymphoplasmacytic lymphoma/Waldenstr\u00f6m macroglobulinemia with solid tumors and myeloid malignancies. Acta Haematol. 2012;127:173\u20137.", "journal-title": "Acta Haematol"}, {"issue": "22", "key": "10_CR42", "doi-asserted-by": "crossref", "first-page": "4464", "DOI": "10.1182/blood-2009-10-247973", "volume": "115", "author": "RH Royer", "year": "2010", "unstructured": "Royer RH, Koshiol J, Giambarresi TR, Vasquez LG, Pfeiffer RM, McMaster ML. Differential characteristics of Waldenstr\u00f6m macroglobulinemia according to patterns of familial aggregation. Blood. 2010;115(22):4464\u201371.", "journal-title": "Blood"}, {"issue": "2", "key": "10_CR43", "doi-asserted-by": "crossref", "first-page": "118", "DOI": "10.1136/jmg.5.2.118", "volume": "5", "author": "MW Elves", "year": "1968", "unstructured": "Elves MW, Brown AK. Cytogenetic studies in a family with Waldenstrom\u2019s macroglobuliaemia. J Med Genet. 1968;5(2):118\u201322.", "journal-title": "J Med Genet"}, {"issue": "4", "key": "10_CR44", "doi-asserted-by": "crossref", "first-page": "230", "DOI": "10.3816/CLM.2005.n.005", "volume": "5", "author": "ML McMaster", "year": "2005", "unstructured": "McMaster ML, Giambarresi T, Vasquez L, Goldstein AM, Tucker MA. Cytogenetics of familial Waldenstr\u00f6m\u2019s macroglobulinemia: in pursuit of an understanding of genetic predisposition. Clin Lymphoma. 2005;5(4):230\u20134.", "journal-title": "Clin Lymphoma"}, {"issue": "6", "key": "10_CR45", "doi-asserted-by": "crossref", "first-page": "1078", "DOI": "10.1002/(SICI)1097-0142(19980315)82:6<1078::AID-CNCR10>3.0.CO;2-3", "volume": "82", "author": "FD Groves", "year": "1998", "unstructured": "Groves FD, Travis LB, Devesa SS, Ries LAG, Fraumeni Jr JF. Waldenstrom\u2019s macroglobulinemia: incidence patterns in the United States, 1988\u20131994. Cancer. 1998;82(6):1078\u201381.", "journal-title": "Cancer"}, {"key": "10_CR46", "first-page": "248", "volume": "35", "author": "J Petite", "year": "1969", "unstructured": "Petite J, Cruchaud A. Qualitative and quantitative abnormalities of immunoglobulins in relatives of patients with idiopathic paraproteinemia: a study of 12 families. Helv Med Acta. 1969;35:248\u201365.", "journal-title": "Helv Med Acta"}, {"issue": "8", "key": "10_CR47", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1093/jnci/djq043", "volume": "102", "author": "SY Kristinsson", "year": "2010", "unstructured": "Kristinsson SY, Koshiol J, Bj\u00f6rkholm M, Goldin LR, McMaster ML, Turesson I, Landgren O. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstr\u00f6m macroglobulinemia. J Natl Cancer Inst. 2010;102(8):557\u201367.", "journal-title": "J Natl Cancer Inst"}, {"key": "10_CR48", "doi-asserted-by": "crossref", "first-page": "1183", "DOI": "10.1002/ijc.23229", "volume": "122", "author": "ML McMaster", "year": "2008", "unstructured": "McMaster ML, Csako G. Protein electrophoresis, immunoelectrophoresis and immunofixation electrophoresis as predictors for high-risk phenotype in familial Waldenstr\u00f6m macroglobulinemia. Int J Cancer. 2008;122:1183\u20138.", "journal-title": "Int J Cancer"}, {"key": "10_CR49", "doi-asserted-by": "crossref", "first-page": "649", "DOI": "10.2500/aap.2009.30.3292", "volume": "30", "author": "HC Crisp", "year": "2009", "unstructured": "Crisp HC, Quinn JM. Quantitative immunoglobulins in adulthood. Allergy Asthma Proc. 2009;30:649\u201354.", "journal-title": "Allergy Asthma Proc"}, {"issue": "2", "key": "10_CR50", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1258/000456303763046067", "volume": "40", "author": "RJ Lock", "year": "2003", "unstructured": "Lock RJ, Unsworth DJ. Immunoglobulins and immunoglobulin subclasses in the elderly. Ann Clin Biochem. 2003;40(2):143\u20138.", "journal-title": "Ann Clin Biochem"}, {"issue": "2", "key": "10_CR51", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1046/j.1365-2249.1999.00971.x", "volume": "117", "author": "HM \u00d6gmundsd\u00f3ttir", "year": "1999", "unstructured": "\u00d6gmundsd\u00f3ttir HM, Sveinsd\u00f3ttir S, Sigf\u00fasson A, Skaftad\u00f3ttir I, J\u00f3nasson JG, Agnarsson BA. Enhanced B cell survival in familial macroglobulinaemia is associated with increased expression of Bcl-2. Clin Exp Immunol. 1999;117(2):252\u201360.", "journal-title": "Clin Exp Immunol"}, {"issue": "6", "key": "10_CR52", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1016/j.clml.2012.08.006", "volume": "12", "author": "SP Treon", "year": "2012", "unstructured": "Treon SP, Tripsas C, Hanzis C, Ioakimidis L, Patterson CJ, Manning RJ, Sheehy P, Turnbull B, Hunter ZR. Familial disease predisposition impacts treatment outcome in patients with Waldenstr\u00f6m macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2012;12(6):433\u20137.", "journal-title": "Clin Lymphoma Myeloma Leuk"}, {"issue": "13", "key": "10_CR53", "doi-asserted-by": "crossref", "first-page": "2174", "DOI": "10.1182/blood-2015-01-622068", "volume": "125", "author": "V Steingr\u00edmsson", "year": "2015", "unstructured": "Steingr\u00edmsson V, Lund SH, Turesson I, Goldin LR, Bj\u00f6rkholm M, Landgren O, Kristinsson SY. Population-based study on the impact of the familial form of Waldenstr\u00f6m macroglobulinemia on overall survival. Blood. 2015;125(13):2174\u20135.", "journal-title": "Blood"}, {"issue": "8", "key": "10_CR54", "doi-asserted-by": "crossref", "first-page": "2996", "DOI": "10.1182/blood.V100.8.2996", "volume": "100", "author": "RF Schop", "year": "2002", "unstructured": "Schop RF, Kuehl WM, Van Wier SA, Ahmann GJ, Price-Troska T, Bailey RJ, Jalal SM, Qi Y, Kyle RA, Greipp PR, Fonseca R. Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood. 2002;100(8):2996\u20133001.", "journal-title": "Blood"}, {"issue": "4", "key": "10_CR55", "doi-asserted-by": "crossref", "first-page": "695", "DOI": "10.1086/507687", "volume": "79", "author": "ML McMaster", "year": "2006", "unstructured": "McMaster ML, Goldin LR, Bai Y, Ter-Minassian M, Boehringer S, Giambarresi TR, Vasquez LG, Tucker MA. Genomewide linkage screen for Waldenstr\u00f6m macroglobulinemia susceptibility loci in high-risk families. Am J Hum Genet. 2006;79(4):695\u2013701.", "journal-title": "Am J Hum Genet"}, {"key": "10_CR56", "doi-asserted-by": "crossref", "first-page": "418", "DOI": "10.1111/j.1365-2141.2009.07790.x", "volume": "146", "author": "XS Liang", "year": "2009", "unstructured": "Liang XS, Caporaso N, McMaster ML, Ng D, Landgren O, Yeager M, Chanock S, Goldin LR. Common genetic variants in candidate genes and risk of familial lymphoid malignancies. Br J Haematol. 2009;146:418\u201323.", "journal-title": "Br J Haematol"}, {"key": "10_CR57", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1111/j.1600-065X.1999.tb01398.x", "volume": "167", "author": "P Price", "year": "1999", "unstructured": "Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F. The genetic basis for the association of the 8.1 ancestral haplogype (A1, Bi, DR3) with multiple immunopathological diseases. Immunol Rev. 1999;167:257\u201374.", "journal-title": "Immunol Rev"}, {"issue": "11", "key": "10_CR58", "first-page": "326949", "volume": "6", "author": "SS Wang", "year": "2011", "unstructured": "Wang SS, Lu Y, Rothman N, Abdou AM, Cerhan JR, De Roos A, Davis S, Severson RK, Cozen W, Chanock SJ, Bernstein L, Morton LM, Hartge P. Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1. PLoS One. 2011;6(11):326949.", "journal-title": "PLoS One"}, {"issue": "5", "key": "10_CR59", "doi-asserted-by": "crossref", "first-page": "1055", "DOI": "10.1038/leu.2010.17", "volume": "24", "author": "AM Abdou", "year": "2010", "unstructured": "Abdou AM, Gao X, Cozen W, Cerhan JR, Rothman N, Martin MP, Davis S, Schenk M, Chanock SJ, Hartge P, Carrington M, Wang SS. Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia. 2010;24(5):1055\u201388.", "journal-title": "Leukemia"}, {"issue": "10", "key": "10_CR60", "doi-asserted-by": "crossref", "first-page": "2918", "DOI": "10.1182/blood-2010-09-306076", "volume": "117", "author": "S Grass", "year": "2011", "unstructured": "Grass S, Preuss KD, Wikowicz A, Terpos E, Ziepert M, Nikolaus D, Yang Y, Fadle N, Regitz E, Dimopoulos MA, Treon SP, Hunter ZR, Pfreundschuh M. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia. Blood. 2011;117(10):2918\u201323.", "journal-title": "Blood"}, {"issue": "2", "key": "10_CR61", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1053/sonc.2003.50042", "volume": "30", "author": "S Adamia", "year": "2003", "unstructured": "Adamia S, Crainie M, Kriangkum J, Mant MJ, Belch AR, Pilarski LM. Abnormal expression of hyaluronan synthases in patients with Waldenstrom\u2019s macroglobulinemia. Semin Oncol. 2003;30(2):165\u20138.", "journal-title": "Semin Oncol"}, {"issue": "13", "key": "10_CR62", "doi-asserted-by": "crossref", "first-page": "5111", "DOI": "10.1182/blood-2008-02-141770", "volume": "112", "author": "S Adamia", "year": "2008", "unstructured": "Adamia S, Reichert AA, Kuppusamy H, Kriangkum J, Ghosh A, Hodges JJ, Pilarski PM, Treon SP, Mant MJ, Reiman T, Belch AR, Pilarski LM. Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia. Blood. 2008;112(13):5111\u201321.", "journal-title": "Blood"}, {"issue": "28", "key": "10_CR63", "doi-asserted-by": "crossref", "first-page": "18840", "DOI": "10.1074/jbc.M109.013813", "volume": "284", "author": "A Ghosh", "year": "2009", "unstructured": "Ghosh A, Kuppusamy H, Pilarski LM. Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer. J Biol Chem. 2009;284(28):18840\u201350.", "journal-title": "J Biol Chem"}, {"issue": "6", "key": "10_CR64", "doi-asserted-by": "crossref", "first-page": "3100691", "DOI": "10.1371/journal.pone.0100691", "volume": "9", "author": "H Kuppusamy", "year": "2014", "unstructured": "Kuppusamy H, \u00d6gmundsd\u00f3ttir HM, Baigorri E, Warkentin A, Steingrimsd\u00f3ttir H, Haraldsd\u00f3ttir V, Mant MJ, Mackey J, Johnston JB, Adamia S, Belch AR, Pilarski LM. Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer. PLoS One. 2014;9(6):3100691.", "journal-title": "PLoS One"}, {"issue": "9", "key": "10_CR65", "doi-asserted-by": "crossref", "first-page": "826", "DOI": "10.1056/NEJMoa1200710", "volume": "367", "author": "SP Treon", "year": "2012", "unstructured": "Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR. MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia. N Engl J Med. 2012;367(9):826\u201333.", "journal-title": "N Engl J Med"}, {"issue": "9", "key": "10_CR66", "doi-asserted-by": "publisher", "first-page": "30136515", "DOI": "10.1371/journal.pone.0136505", "volume": "10", "author": "M Pertesi", "year": "2015", "unstructured": "Pertesi M, Galia P, Nazaret N, Vall\u00e9e M, Garderet L, Leleu X, Avet-Loiseau H, Foll M, Byrnes G, Lachuer J, McKay JD, Dumontet C. Rare circulating cells in familial Waldenstr\u00f6m macroglobulinemia displaying the MYD88 L265P mutation are enriched by Epstein-Barr virus immortalization. PLoS One. 2015;10(9):30136515. doi: 10.1371/journal.pone.0136505 .", "journal-title": "PLoS One"}, {"issue": "8", "key": "10_CR67", "first-page": "919", "volume": "34", "author": "KB Jacobs", "year": "2010", "unstructured": "Jacobs KB, Yeager M, Cullen MG, Zhang XJ, Boland J, Bacior J, Lonsberry V, Matthews C, Roberson D, Chen QA, Burdett L, Menashe I, Yang XR, Goldin LR, McMaster ML, Caporaso NE, Taylor PR, Landi MT, Sampson J, Chatterjee N, Nickerson ML, Mcgee K, Dean MC, Khan J, Tucker MA, Chanock SJ, Goldstein AM. Realities and limitations of coverage in current \u201cwhole\u201d-exome sequencing capture approaches [abstract]. Genet Epidemiol. 2010;34(8):919\u201320.", "journal-title": "Genet Epidemiol"}, {"key": "10_CR68", "unstructured": "McMaster ML, Goldin LR, Rotunno M, He J, Burdette L, Hutchinson A, Boland J, Yeager M, Tucker MA, Chanock SJ, Caporaso NE. Exploration of rare variants from exome sequencing in families with Waldenstr\u00f6m macroglobulinemia [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2014, Apr 5\u20139; San Diego, CA: AACR; 2014. Abstract nr 1300.", "DOI": "10.1158/1538-7445.AM2014-1300", "doi-asserted-by": "crossref"}, {"issue": "21", "key": "10_CR69", "doi-asserted-by": "crossref", "first-page": "2598", "DOI": "10.1182/blood-2015-11-680199", "volume": "127", "author": "AM Roccaro", "year": "2016", "unstructured": "Roccaro AM, Sacco A, Shi J, Chiarini M, Perilla-Glen A, Manier S, Glavey S, Aljawai Y, Mishima Y, Kawano Y, Moschetta M, Correll M, Improgo MR, Brown JR, Imberti L, Rossi G, Castillo JJ, Treon SP, Freedman ML, Van Allen EM, Hide W, Hiller E, Rainville I, Ghobrial IM. Exome sequencing reveals recurrent germ line variants in patients with familial Waldenstr\u00f6m macroglobulinemia. Blood. 2016;127(21):2598\u2013606.", "journal-title": "Blood"}, {"key": "10_CR70", "first-page": "302", "volume": "54", "author": "MA Jaccottet", "year": "1965", "unstructured": "Jaccottet MA, Ramel C. A propos des paraproteinoses atypique. Praxis. 1965;54:302\u201311.", "journal-title": "Praxis"}, {"key": "10_CR71", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1111/j.0954-6820.1982.tb01959.x", "volume": "211", "author": "\u00d3 Jensson", "year": "1982", "unstructured": "Jensson \u00d3, Bj\u00f6rnsson \u00d3G, \u00c1rnason A, Birgisd\u00f3ttir B, Pepys MB. Serum amyloid P-component and C-reactive protein in serum of healthy Icelanders and members of an Icelandic family with macroglobulinaemia. Acta Med Scand. 1982;211:341\u20135.", "journal-title": "Acta Med Scand"}, {"issue": "12", "key": "10_CR72", "first-page": "2263", "volume": "121", "author": "SP Wu", "year": "2013", "unstructured": "Wu SP, Minter A, Costello R, Zinglone A, Lee CK, Au WY, Landgren O. MGUS prevalence in an ethnically Chinese population in Hong Kong. Blood. 2013;121(12):2263\u2013364.", "journal-title": "Blood"}], "container-title": ["Waldenstr\u00f6m\u2019s Macroglobulinemia"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-22584-5_10", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 14]], "date-time": "2019-09-14T09:18:25Z", "timestamp": 1568452705000}, "score": 41.739708, "issued": {"date-parts": [[2016, 10, 7]]}, "ISBN": ["9783319225838", "9783319225845"], "references-count": 72, "URL": "http://dx.doi.org/10.1007/978-3-319-22584-5_10", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T09:38:26Z", "timestamp": 1574329106564}, "reference-count": 37, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 2855, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int. J. Cancer"], "DOI": "10.1002/ijc.23229", "type": "journal-article", "created": {"date-parts": [[2007, 11, 7]], "date-time": "2007-11-07T20:19:33Z", "timestamp": 1194466773000}, "page": "1183-1188", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Protein electrophoresis, immunoelectrophoresis and immunofixation electrophoresis as predictors for high-risk phenotype in familial Waldenstr\u00f6m macroglobulinemia"], "prefix": "10.1002", "volume": "122", "author": [{"given": "Mary L.", "family": "McMaster", "sequence": "first", "affiliation": []}, {"given": "Gyorgy", "family": "Csako", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2007, 11, 7]]}, "reference": [{"key": "10.1002/ijc.23229-BIB1|cit2", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1053/sonc.2003.50082", "article-title": "Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia", "volume": "30", "author": "Owen", "year": "2003", "journal-title": "Semin Oncol"}, {"key": "10.1002/ijc.23229-BIB2|cit3", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1053/sonc.2003.50063", "article-title": "Familial Waldenstrom's macroglobulinemia", "volume": "30", "author": "McMaster", "year": "2003", "journal-title": "Semin Oncol"}, {"key": "10.1002/ijc.23229-BIB3|cit4", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1097/00001648-199001000-00012", "article-title": "Illustration of the effects of genotype misclassification on the measurement of familial aggregation in epidemiologic studies", "volume": "1", "author": "Khoury", "year": "1990", "journal-title": "Epidemiology"}, {"key": "10.1002/ijc.23229-BIB4|cit5", "doi-asserted-by": "crossref", "first-page": "1564", "DOI": "10.1200/JCO.2005.03.144", "article-title": "Diagnosis and management of Waldenstrom's macroglobulinemia", "volume": "23", "author": "Dimopoulos", "year": "2005", "journal-title": "J Clin Oncol"}, {"key": "10.1002/ijc.23229-BIB5|cit6", "first-page": "126", "article-title": "Procedures for the evaluation of monoclonal immunoglobulins", "volume": "123", "author": "Keren", "year": "1999", "journal-title": "Arch Pathol Lab Med"}, {"key": "10.1002/ijc.23229-BIB6|cit7", "first-page": "114", "article-title": "Sequence of testing for monoclonal gammopathies", "volume": "123", "author": "Kyle", "year": "1999", "journal-title": "Arch Pathol Lab Med"}, {"key": "10.1002/ijc.23229-BIB7|cit8", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.3109/00313028909059528", "article-title": "Detection and typing of paraproteins: comparison of different methods in a routine diagnostic laboratory", "volume": "21", "author": "Guinan", "year": "1989", "journal-title": "Pathology"}, {"key": "10.1002/ijc.23229-BIB8|cit9", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1111/j.1365-2141.2006.06235.x", "article-title": "Monoclonal gammopathy of undetermined significance", "volume": "134", "author": "Kyle", "year": "2006", "journal-title": "Br J Haematol"}, {"key": "10.1002/ijc.23229-BIB9|cit10", "doi-asserted-by": "crossref", "first-page": "830", "DOI": "10.7326/0003-4819-93-6-830", "article-title": "Waldenstrom's macroglobulinemia and autoimmune disease in a family", "volume": "93", "author": "Blattner", "year": "1980", "journal-title": "Ann Intern Med"}, {"key": "10.1002/ijc.23229-BIB10|cit11", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1016/0022-1759(79)90099-1", "article-title": "Detection of M-components by an easy immunofixation procedure: comparison with agarose gel electrophoresis and classical immunoelectrophoresis", "volume": "30", "author": "Pedersen", "year": "1979", "journal-title": "J Immunol Methods"}, {"key": "10.1002/ijc.23229-BIB11|cit12", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/0009-8981(80)90129-1", "article-title": "Comparison of immunofixation and immunoelectrophoresis methods in the identification of monoclonal immunoglobulins in serum", "volume": "104", "author": "Marshall", "year": "1980", "journal-title": "Clin Chim Acta"}, {"key": "10.1002/ijc.23229-BIB12|cit13", "first-page": "1862", "article-title": "Detection and identification of monoclonal components: immunoelectrophoresis on agarose gel and immunofixation on cellulose acetate compared", "volume": "27", "author": "Merlini", "year": "1981", "journal-title": "Clin Chem"}, {"key": "10.1002/ijc.23229-BIB13|cit14", "first-page": "402", "article-title": "Immunofixation on cellulose acetate is more efficient than immunoelectrophoresis for detection of paraproteins", "volume": "29", "author": "Whicher", "year": "1983", "journal-title": "Clin Chem"}, {"key": "10.1002/ijc.23229-BIB14|cit15", "doi-asserted-by": "crossref", "first-page": "198", "DOI": "10.1093/ajcp/88.2.198", "article-title": "Immunofixation compared with immunoelectrophoresis for the routine characterization of paraprotein disorders", "volume": "88", "author": "Gerard", "year": "1987", "journal-title": "Am J Clin Pathol"}, {"key": "10.1002/ijc.23229-BIB15|cit16", "first-page": "141", "article-title": "Identification of monoclonal gammopathies: a comparison of immunofixation, immunoelectrophoresis and measurements of \u03ba- and \u03bb-immunoglobulin levels", "volume": "26", "author": "Duc", "year": "1988", "journal-title": "J Clin Lab Immunol"}, {"key": "10.1002/ijc.23229-BIB16|cit17", "first-page": "1633", "article-title": "Sensitivity of immunofixation electrophoresis for detecting IgM paraproteins in serum", "volume": "34", "author": "Kahn", "year": "1988", "journal-title": "Clin Chem"}, {"key": "10.1002/ijc.23229-BIB17|cit18", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/0009-9120(95)02002-0", "article-title": "A retrospective study of the relative utility of electrophoresis, immunoelectrophoresis, immunofixation, and nephelometry in the investigation of serum proteins", "volume": "29", "author": "Salkie", "year": "1996", "journal-title": "Clin Biochem"}, {"key": "10.1002/ijc.23229-BIB18|cit19", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1093/ajcp/72.1.5", "article-title": "Study of gammopathies with immunofixation electrophoresis", "volume": "72", "author": "Sun", "year": "1979", "journal-title": "Am J Clin Pathol"}, {"key": "10.1002/ijc.23229-BIB19|cit20", "first-page": "1982", "article-title": "Immunofixation. III. Application to the study of monoclonal proteins", "volume": "22", "author": "Ritchie", "year": "1976", "journal-title": "Clin Chem"}, {"key": "10.1002/ijc.23229-BIB20|cit21", "doi-asserted-by": "crossref", "first-page": "192", "DOI": "10.1111/j.1600-0609.1992.tb01584.x", "article-title": "Occurrence of monoclonal components in general practice: clinical implications", "volume": "48", "author": "Aguzzi", "year": "1992", "journal-title": "Eur J Haematol"}, {"key": "10.1002/ijc.23229-BIB21|cit22", "first-page": "451", "article-title": "The incidence of monoclonal proteins during 7 years of screening in a District General Hospital", "volume": "51", "author": "Adams", "year": "1984", "journal-title": "Immunology"}, {"key": "10.1002/ijc.23229-BIB22|cit23", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1007/s00277-002-0493-0", "article-title": "Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece", "volume": "81", "author": "Anagnostopoulos", "year": "2002", "journal-title": "Ann Hematol"}, {"key": "10.1002/ijc.23229-BIB23|cit24", "doi-asserted-by": "crossref", "first-page": "914", "DOI": "10.1046/j.1365-2141.1997.4943298.x", "article-title": "A population-based registry on paraproteinaemia in The Netherlands. Comprehensive Cancer Centre West, Leiden, The Netherlands", "volume": "99", "author": "Ong", "year": "1997", "journal-title": "Br J Haematol"}, {"key": "10.1002/ijc.23229-BIB24|cit25", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1093/ajcp/106.4.449", "article-title": "Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong", "volume": "106", "author": "Lolin", "year": "1996", "journal-title": "Am J Clin Pathol"}, {"key": "10.1002/ijc.23229-BIB25|cit26", "doi-asserted-by": "crossref", "first-page": "564", "DOI": "10.1056/NEJMoa01133202", "article-title": "A long-term study of prognosis in monoclonal gammopathy of undetermined significance", "volume": "346", "author": "Kyle", "year": "2002", "journal-title": "N Engl J Med"}, {"key": "10.1002/ijc.23229-BIB26|cit27", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1111/j.0954-6820.1986.tb03349.x", "article-title": "A 20-year follow-up study of 64 subjects with M-components", "volume": "219", "author": "Axelsson", "year": "1986", "journal-title": "Acta Med Scand"}, {"key": "10.1002/ijc.23229-BIB27|cit28", "doi-asserted-by": "crossref", "first-page": "859", "DOI": "10.4065/79.7.859", "article-title": "Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later", "volume": "79", "author": "Kyle", "year": "2004", "journal-title": "Mayo Clin Proc"}, {"key": "10.1002/ijc.23229-BIB28|cit29", "doi-asserted-by": "crossref", "first-page": "336", "DOI": "10.1111/j.1423-0410.1972.tb03468.x", "article-title": "Frequency of monoclonal gammapathy (\u2018M components\u2019) in 13,400 sera from blood donors", "volume": "23", "author": "Fine", "year": "1972", "journal-title": "Vox Sang"}, {"key": "10.1002/ijc.23229-BIB29|cit30", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1136/jcp.35.1.63", "article-title": "Monoclonal gammopathies in the adult population of Finistere, France", "volume": "35", "author": "Saleun", "year": "1982", "journal-title": "J Clin Pathol"}, {"key": "10.1002/ijc.23229-BIB30|cit31", "doi-asserted-by": "crossref", "first-page": "166", "DOI": "10.1046/j.1365-2141.2002.03589.x", "article-title": "Monoclonal gammopathy in Iceland: a population-based registry and follow-up", "volume": "118", "author": "Ogmundsdottir", "year": "2002", "journal-title": "Br J Haematol"}, {"key": "10.1002/ijc.23229-BIB31|cit32", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1016/S0002-9343(98)00080-1", "article-title": "Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly", "volume": "104", "author": "Cohen", "year": "1998", "journal-title": "Am J Med"}, {"key": "10.1002/ijc.23229-BIB32|cit33", "doi-asserted-by": "crossref", "first-page": "476", "DOI": "10.4065/76.5.476", "article-title": "Retrospective cohort study of 148 patients with polyclonal gammopathy", "volume": "76", "author": "Dispenzieri", "year": "2001", "journal-title": "Mayo Clin Proc"}, {"issue": "3", "key": "10.1002/ijc.23229-BIB33|cit34", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1158/1055-9965.EPI-06-1056", "article-title": "Infectious agents as causes of non-Hodgkin lymphoma", "volume": "16", "author": "Engels", "year": "2007", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "10.1002/ijc.23229-BIB34|cit35", "doi-asserted-by": "crossref", "first-page": "6524", "DOI": "10.1038/sj.onc.1207843", "article-title": "The epidemiology of non-Hodgkin's lymphoma", "volume": "23", "author": "Fisher", "year": "2004", "journal-title": "Oncogene"}, {"key": "10.1002/ijc.23229-BIB35|cit36", "doi-asserted-by": "crossref", "first-page": "1185", "DOI": "10.1136/ard.51.11.1185", "article-title": "Hypergammaglobulinaemia and autoimmune rheumatic diseases", "volume": "51", "author": "Ehrenstein", "year": "1992", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/ijc.23229-BIB36|cit37", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.1093/ajcp/74.1.12", "article-title": "Serum immunoglobulin levels in patients with non-Hodgkin's lymphoma", "volume": "74", "author": "Lichtenstein", "year": "1980", "journal-title": "Am J Clin Pathol"}, {"key": "10.1002/ijc.23229-BIB37|cit38", "doi-asserted-by": "crossref", "first-page": "695", "DOI": "10.1086/507687", "article-title": "Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families", "volume": "79", "author": "McMaster", "year": "2006", "journal-title": "Am J Hum Genet"}], "container-title": ["International Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.23229", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.23229", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 5]], "date-time": "2019-02-05T10:50:30Z", "timestamp": 1549363830000}, "score": 37.907185, "issued": {"date-parts": [[2007, 11, 7]]}, "references-count": 37, "journal-issue": {"issue": "5"}, "URL": "http://dx.doi.org/10.1002/ijc.23229", "relation": {"cites": []}, "ISSN": ["0020-7136"], "issn-type": [{"value": "0020-7136", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:14:58Z", "timestamp": 1574496898805}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2010, 4, 15]]}, "DOI": "10.1158/1538-7445.am10-1814", "type": "proceedings-article", "created": {"date-parts": [[2011, 2, 25]], "date-time": "2011-02-25T18:18:02Z", "timestamp": 1298657882000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 1814: Waldenstr\u00f6m macroglobulinemia and lymphoplasmacytic lymphoma: incidence and demographic patterns in the United States, 1988 \u2013 2006"], "prefix": "10.1158", "author": [{"given": "Mary L.", "family": "McMaster", "sequence": "first", "affiliation": []}, {"given": "Phillip", "family": "Rosenberg", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 17]]}, "event": {"name": "Proceedings: AACR 101st Annual Meeting 2010\u2010\u2010 Apr 17\u201021, 2010; Washington, DC"}, "container-title": ["Epidemiology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM10-1814", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T17:08:23Z", "timestamp": 1558199303000}, "score": 34.288635, "issued": {"date-parts": [[2010, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM10-1814"], "URL": "http://dx.doi.org/10.1158/1538-7445.am10-1814"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:24:55Z", "timestamp": 1574162695826}, "reference-count": 36, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 4, 1]], "date-time": "2003-04-01T00:00:00Z", "timestamp": 1049155200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Seminars in Oncology"], "published-print": {"date-parts": [[2003, 4]]}, "DOI": "10.1053/sonc.2003.50063", "type": "journal-article", "created": {"date-parts": [[2003, 4, 28]], "date-time": "2003-04-28T19:53:00Z", "timestamp": 1051559580000}, "page": "146-152", "source": "Crossref", "is-referenced-by-count": 46, "title": ["Familial Waldenstrom's macroglobulinemia"], "prefix": "10.1053", "volume": "30", "author": [{"given": "Mary L.", "family": "McMaster", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Seminars in Oncology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0093775403700669?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0093775403700669?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 21]], "date-time": "2019-03-21T20:27:48Z", "timestamp": 1553200068000}, "score": 34.066124, "issued": {"date-parts": [[2003, 4]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2003, 4]]}, "issue": "2"}, "alternative-id": ["S0093775403700669"], "URL": "http://dx.doi.org/10.1053/sonc.2003.50063", "ISSN": ["0093-7754"], "issn-type": [{"value": "0093-7754", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T10:45:57Z", "timestamp": 1574419557114}, "reference-count": 44, "publisher": "American Society of Hematology", "issue": "22", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2010, 6, 3]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Familial aggregation of Waldenstr\u00f6m macroglobulinemia (WM) and related B-cell disorders (BCDs) suggests a role for genetic factors, but few data address environmental influences. We designed a questionnaire-based study to examine clinical and environmental factors in a cohort of WM families with various patterns of case aggregation. We analyzed data on 103 WM patients and 272 unaffected relatives from 35 multiple-case WM and 46 mixed WM/BCD kindred and 28 nonfamilial (sporadic) WM patients, using logistic regression models with generalized estimating equations to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for association. In this study population, the WM disease process appeared similar among patients regardless of family history. Familial WM patients were more likely than unaffected relatives to report a history of autoimmune disease (OR, 2.27; 95% CI = 1.21-4.28) and infections (OR, 2.13; 95% CI = 1.25-3.64). Familial WM patients were also more likely to report exposure to farming (OR, 2.70; 95% CI = 1.34-5.42), pesticides (OR, 2.83; 95% CI = 1.56-5.11), wood dust (OR, 2.86; 95% CI = 1.54-5.33), and organic solvents (multiple-case WM OR, 4.21; 95% CI = 1.69-10.51) compared with unaffected family members. These data provide clues to both genetic and environmental factors that may influence development of WM. Well-designed case-control studies are needed to confirm these findings.</jats:p>", "DOI": "10.1182/blood-2009-10-247973", "type": "journal-article", "created": {"date-parts": [[2010, 3, 23]], "date-time": "2010-03-23T02:36:00Z", "timestamp": 1269311760000}, "page": "4464-4471", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 32, "title": ["Differential characteristics of Waldenstr\u00f6m macroglobulinemia according to patterns of familial aggregation"], "prefix": "10.1182", "volume": "115", "author": [{"given": "Regan H.", "family": "Royer", "sequence": "first", "affiliation": [{"name": "Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD;"}]}, {"given": "Jill", "family": "Koshiol", "sequence": "additional", "affiliation": [{"name": "Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD;"}]}, {"given": "Therese R.", "family": "Giambarresi", "sequence": "additional", "affiliation": [{"name": "Westat, Inc, Rockville, MD; and"}]}, {"given": "Linda G.", "family": "Vasquez", "sequence": "additional", "affiliation": [{"name": "Westat, Inc, Rockville, MD; and"}]}, {"given": "Ruth M.", "family": "Pfeiffer", "sequence": "additional", "affiliation": [{"name": "Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD;"}]}, {"given": "Mary L.", "family": "McMaster", "sequence": "additional", "affiliation": [{"name": "Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD;"}, {"name": "Commissioned Corps, United States Public Health Service, Department of Health and Human Services, Washington, DC"}]}], "member": "234", "reference": [{"issue": "2", "key": "2019111722224181200_B1", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1053/sonc.2003.50082", "article-title": "Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.", "volume": "30", "author": "Owen", "year": "2003", "journal-title": "Semin Oncol"}, {"key": "2019111722224181200_B2", "author": "Berger", "first-page": "132", "year": "2001", "article-title": "Lympho-plasmacytic lymphoma/Waldenstr\u00f6m macroglobulinemia.", "volume-title": "Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues"}, {"issue": "12", "key": "2019111722224181200_B3", "doi-asserted-by": "crossref", "first-page": "5096", "DOI": "10.1182/blood-2006-11-055012", "article-title": "Waldenstrom macroglobulinemia.", "volume": "109", "author": "Vijay", "year": "2007", "journal-title": "Blood"}, {"key": "2019111722224181200_B4", "unstructured": "American Cancer Society\n          Detailed guide: Waldenstrom macroglobulinemia\n          Accessed December 22, 2009\n          \n            http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=76"}, {"issue": "10", "key": "2019111722224181200_B5", "doi-asserted-by": "crossref", "first-page": "3759", "DOI": "10.1182/blood-2003-03-0801", "article-title": "Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.", "volume": "102", "author": "Kyle", "year": "2003", "journal-title": "Blood"}, {"issue": "13", "key": "2019111722224181200_B6", "doi-asserted-by": "crossref", "first-page": "1362", "DOI": "10.1056/NEJMoa054494", "article-title": "Prevalence of monoclonal gammopathy of undetermined significance.", "volume": "354", "author": "Kyle", "year": "2006", "journal-title": "N Engl J Med"}, {"issue": "6", "key": "2019111722224181200_B7", "doi-asserted-by": "crossref", "first-page": "1078", "DOI": "10.1002/(SICI)1097-0142(19980315)82:6<1078::AID-CNCR10>3.0.CO;2-3", "article-title": "Waldenstr\u00f6m's macroglobulinemia: incidence patterns in the United States, 1988-1994.", "volume": "82", "author": "Groves", "year": "1998", "journal-title": "Cancer"}, {"issue": "8", "key": "2019111722224181200_B8", "doi-asserted-by": "crossref", "first-page": "564", "DOI": "10.1056/NEJMoa01133202", "article-title": "A long-term study of prognosis in monoclonal gammopathy of undetermined significance.", "volume": "346", "author": "Kyle", "year": "2002", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "2019111722224181200_B9", "first-page": "397", "article-title": "Waldenstrom's macroglobulinaemia in a bird breeder: a case history with pulmonary involvement and antibody activity of the monoclonal IgM to canary's droppings.", "volume": "68", "author": "James", "year": "1987", "journal-title": "Clin Exp Immunol"}, {"issue": "6672", "key": "2019111722224181200_B10", "doi-asserted-by": "crossref", "first-page": "498", "DOI": "10.1136/bmj.298.6672.498", "article-title": "Waldenstrom's macroglobulinaemia: three cases in shoe repairers.", "volume": "298", "author": "Williamson", "year": "1989", "journal-title": "BMJ"}, {"issue": "2", "key": "2019111722224181200_B11", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1097/00043764-199402000-00007", "article-title": "Waldenstrom's macroglobulinemia: search for occupational exposure.", "volume": "36", "author": "Tepper", "year": "1994", "journal-title": "J Occup Med"}, {"issue": "9", "key": "2019111722224181200_B12", "first-page": "1363", "article-title": "A case-control and family study of Waldenstrom's macroglobulinemia.", "volume": "7", "author": "Linet", "year": "1993", "journal-title": "Leukemia"}, {"key": "2019111722224181200_B13", "author": "Risch", "first-page": "89", "year": "2006", "article-title": "Genetic concepts and methods in epidemiologic research.", "volume-title": "Cancer Epidemiology and Prevention", "DOI": "10.1093/acprof:oso/9780195149616.003.0007", "doi-asserted-by": "crossref"}, {"issue": "7", "key": "2019111722224181200_B14", "doi-asserted-by": "crossref", "first-page": "1554", "DOI": "10.1002/1097-0142(19891001)64:7<1554::AID-CNCR2820640734>3.0.CO;2-3", "article-title": "Four brothers with Waldenstrom's macroglobulinemia.", "volume": "64", "author": "Renier", "year": "1989", "journal-title": "Cancer"}, {"issue": "4", "key": "2019111722224181200_B15", "doi-asserted-by": "crossref", "first-page": "369", "DOI": "10.1111/j.0954-6820.1986.tb02780.x", "article-title": "Waldenstrom's macroglobulinemia in monozygotic twins.", "volume": "220", "author": "Fine", "year": "1986", "journal-title": "Acta Med Scand"}, {"key": "2019111722224181200_B16", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1038/196176b0", "article-title": "Waldenstrom's macroglobulin\u00e6mia observed in two brothers.", "volume": "196", "author": "Massari", "year": "1962", "journal-title": "Nature"}, {"issue": "3", "key": "2019111722224181200_B17", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1111/j.0954-6820.1982.tb01935.x", "article-title": "Malignant evolution of asymptomatic monoclonal IgM after seven and fifteen years in two siblings of a patient with Waldenstr\u00f6m's macroglobulinemia.", "volume": "211", "author": "Fine", "year": "1982", "journal-title": "Acta Med Scand"}, {"issue": "6", "key": "2019111722224181200_B18", "doi-asserted-by": "crossref", "first-page": "830", "DOI": "10.7326/0003-4819-93-6-830", "article-title": "Waldenstrom's macroglobulinemia and autoimmune disease in a family.", "volume": "93", "author": "Blattner", "year": "1980", "journal-title": "Ann Intern Med"}, {"issue": "12", "key": "2019111722224181200_B19", "doi-asserted-by": "crossref", "first-page": "2342", "DOI": "10.1038/sj.leu.2403991", "article-title": "Familial aggregation of lymphoplasmacytic lymphoma with non-Hodgkin lymphoma and other neoplasms.", "volume": "19", "author": "Altieri", "year": "2005", "journal-title": "Leukemia"}, {"issue": "8", "key": "2019111722224181200_B20", "doi-asserted-by": "crossref", "first-page": "3052", "DOI": "10.1182/blood-2008-06-162768", "article-title": "Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.", "volume": "112", "author": "Kristinsson", "year": "2008", "journal-title": "Blood"}, {"issue": "3", "key": "2019111722224181200_B21", "doi-asserted-by": "crossref", "first-page": "488", "DOI": "10.1093/annonc/mdj111", "article-title": "Characterization of familial Waldenstrom's macroglobulinemia.", "volume": "17", "author": "Treon", "year": "2006", "journal-title": "Ann Oncol"}, {"issue": "2", "key": "2019111722224181200_B22", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1111/j.1365-3083.1994.tb03450.x", "article-title": "Familial macroglobulinaemia: hyperactive B-cells but normal natural killer function.", "volume": "40", "author": "Ogmundsd\u00f3ttir", "year": "1994", "journal-title": "Scand J Immunol"}, {"issue": "2", "key": "2019111722224181200_B23", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1053/sonc.2003.50063", "article-title": "Familial Waldenstrom's macroglobulinemia.", "volume": "30", "author": "McMaster", "year": "2003", "journal-title": "Semin Oncol"}, {"issue": "17", "key": "2019111722224181200_B24", "doi-asserted-by": "crossref", "first-page": "5063", "DOI": "10.1158/1078-0432.CCR-07-0299", "article-title": "Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families.", "volume": "13", "author": "McMaster", "year": "2007", "journal-title": "Clin Cancer Res"}, {"issue": "5", "key": "2019111722224181200_B25", "doi-asserted-by": "crossref", "first-page": "1183", "DOI": "10.1002/ijc.23229", "article-title": "Protein electrophoresis, immunoelectrophoresis and immunofixation electrophoresis as predictors for high-risk phenotype in familial Waldenstrom macroglobulinemia.", "volume": "122", "author": "McMaster", "year": "2008", "journal-title": "Int J Cancer"}, {"issue": "5", "key": "2019111722224181200_B26", "doi-asserted-by": "crossref", "first-page": "663", "DOI": "10.1111/j.1365-2141.2007.06845.x", "article-title": "Waldenstrom macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.", "volume": "139", "author": "McMaster", "year": "2007", "journal-title": "Br J Haematol"}, {"issue": "3", "key": "2019111722224181200_B27", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1002/art.23267", "article-title": "Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma.", "volume": "58", "author": "Mellemkjaer", "year": "2008", "journal-title": "Arthritis Rheum"}, {"issue": "1", "key": "2019111722224181200_B28", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1093/biomet/73.1.13", "article-title": "Longitudinal data analysis using generalized linear models.", "volume": "73", "author": "Liang", "year": "1986", "journal-title": "Biometrika"}, {"issue": "21", "key": "2019111722224181200_B29", "doi-asserted-by": "crossref", "first-page": "1600", "DOI": "10.1093/jnci/86.21.1600", "article-title": "Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.", "volume": "86", "author": "Goldgar", "year": "1994", "journal-title": "J Natl Cancer Inst"}, {"issue": "9", "key": "2019111722224181200_B30", "first-page": "1415", "article-title": "Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.", "volume": "13", "author": "Chatterjee", "year": "2004", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"issue": "8", "key": "2019111722224181200_B31", "doi-asserted-by": "crossref", "first-page": "3479", "DOI": "10.1182/blood-2006-06-031948", "article-title": "Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10211 cases and 11905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).", "volume": "109", "author": "Wang", "year": "2007", "journal-title": "Blood"}, {"issue": "12", "key": "2019111722224181200_B32", "doi-asserted-by": "crossref", "first-page": "3647", "DOI": "10.1182/blood.V83.12.3647.3647", "article-title": "Similar patterns of Vk gene usage but different degrees of somatic mutation in hairy-cell leukemia, prolymphocytic leukemia, Waldenstroms macroglobulinemia, and myeloma.", "volume": "83", "author": "Wagner", "year": "1994", "journal-title": "Blood"}, {"issue": "7", "key": "2019111722224181200_B33", "doi-asserted-by": "crossref", "first-page": "1913", "DOI": "10.1182/blood.V85.7.1913.bloodjournal8571913", "article-title": "Frequent somatic mutations in D and/or JH segments of Ig gene in Waldenstrom's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not in common CLL.", "volume": "85", "author": "Aoki", "year": "1995", "journal-title": "Blood"}, {"issue": "18", "key": "2019111722224181200_B34", "doi-asserted-by": "crossref", "first-page": "2010", "DOI": "10.1001/jama.297.18.2010", "article-title": "Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.", "volume": "297", "author": "Giordano", "year": "2007", "journal-title": "JAMA"}, {"issue": "17", "key": "2019111722224181200_B35", "doi-asserted-by": "crossref", "first-page": "1903", "DOI": "10.1001/archinternmed.2008.4", "article-title": "Chronic immune stimulation and subsequent Waldenstrom macroglobulinemia.", "volume": "168", "author": "Koshiol", "year": "2008", "journal-title": "Arch Int Med"}, {"issue": "4", "key": "2019111722224181200_B36", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1016/j.cgh.2008.02.011", "article-title": "Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.", "volume": "6", "author": "De Sanjose", "year": "2008", "journal-title": "Clinl Gastroenterol Hepatol"}, {"issue": "8", "key": "2019111722224181200_B37", "doi-asserted-by": "crossref", "first-page": "3034", "DOI": "10.1182/blood-2005-09-3679", "article-title": "Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation.", "volume": "107", "author": "Suarez", "year": "2006", "journal-title": "Blood"}, {"issue": "7", "key": "2019111722224181200_B38", "doi-asserted-by": "crossref", "first-page": "3388", "DOI": "10.1182/blood-2007-10-121285", "article-title": "Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.", "volume": "111", "author": "Brown", "year": "2008", "journal-title": "Blood"}, {"issue": "12", "key": "2019111722224181200_B39", "first-page": "1697", "article-title": "Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia.", "volume": "91", "author": "Landgren", "year": "2006", "journal-title": "Haematologica"}, {"key": "2019111722224181200_B40", "first-page": "S5465", "article-title": "Primary immunodeficiencies: genetic risk-factors for lymphoma.", "volume": "52", "author": "Filipovich", "year": "1992", "journal-title": "Cancer Res"}, {"issue": "8", "key": "2019111722224181200_B41", "doi-asserted-by": "crossref", "first-page": "4029", "DOI": "10.1182/blood-2007-10-119974", "article-title": "Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph consortium.", "volume": "111", "author": "Ekstr\u00f6m Smedby", "year": "2008", "journal-title": "Blood"}, {"issue": "3", "key": "2019111722224181200_B42", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.3324/haematol.11934", "article-title": "Autoimmune thrombocytopenia in non-Hodgkin's lymphomas.", "volume": "93", "author": "Hauswirth", "year": "2008", "journal-title": "Haematologica"}, {"key": "2019111722224181200_B43", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1002/ijc.22719", "article-title": "The non-Hodgkin lymphomas: a review of the epidemiologic literature.", "volume": "120", "author": "Alexander", "year": "2007", "journal-title": "Int J Cancer"}, {"issue": "6", "key": "2019111722224181200_B44", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1080/00313020500370192", "article-title": "The epidemiology of non-Hodgkin lymphoma.", "volume": "37", "author": "Grulich", "year": "2005", "journal-title": "Pathology"}], "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/115/22/4464/1327589/zh802210004464.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/115/22/4464/1327589/zh802210004464.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T03:23:01Z", "timestamp": 1574047381000}, "score": 33.52909, "issued": {"date-parts": [[2010, 6, 3]]}, "references-count": 44, "journal-issue": {"published-print": {"date-parts": [[2010, 6, 3]]}, "issue": "22"}, "URL": "http://dx.doi.org/10.1182/blood-2009-10-247973", "relation": {"cites": []}, "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T12:32:43Z", "timestamp": 1574771563068}, "reference-count": 69, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 3, 1]], "date-time": "2016-03-01T00:00:00Z", "timestamp": 1456790400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Curr. Treat. Options in Oncol."], "published-print": {"date-parts": [[2016, 3]]}, "DOI": "10.1007/s11864-016-0391-7", "type": "journal-article", "created": {"date-parts": [[2016, 3, 4]], "date-time": "2016-03-04T07:20:03Z", "timestamp": 1457076003000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection"], "prefix": "10.1007", "volume": "17", "author": [{"given": "Prashant", "family": "Kapoor", "sequence": "first", "affiliation": []}, {"given": "Jonas", "family": "Paludo", "sequence": "additional", "affiliation": []}, {"given": "Stephen M.", "family": "Ansell", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 3, 4]]}, "reference": [{"issue": "6", "key": "391_CR1", "doi-asserted-by": "crossref", "first-page": "1078", "DOI": "10.1002/(SICI)1097-0142(19980315)82:6<1078::AID-CNCR10>3.0.CO;2-3", "volume": "82", "author": "FD Groves", "year": "1998", "unstructured": "Groves FD, Travis LB, Devesa SS, Ries LA, Fraumeni Jr JF. Waldenstrom\u2019s macroglobulinemia: incidence patterns in the United States, 1988\u20131994. Cancer. 1998;82(6):1078\u201381.", "journal-title": "Cancer"}, {"issue": "3\u20134", "key": "391_CR2", "first-page": "216", "volume": "117", "author": "J Waldenstrom", "year": "1944", "unstructured": "Waldenstrom J. Incipient myelomatosis or essential hyperglobulinemia with fibrinogenopenia\u2014a new syndrome? Acta Med Scand. 1944;117(3\u20134):216\u201347. doi: 10.1111/j.0954-6820.1944.tb03955.x .", "journal-title": "Acta Med Scand"}, {"issue": "2", "key": "391_CR3", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1053/sonc.2003.50082", "volume": "30", "author": "RG Owen", "year": "2003", "unstructured": "Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, et al. Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom\u2019s macroglobulinemia. Semin Oncol. 2003;30(2):110\u20135. doi: 10.1053/sonc.2003.50082 .", "journal-title": "Semin Oncol"}, {"issue": "9", "key": "391_CR4", "doi-asserted-by": "crossref", "first-page": "824", "DOI": "10.4065/mcp.2010.0304", "volume": "85", "author": "SM Ansell", "year": "2010", "unstructured": "Ansell SM, Kyle RA, Reeder CB, Fonseca R, Mikhael JR, Morice WG, et al. Diagnosis and management of Waldenstrom macroglobulinemia: mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines. Mayo Clin Proc. 2010;85(9):824\u201333. doi: 10.4065/mcp.2010.0304 .", "journal-title": "Mayo Clin Proc"}, {"issue": "15", "key": "391_CR5", "doi-asserted-by": "crossref", "first-page": "2370", "DOI": "10.1182/blood-2014-09-602565", "volume": "125", "author": "B Paiva", "year": "2015", "unstructured": "Paiva B, Corchete LA, Vidrialis M, Garc\u00eda-Sanz R, Perez JJ, Aires-Mejia I. The cellular origin and malignant transformation of Waldenstr\u00f6m\u2019s macroglobulinemia. Blood. 2015;125(15):2370\u201380. doi: 10.1182/blood-2014-09-602565 . This recent paper demonstrated that the transcriptome of the Waldenstr\u00f6m\u2019s B-cell clone was highly different than that of normal CD25\u2212CD22+ B-cells and that the clonal B-cells of IgM MGUS and smoldering WM already harbor the phenotypic and molecular signatures of the malignant Waldenstr\u00f6m\u2019s clone but the frequency of specific copy number abnormalities [+4, del(6q23.3-6q25.3), +12, and +18q11-18q23] progressively increased from IgM MGUS and smoldering WM to symptomatic WM.", "journal-title": "Blood"}, {"issue": "2", "key": "391_CR6", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1111/bjh.13091", "volume": "168", "author": "M Varettoni", "year": "2015", "unstructured": "Varettoni M, Arcaini L, Rattotti S, Ferretti V, Cazzola M. Bone marrow assessment in asymptomatic immunoglobulin M monoclonal gammopathies. Br J Haematol. 2015;168(2):301\u20132. doi: 10.1111/bjh.13091 . A study underscoring the value of bone marrow assessment in asymptomatic immunoglobulin M monoclonal gammopathies with a serum IgM level lower than 1g/dL.", "journal-title": "Br J Haematol"}, {"issue": "19", "key": "391_CR7", "doi-asserted-by": "crossref", "first-page": "4462", "DOI": "10.1182/blood-2011-10-384768", "volume": "119", "author": "RA Kyle", "year": "2012", "unstructured": "Kyle RA, Benson JT, Larson DR, Therneau TM, Dispenzieri A, Kumar S, et al. Progression in smoldering Waldenstr\u00f6m macroglobulinemia: long-term results. Blood. 2012;119(19):4462\u20136. doi: 10.1182/blood-2011-10-384768 .", "journal-title": "Blood"}, {"issue": "5", "key": "391_CR8", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1016/j.blre.2015.03.001", "volume": "29", "author": "P Kapoor", "year": "2015", "unstructured": "Kapoor P, Paludo J, Vallumsetla N, Greipp PR. Waldenstrom macroglobulinemia: what a hematologist needs to know. Blood Rev. 2015;29(5):301\u201319. doi: 10.1016/j.blre.2015.03.001 .", "journal-title": "Blood Rev"}, {"issue": "7", "key": "391_CR9", "doi-asserted-by": "crossref", "first-page": "2134", "DOI": "10.1182/blood-2003-11-4024", "volume": "104", "author": "J Kriangkum", "year": "2004", "unstructured": "Kriangkum J, Taylor BJ, Treon SP, Mant MJ, Belch AR, Pilarski LM. Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood. Blood. 2004;104(7):2134\u201342. doi: 10.1182/blood-2003-11-4024 .", "journal-title": "Blood"}, {"issue": "3", "key": "391_CR10", "doi-asserted-by": "crossref", "first-page": "230", "DOI": "10.1038/nri1572", "volume": "5", "author": "M Shapiro-Shelef", "year": "2005", "unstructured": "Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol. 2005;5(3):230\u201342. doi: 10.1038/nri1572 .", "journal-title": "Nat Rev Immunol"}, {"issue": "3", "key": "391_CR11", "doi-asserted-by": "crossref", "first-page": "541", "DOI": "10.1038/sj.leu.2404520", "volume": "21", "author": "NC Gutierrez", "year": "2007", "unstructured": "Gutierrez NC, Ocio EM, Delas Rivas J, Maiso P, Delgado M, Ferminan E, et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom\u2019s macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia. 2007;21(3):541\u20139. http://www.nature.com/leu/journal/v21/n3/suppinfo/2404520s1.html . A comparison of WM- cells with CLL and MM using gene expression profile with results indicating that both plasma cells and B lymphocytes from WM are genetically different from the multiple myeloma and chronic lymphocytic leukemia cell counterpart.", "journal-title": "Leukemia"}, {"issue": "5", "key": "391_CR12", "doi-asserted-by": "crossref", "first-page": "246", "DOI": "10.1097/01.pap.0000184176.65919.17", "volume": "12", "author": "P Lin", "year": "2005", "unstructured": "Lin P, Medeiros LJ. Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia: an evolving concept. Adv Anat Pathol. 2005;12(5):246\u201355. Paiva.", "journal-title": "Adv Anat Pathol"}, {"issue": "8", "key": "391_CR13", "doi-asserted-by": "crossref", "first-page": "564", "DOI": "10.1056/NEJMoa01133202", "volume": "346", "author": "RA Kyle", "year": "2002", "unstructured": "Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346(8):564\u20139. doi: 10.1056/NEJMoa01133202 .", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "391_CR14", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1053/sonc.2003.50063", "volume": "30", "author": "ML McMaster", "year": "2003", "unstructured": "McMaster ML. Familial Waldenstrom\u2019s macroglobulinemia. Semin Oncol. 2003;30(2):146\u201352. doi: 10.1053/sonc.2003.50063 .", "journal-title": "Semin Oncol"}, {"issue": "3", "key": "391_CR15", "doi-asserted-by": "crossref", "first-page": "488", "DOI": "10.1093/annonc/mdj111", "volume": "17", "author": "SP Treon", "year": "2006", "unstructured": "Treon SP, Hunter ZR, Aggarwal A, Ewen EP, Masota S, Lee C, et al. Characterization of familial Waldenstrom\u2019s macroglobulinemia. Ann Oncol. 2006;17(3):488\u201394. doi: 10.1093/annonc/mdj111 .", "journal-title": "Ann Oncol"}, {"issue": "1", "key": "391_CR16", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.3816/CLML.2011.n.016", "volume": "11", "author": "C Hanzis", "year": "2011", "unstructured": "Hanzis C, Ojha RP, Hunter Z, Manning R, Lewicki M, Brodsky P, et al. Associated malignancies in patients with Waldenstrom\u2019s macroglobulinemia and their kin. Clin Lymphoma Myeloma Leuk. 2011;11(1):88\u201392. doi: 10.3816/CLML.2011.n.016 .", "journal-title": "Clin Lymphoma Myeloma Leuk"}, {"issue": "1", "key": "391_CR17", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.3816/CLML.2011.n.015", "volume": "11", "author": "SY Kristinsson", "year": "2011", "unstructured": "Kristinsson SY, Landgren O. What causes Waldenstrom\u2019s macroglobulinemia: genetic or immune-related factors, or a combination? Clin Lymphoma Myeloma Leuk. 2011;11(1):85\u20137. doi: 10.3816/CLML.2011.n.015 .", "journal-title": "Clin Lymphoma Myeloma Leuk"}, {"issue": "4", "key": "391_CR18", "doi-asserted-by": "crossref", "first-page": "695", "DOI": "10.1086/507687", "volume": "79", "author": "ML McMaster", "year": "2006", "unstructured": "McMaster ML, Goldin LR, Bai Y, Ter-Minassian M, Boehringer S, Giambarresi TR, et al. Genomewide linkage screen for Waldenstr\u00f6m macroglobulinemia susceptibility loci in high-risk families. Am J Hum Genet. 2006;79(4):695\u2013701. doi: 10.1086/507687 .", "journal-title": "Am J Hum Genet"}, {"issue": "10", "key": "391_CR19", "doi-asserted-by": "crossref", "first-page": "2918", "DOI": "10.1182/blood-2010-09-306076", "volume": "117", "author": "S Grass", "year": "2011", "unstructured": "Grass S, Preuss KD, Wikowicz A, Terpos E, Ziepert M, Nikolaus D, et al. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia. Blood. 2011;117(10):2918\u201323. doi: 10.1182/blood-2010-09-306076 .", "journal-title": "Blood"}, {"issue": "6", "key": "391_CR20", "doi-asserted-by": "crossref", "first-page": "700", "DOI": "10.1016/j.clml.2013.05.008", "volume": "13", "author": "E Morra", "year": "2013", "unstructured": "Morra E, Varettoni M, Tedeschi A, Arcaini L, Ricci F, Pascutto C, et al. Associated cancers in Waldenstrom macroglobulinemia: clues for common genetic predisposition. Clin Lymphoma Myeloma Leuk. 2013;13(6):700\u20133. doi: 10.1016/j.clml.2013.05.008 .", "journal-title": "Clin Lymphoma Myeloma Leuk"}, {"issue": "17", "key": "391_CR21", "doi-asserted-by": "crossref", "first-page": "1903", "DOI": "10.1001/archinternmed.2008.4", "volume": "168", "author": "J Koshiol", "year": "2008", "unstructured": "Koshiol J, Gridley G, Engels EA, McMaster ML, Landgren O. Chronic immune stimulation and subsequent Waldenstrom macroglobulinemia. Arch Intern Med. 2008;168(17):1903\u20139. doi: 10.1001/archinternmed.2008.4 .", "journal-title": "Arch Intern Med"}, {"issue": "18", "key": "391_CR22", "doi-asserted-by": "crossref", "first-page": "2010", "DOI": "10.1001/jama.297.18.2010", "volume": "297", "author": "TP Giordano", "year": "2007", "unstructured": "Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007;297(18):2010\u20137. doi: 10.1001/jama.297.18.2010 .", "journal-title": "JAMA"}, {"issue": "8", "key": "391_CR23", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1093/jnci/djq043", "volume": "102", "author": "SY Kristinsson", "year": "2010", "unstructured": "Kristinsson SY, Koshiol J, Bjorkholm M, Goldin LR, McMaster ML, Turesson I, et al. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. J Natl Cancer Inst. 2010;102(8):557\u201367. doi: 10.1093/jnci/djq043 .", "journal-title": "J Natl Cancer Inst"}, {"issue": "4", "key": "391_CR24", "doi-asserted-by": "crossref", "first-page": "649", "DOI": "10.3324/haematol.2012.070458", "volume": "98", "author": "F Nguyen-Khac", "year": "2013", "unstructured": "Nguyen-Khac F, Lambert J, Chapiro E, Grelier A, Mould S, Barin C, et al. Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstrom\u2019s macroglobulinemia. Haematologica. 2013;98(4):649\u201354. doi: 10.3324/haematol.2012.070458 .", "journal-title": "Haematologica"}, {"issue": "5", "key": "391_CR25", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1038/modpathol.2011.213", "volume": "25", "author": "E Braggio", "year": "2012", "unstructured": "Braggio E, Dogan A, Keats JJ, Chng WJ, Huang G, Matthews JM, et al. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. Mod Pathol. 2012;25(5):651\u201360. doi: 10.1038/modpathol.2011.213 .", "journal-title": "Mod Pathol"}, {"issue": "2", "key": "391_CR26", "doi-asserted-by": "crossref", "first-page": "198", "DOI": "10.1016/j.clml.2013.02.015", "volume": "13", "author": "E Braggio", "year": "2013", "unstructured": "Braggio E, Fonseca R. Genomic abnormalities of Waldenstrom macroglobulinemia and related low-grade B-cell lymphomas. Clin Lymphoma Myeloma Leuk. 2013;13(2):198\u2013201. doi: 10.1016/j.clml.2013.02.015 .", "journal-title": "Clin Lymphoma Myeloma Leuk"}, {"issue": "8", "key": "391_CR27", "doi-asserted-by": "crossref", "first-page": "3579", "DOI": "10.1158/0008-5472.CAN-08-3701", "volume": "69", "author": "E Braggio", "year": "2009", "unstructured": "Braggio E, Keats JJ, Leleu X, Van Wier S, Jimenez-Zepeda VH, Valdez R, et al. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom\u2019s macroglobulinemia. Cancer Res. 2009;69(8):3579\u201388. doi: 10.1158/0008-5472.CAN-08-3701 .", "journal-title": "Cancer Res"}, {"issue": "39", "key": "391_CR28", "doi-asserted-by": "crossref", "first-page": "13944", "DOI": "10.1073/pnas.0506654102", "volume": "102", "author": "A Cimmino", "year": "2005", "unstructured": "Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102(39):13944\u20139. doi: 10.1073/pnas.0506654102 .", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "9", "key": "391_CR29", "doi-asserted-by": "crossref", "first-page": "826", "DOI": "10.1056/NEJMoa1200710", "volume": "367", "author": "SP Treon", "year": "2012", "unstructured": "Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. MYD88 L265P somatic mutation in Waldenstrom\u2019s macroglobulinemia. N Engl J Med. 2012;367(9):826\u201333. doi: 10.1056/NEJMoa1200710 . A seminal paper suggesting the presence of MYD88L265P mutation in the vast majority of WM patients.", "journal-title": "N Engl J Med"}, {"issue": "9", "key": "391_CR30", "doi-asserted-by": "crossref", "first-page": "e0136505", "DOI": "10.1371/journal.pone.0136505", "volume": "10", "author": "M Pertesi", "year": "2015", "unstructured": "Pertesi M, Galia P, Nazaret N, Vallee M, Garderet L, Leleu X, et al. Rare circulating cells in familial Waldenstrom macroglobulinemia displaying the MYD88 L265P mutation are enriched by Epstein-Barr virus immortalization. PLoS ONE. 2015;10(9):e0136505. doi: 10.1371/journal.pone.0136505 .", "journal-title": "PLoS ONE"}, {"key": "391_CR31", "doi-asserted-by": "crossref", "first-page": "e183", "DOI": "10.1038/bcj.2014.4", "volume": "4", "author": "SM Ansell", "year": "2014", "unstructured": "Ansell SM, Hodge LS, Secreto FJ, Manske M, Braggio E, Price-Troska T, et al. Activation of TAK1 by MYD88 L265P drives malignant B-cell growth in non-Hodgkin lymphoma. Blood Cancer J. 2014;4:e183. doi: 10.1038/bcj.2014.4 .", "journal-title": "Blood Cancer J"}, {"issue": "13", "key": "391_CR32", "doi-asserted-by": "crossref", "first-page": "2522", "DOI": "10.1182/blood-2012-09-457101", "volume": "121", "author": "M Varettoni", "year": "2013", "unstructured": "Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R, et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom\u2019s macroglobulinemia and related lymphoid neoplasms. Blood. 2013;121(13):2522\u20138. doi: 10.1182/blood-2012-09-457101 .", "journal-title": "Blood"}, {"issue": "11", "key": "391_CR33", "doi-asserted-by": "crossref", "first-page": "1637", "DOI": "10.1182/blood-2013-09-525808", "volume": "123", "author": "ZR Hunter", "year": "2014", "unstructured": "Hunter ZR, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood. 2014;123(11):1637\u201346. doi: 10.1182/blood-2013-09-525808 .", "journal-title": "Blood"}, {"issue": "22", "key": "391_CR34", "doi-asserted-by": "crossref", "first-page": "4504", "DOI": "10.1182/blood-2012-06-436329", "volume": "121", "author": "S Poulain", "year": "2013", "unstructured": "Poulain S, Roumier C, Decambron A, Renneville A, Herbaux C, Bertrand E, et al. MYD88 L265P mutation in Waldenstrom macroglobulinemia. Blood. 2013;121(22):4504\u201311. doi: 10.1182/blood-2012-06-436329 .", "journal-title": "Blood"}, {"issue": "11", "key": "391_CR35", "doi-asserted-by": "crossref", "first-page": "2051", "DOI": "10.1182/blood-2012-09-454355", "volume": "121", "author": "L Xu", "year": "2013", "unstructured": "Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X, et al. MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood. 2013;121(11):2051\u20138. doi: 10.1182/blood-2012-09-454355 .", "journal-title": "Blood"}, {"issue": "23", "key": "391_CR36", "doi-asserted-by": "crossref", "first-page": "2255", "DOI": "10.1056/NEJMc1211959", "volume": "367", "author": "O Landgren", "year": "2012", "unstructured": "Landgren O, Staudt L. MYD88 L265P somatic mutation in IgM MGUS. N Engl J Med. 2012;367(23):2255\u20136. doi: 10.1056/NEJMc1211959#SA1 . author reply 6\u20137.", "journal-title": "N Engl J Med"}, {"issue": "1", "key": "391_CR37", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1038/leu.2012.257", "volume": "27", "author": "N Gachard", "year": "2013", "unstructured": "Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, et al. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia. 2013;27(1):183\u20139. doi: 10.1038/leu.2012.257 .", "journal-title": "Leukemia"}, {"issue": "8", "key": "391_CR38", "doi-asserted-by": "crossref", "first-page": "1722", "DOI": "10.1038/leu.2013.62", "volume": "27", "author": "C Jimenez", "year": "2013", "unstructured": "Jimenez C, Sebastian E, Chillon MC, Giraldo P, Mariano Hernandez J, Escalante F, et al. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom\u2019s macroglobulinemia. Leukemia. 2013;27(8):1722\u20138. doi: 10.1038/leu.2013.62 .", "journal-title": "Leukemia"}, {"issue": "7332", "key": "391_CR39", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1038/nature09671", "volume": "470", "author": "VN Ngo", "year": "2011", "unstructured": "Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature. 2011;470(7332):115\u20139. doi: 10.1038/nature09671 .", "journal-title": "Nature"}, {"issue": "8", "key": "391_CR40", "doi-asserted-by": "crossref", "first-page": "1698", "DOI": "10.1038/leu.2014.65", "volume": "28", "author": "L Xu", "year": "2014", "unstructured": "Xu L, Hunter ZR, Yang G, Cao Y, Liu X, Manning R, et al. Detection of MYD88 L265P in peripheral blood of patients with Waldenstrom\u2019s macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. Leukemia. 2014;28(8):1698\u2013704. doi: 10.1038/leu.2014.65 .", "journal-title": "Leukemia"}, {"issue": "18", "key": "391_CR41", "doi-asserted-by": "crossref", "first-page": "2791", "DOI": "10.1182/blood-2014-01-550905", "volume": "123", "author": "SP Treon", "year": "2014", "unstructured": "Treon SP, Cao Y, Xu L, Yang G, Liu X, Hunter ZR. Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia. Blood. 2014;123(18):2791\u20136. doi: 10.1182/blood-2014-01-550905 .", "journal-title": "Blood"}, {"key": "391_CR42", "unstructured": "Xu L, Hunter Z, Tsakmaklis N, Cao Y, Yang G, Chen J et al. The clonal architecture of CXCR4 mutations in Waldenstrom\u2019s macroglobulinemia shows highly variable subclonal distribution, and multiple mutations within individual patients indicative of targeted genomic instability. ASH Annual Meeting December 5, 20152015."}, {"issue": "1", "key": "391_CR43", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1182/blood-2007-12-129395", "volume": "112", "author": "HT Ngo", "year": "2008", "unstructured": "Ngo HT, Leleu X, Lee J, Jia X, Melhem M, Runnels J, et al. SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia. Blood. 2008;112(1):150\u20138. doi: 10.1182/blood-2007-12-129395 .", "journal-title": "Blood"}, {"issue": "6", "key": "391_CR44", "doi-asserted-by": "crossref", "first-page": "795", "DOI": "10.1111/bjh.13361", "volume": "169", "author": "J Schmidt", "year": "2015", "unstructured": "Schmidt J, Federmann B, Schindler N, Steinhilber J, Bonzheim I, Fend F, et al. MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity. Br J Haematol. 2015;169(6):795\u2013803. doi: 10.1111/bjh.13361 .", "journal-title": "Br J Haematol"}, {"issue": "5", "key": "391_CR45", "doi-asserted-by": "crossref", "first-page": "701", "DOI": "10.1111/bjh.13200", "volume": "168", "author": "Y Cao", "year": "2015", "unstructured": "Cao Y, Hunter ZR, Liu X, Xu L, Yang G, Chen J, et al. CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenstrom macroglobulinaemia cells. Br J Haematol. 2015;168(5):701\u20137. doi: 10.1111/bjh.13200 .", "journal-title": "Br J Haematol"}, {"issue": "26", "key": "391_CR46", "doi-asserted-by": "crossref", "first-page": "4120", "DOI": "10.1182/blood-2014-03-564583", "volume": "123", "author": "AM Roccaro", "year": "2014", "unstructured": "Roccaro AM, Sacco A, Jimenez C, Maiso P, Moschetta M, Mishima Y, et al. C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma. Blood. 2014;123(26):4120\u201331. doi: 10.1182/blood-2014-03-564583 .", "journal-title": "Blood"}, {"issue": "15", "key": "391_CR47", "doi-asserted-by": "crossref", "first-page": "1430", "DOI": "10.1056/NEJMoa1501548", "volume": "372", "author": "SP Treon", "year": "2015", "unstructured": "Treon SP, Tripsas CK, Meid K, Warren D, Varma G, Green R, et al. Ibrutinib in previously treated Waldenstrom\u2019s macroglobulinemia. N Engl J Med. 2015;372(15):1430\u201340. doi: 10.1056/NEJMoa1501548 . A report suggesting the activity of Ibrutinib in WM patients leading to its approval for WM.", "journal-title": "N Engl J Med"}, {"issue": "5", "key": "391_CR48", "doi-asserted-by": "crossref", "first-page": "1155", "DOI": "10.1158/1535-7163.MCT-13-0410", "volume": "13", "author": "K Beider", "year": "2014", "unstructured": "Beider K, Darash-Yahana M, Blaier O, Koren-Michowitz M, Abraham M, Wald H, et al. Combination of Imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivo. Mol Cancer Ther. 2014;13(5):1155\u201369. doi: 10.1158/1535-7163.mct-13-0410 .", "journal-title": "Mol Cancer Ther"}, {"issue": "19", "key": "391_CR49", "doi-asserted-by": "crossref", "first-page": "4278", "DOI": "10.1158/1078-0432.CCR-14-0914", "volume": "21", "author": "S Scala", "year": "2015", "unstructured": "Scala S. Molecular pathways: targeting the CXCR4-CXCL12 axis-untapped potential in the tumor microenvironment. Clin Cancer Res. 2015;21(19):4278\u201385. doi: 10.1158/1078-0432.CCR-14-0914 .", "journal-title": "Clin Cancer Res"}, {"issue": "13", "key": "391_CR50", "doi-asserted-by": "crossref", "first-page": "2174", "DOI": "10.1182/blood-2015-01-622068", "volume": "125", "author": "V Steingrimsson", "year": "2015", "unstructured": "Steingrimsson V, Lund SH, Turesson I, Goldin LR, Bjorkholm M, Landgren O, et al. Population-based study on the impact of the familial form of Waldenstrom macroglobulinemia on overall survival. Blood. 2015;125(13):2174\u20135. doi: 10.1182/blood-2015-01-622068 .", "journal-title": "Blood"}, {"issue": "3", "key": "391_CR51", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1159/000335618", "volume": "127", "author": "SY Kristinsson", "year": "2012", "unstructured": "Kristinsson SY, Goldin LR, Turesson I, Bjorkholm M, Landgren O. Familial aggregation of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia with solid tumors and myeloid malignancies. Acta Haematol. 2012;127(3):173\u20137. doi: 10.1159/000335618 .", "journal-title": "Acta Haematol"}, {"issue": "6", "key": "391_CR52", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1016/j.clml.2012.08.006", "volume": "12", "author": "SP Treon", "year": "2012", "unstructured": "Treon SP, Tripsas C, Hanzis C, Ioakimidis L, Patterson CJ, Manning RJ, et al. Familial disease predisposition impacts treatment outcome in patients with Waldenstrom macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2012;12(6):433\u20137. doi: 10.1016/j.clml.2012.08.006 . One of the few studies highlighting the clinical and therapeutic implications of a diagnosis of familial WM.", "journal-title": "Clin Lymphoma Myeloma Leuk"}, {"issue": "6", "key": "391_CR53", "doi-asserted-by": "crossref", "first-page": "584", "DOI": "10.1056/NEJMc1506192", "volume": "373", "author": "SP Treon", "year": "2015", "unstructured": "Treon SP, Xu L, Treon SP, Xu L, Hunter Z. MYD88 mutations and response to ibrutinib in Waldenstrom\u2019s macroglobulinemia. N Engl J Med. 2015;373(6):584\u20136.", "journal-title": "N Engl J Med"}, {"key": "391_CR54", "unstructured": "Dimopoulos M, Trotman J, Tedeschi A, Matous J, Macdonald D, Tam C et al. Ibrutinib therapy in rituximab-refractory patients with Waldenstr\u00f6m\u2019s macroglobulinemia: initial results from an international, multicenter, open-label phase 3 substudy (iNNOVATE). ASH Annual Meeting; December 6, 20152015."}, {"issue": "13", "key": "391_CR55", "doi-asserted-by": "crossref", "first-page": "4417", "DOI": "10.1182/blood-2007-05-092098", "volume": "110", "author": "X Leleu", "year": "2007", "unstructured": "Leleu X, Jia X, Runnels J, Ngo HT, Moreau AS, Farag M, et al. The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia. Blood. 2007;110(13):4417\u201326. doi: 10.1182/blood-2007-05-092098 .", "journal-title": "Blood"}, {"issue": "1", "key": "391_CR56", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1111/bjh.13278", "volume": "170", "author": "Y Cao", "year": "2015", "unstructured": "Cao Y, Yang G, Hunter ZR, Liu X, Xu L, Chen J, et al. The BCL2 antagonist ABT-199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4 wild-type and CXCR4 WHIM mutated Waldenstrom macroglobulinaemia cells. Br J Haematol. 2015;170(1):134\u20138. doi: 10.1111/bjh.13278 .", "journal-title": "Br J Haematol"}, {"key": "391_CR57", "doi-asserted-by": "crossref", "first-page": "5s", "DOI": "10.1200/JCO.2013.49.4757", "volume": "32", "author": "M Davids", "year": "2014", "unstructured": "Davids M, Seymour J, Gerecitano J, Kahl B, Pagel J, Wierda W, et al. Phase I study of ABT-199 (GDC-0199) in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL): responses observed in diffuse large B-cell (DLBCL) and follicular lymphoma (FL) at higher cohort doses. J Clin Oncol. 2014;32:5s. suppl; abstr 8522.", "journal-title": "J Clin Oncol"}, {"issue": "11", "key": "391_CR58", "doi-asserted-by": "crossref", "first-page": "1008", "DOI": "10.1056/NEJMoa1314583", "volume": "370", "author": "AK Gopal", "year": "2014", "unstructured": "Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ, et al. PI3Kdelta inhibition by idelalisib in patients with relapsed indolent lymphoma. N Engl J Med. 2014;370(11):1008\u201318. doi: 10.1056/NEJMoa1314583 .", "journal-title": "N Engl J Med"}, {"issue": "3", "key": "391_CR59", "doi-asserted-by": "crossref", "first-page": "559", "DOI": "10.1182/blood-2009-07-235747", "volume": "115", "author": "AM Roccaro", "year": "2010", "unstructured": "Roccaro AM, Sacco A, Husu EN, Pitsillides C, Vesole S, Azab AK, et al. Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia. Blood. 2010;115(3):559\u201369. doi: 10.1182/blood-2009-07-235747 .", "journal-title": "Blood"}, {"issue": "23", "key": "391_CR60", "first-page": "1540", "volume": "126", "author": "SK Thomas", "year": "2015", "unstructured": "Thomas SK, Harb WA, Beck JT, Nashat G, Palomba ML, Ansell SM, et al. Preliminary results from a phase 1/2, open-label, dose-escalation clinical trial of IMO-8400 in patients with relapsed or refractory Waldenstrom\u2019s macroglobulinemia. Blood. 2015;126(23):1540.", "journal-title": "Blood"}, {"issue": "11", "key": "391_CR61", "doi-asserted-by": "crossref", "first-page": "1392", "DOI": "10.1182/blood-2015-05-647420", "volume": "126", "author": "E Kastritis", "year": "2015", "unstructured": "Kastritis E, Gavriatopoulou M, Kyrtsonis MC, Roussou M, Hadjiharissi E, Symeonidis A, et al. Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenstrom macroglobulinemia: final analysis of a phase 2 study. Blood. 2015;126(11):1392\u20134. doi: 10.1182/blood-2015-05-647420 . An updated analysis of a phase 2 trial of DRC, a commonly used regimen, as initial therapy for WM patients.", "journal-title": "Blood"}, {"issue": "4", "key": "391_CR62", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1182/blood-2014-03-566273", "volume": "124", "author": "SP Treon", "year": "2014", "unstructured": "Treon SP, Tripsas CK, Meid K, Kanan S, Sheehy P, Chuma S, et al. Carfilzomib, rituximab, and Dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenstrom\u2019s macroglobulinemia. Blood. 2014;124(4):503\u201310. doi: 10.1182/blood-2014-03-566273 .", "journal-title": "Blood"}, {"issue": "1", "key": "391_CR63", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.3109/10428194.2014.911869", "volume": "56", "author": "I Herth", "year": "2015", "unstructured": "Herth I, Hensel M, Rieger M, Horstmann K, Hiddemann W, Dreyling M, et al. Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenstrom\u2019s macroglobulinemia. Leuk Lymphoma. 2015;56(1):97\u2013102. doi: 10.3109/10428194.2014.911869 .", "journal-title": "Leuk Lymphoma"}, {"issue": "3", "key": "391_CR64", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1002/ajh.23620", "volume": "89", "author": "IM Ghobrial", "year": "2014", "unstructured": "Ghobrial IM, Witzig TE, Gertz M, LaPlant B, Hayman S, Camoriano J, et al. Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom macroglobulinemia. Am J Hematol. 2014;89(3):237\u201342. doi: 10.1002/ajh.23620 .", "journal-title": "Am J Hematol"}, {"issue": "5", "key": "391_CR65", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1016/j.clml.2013.04.006", "volume": "13", "author": "M Bishton", "year": "2013", "unstructured": "Bishton M, Spencer A, Dickinson M, Ritchie D. A single-arm, phase II study of the anti-blys monoclonal antibody belimumab in symptomatic Waldenstrom macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2013;13(5):575\u20138. doi: 10.1016/j.clml.2013.04.006 .", "journal-title": "Clin Lymphoma Myeloma Leuk"}, {"issue": "2", "key": "391_CR66", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1016/j.clml.2013.02.011", "volume": "13", "author": "A Tedeschi", "year": "2013", "unstructured": "Tedeschi A, Ricci F, Goldaniga MC, Benevolo G, Varettoni M, Motta M, et al. Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenstrom\u2019s macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2013;13(2):231\u20134. doi: 10.1016/j.clml.2013.02.011 .", "journal-title": "Clin Lymphoma Myeloma Leuk"}, {"issue": "8", "key": "391_CR67", "doi-asserted-by": "crossref", "first-page": "1296", "DOI": "10.1182/blood-2012-06-439307", "volume": "121", "author": "IM Ghobrial", "year": "2013", "unstructured": "Ghobrial IM, Campigotto F, Murphy TJ, Boswell EN, Banwait R, Azab F, et al. Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia. Blood. 2013;121(8):1296\u2013303. doi: 10.1182/blood-2012-06-439307 .", "journal-title": "Blood"}, {"issue": "3", "key": "391_CR68", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1200/JCO.2012.44.7920", "volume": "31", "author": "V Leblond", "year": "2013", "unstructured": "Leblond V, Johnson S, Chevret S, Copplestone A, Rule S, Tournilhac O, et al. Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenstrom macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma. J Clin Oncol. 2013;31(3):301\u20137. doi: 10.1200/JCO.2012.44.7920 .", "journal-title": "J Clin Oncol"}, {"issue": "9873", "key": "391_CR69", "doi-asserted-by": "crossref", "first-page": "1203", "DOI": "10.1016/S0140-6736(12)61763-2", "volume": "381", "author": "MJ Rummel", "year": "2013", "unstructured": "Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grunhagen U, Losem C, et al. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet. 2013;381(9873):1203\u201310. doi: 10.1016/S0140-6736(12)61763-2 . One of the few randomized, phase 3 studies reporting on the excellent PFS in WM with bendamustine and rituximab in frontline setting compared to R-CHOP regimen.", "journal-title": "Lancet"}], "container-title": ["Current Treatment Options in Oncology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s11864-016-0391-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s11864-016-0391-7/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11864-016-0391-7", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 1]], "date-time": "2019-06-01T23:34:32Z", "timestamp": 1559432072000}, "score": 28.481989, "issued": {"date-parts": [[2016, 3]]}, "references-count": 69, "journal-issue": {"published-print": {"date-parts": [[2016, 3]]}, "issue": "3"}, "alternative-id": ["391"], "URL": "http://dx.doi.org/10.1007/s11864-016-0391-7", "relation": {"cites": []}, "ISSN": ["1527-2729", "1534-6277"], "issn-type": [{"value": "1527-2729", "type": "print"}, {"value": "1534-6277", "type": "electronic"}], "article-number": "16"}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T21:22:01Z", "timestamp": 1574716921427}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2015, 8, 1]]}, "DOI": "10.1158/1538-7445.am2015-3709", "type": "proceedings-article", "created": {"date-parts": [[2015, 8, 5]], "date-time": "2015-08-05T01:32:43Z", "timestamp": 1438738363000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 3709: Second cancers following Waldenstr\u00f6m macroglobulinemia/lymphoplasmacytic lymphoma in the United States: analysis of Surveillance, Epidemiology and End Results (SEER) registry data, 1992 - 2011"], "prefix": "10.1158", "author": [{"given": "Mary L.", "family": "McMaster", "sequence": "first", "affiliation": []}, {"given": "Lynn R.", "family": "Goldin", "sequence": "additional", "affiliation": []}, {"given": "Neil E.", "family": "Caporaso", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2015, 8, 2]]}, "event": {"name": "Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA"}, "container-title": ["Epidemiology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2015-3709", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T21:01:06Z", "timestamp": 1558213266000}, "score": 28.337791, "issued": {"date-parts": [[2015, 8, 1]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2015-3709"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2015-3709"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T17:40:19Z", "timestamp": 1575308419397}, "reference-count": 0, "publisher": "American Medical Association (AMA)", "issue": "17", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arch Intern Med"], "published-print": {"date-parts": [[2008, 9, 22]]}, "DOI": "10.1001/archinternmed.2008.4", "type": "journal-article", "created": {"date-parts": [[2008, 9, 22]], "date-time": "2008-09-22T20:18:09Z", "timestamp": 1222114689000}, "page": "1903", "source": "Crossref", "is-referenced-by-count": 34, "title": ["Chronic Immune Stimulation and Subsequent Waldenstr\u00f6m Macroglobulinemia"], "prefix": "10.1001", "volume": "168", "author": [{"given": "Jill", "family": "Koshiol", "sequence": "first", "affiliation": []}, {"given": "Gloria", "family": "Gridley", "sequence": "additional", "affiliation": []}, {"given": "Eric A.", "family": "Engels", "sequence": "additional", "affiliation": []}, {"given": "Mary L.", "family": "McMaster", "sequence": "additional", "affiliation": []}, {"given": "Ola", "family": "Landgren", "sequence": "additional", "affiliation": []}], "member": "10", "container-title": ["Archives of Internal Medicine"], "language": "en", "link": [{"URL": "http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/414490", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 17]], "date-time": "2016-12-17T04:14:16Z", "timestamp": 1481948056000}, "score": 26.454433, "issued": {"date-parts": [[2008, 9, 22]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008, 9, 22]]}, "issue": "17"}, "URL": "http://dx.doi.org/10.1001/archinternmed.2008.4", "ISSN": ["0003-9926"], "issn-type": [{"value": "0003-9926", "type": "print"}], "subject": ["Internal Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T18:13:04Z", "timestamp": 1574705584660}, "publisher-location": "Cham", "reference-count": 44, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319225838", "type": "print"}, {"value": "9783319225845", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 10, 7]], "date-time": "2016-10-07T00:00:00Z", "timestamp": 1475798400000}, "delay-in-days": 0, "content-version": "unspecified"}, {"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 10, 7]], "date-time": "2016-10-07T00:00:00Z", "timestamp": 1475798400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2017]]}, "DOI": "10.1007/978-3-319-22584-5_3", "type": "book-chapter", "created": {"date-parts": [[2016, 10, 6]], "date-time": "2016-10-06T06:25:38Z", "timestamp": 1475735138000}, "page": "35-48", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Predispositions and Origins of Waldenstrom Macroglobulinemia: Implications from Genetic Analysis"], "prefix": "10.1007", "author": [{"given": "Linda M.", "family": "Pilarski", "sequence": "first", "affiliation": []}, {"given": "Jitra", "family": "Kriangkum", "sequence": "additional", "affiliation": []}, {"given": "Sophia", "family": "Adamia", "sequence": "additional", "affiliation": []}, {"given": "Helga M.", "family": "Ogmundsdottir", "sequence": "additional", "affiliation": []}, {"given": "Andrew R.", "family": "Belch", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 10, 7]]}, "reference": [{"issue": "3", "key": "3_CR1", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1159/000335618", "volume": "127", "author": "SY Kristinsson", "year": "2012", "unstructured": "Kristinsson SY, Goldin LR, Turesson I, Bjorkholm M, Landgren O. Familial aggregation of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia with solid tumors and myeloid malignancies. Acta Haematol. 2012;127(3):173\u20137.", "journal-title": "Acta Haematol"}, {"issue": "4", "key": "3_CR2", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1182/blood-2008-12-191676", "volume": "114", "author": "O Landgren", "year": "2009", "unstructured": "Landgren O, Kristinsson SY, Goldin LR, Caporaso NE, Blimark C, Mellqvist UH, Wahlin A, Bjorkholm M, Turesson I. Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood. 2009;114(4):791\u20135.", "journal-title": "Blood"}, {"issue": "2", "key": "3_CR3", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1053/sonc.2003.50061", "volume": "30", "author": "J Kriangkum", "year": "2003", "unstructured": "Kriangkum J, Taylor BJ, Mant MJ, Treon SP, Belch AR, Pilarski LM. The malignant clone in Waldenstrom\u2019s macroglobulinemia. Semin Oncol. 2003;30(2):132\u20135.", "journal-title": "Semin Oncol"}, {"issue": "7", "key": "3_CR4", "doi-asserted-by": "crossref", "first-page": "2920", "DOI": "10.1182/blood-2005-09-3613", "volume": "107", "author": "J Kriangkum", "year": "2006", "unstructured": "Kriangkum J, Taylor BJ, Strachan E, Mant MJ, Reiman T, Belch AR, Pilarski LM. Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery. Blood. 2006;107(7):2920\u20137.", "journal-title": "Blood"}, {"key": "3_CR5", "doi-asserted-by": "crossref", "first-page": "2134", "DOI": "10.1182/blood-2003-11-4024", "volume": "104", "author": "J Kriangkum", "year": "2004", "unstructured": "Kriangkum J, Taylor BJ, Treon SP, Mant MJ, Belch AR, Pilarski LM. Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood. Blood. 2004;104:2134\u201342.", "journal-title": "Blood"}, {"issue": "4", "key": "3_CR6", "first-page": "1505", "volume": "100", "author": "SS Sahota", "year": "2002", "unstructured": "Sahota SS, Forconi F, Ottensmeier CH, Provan D, Oscier DG, Hamblin TJ, Stevenson FK. Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood. 2002;100(4):1505\u20137.", "journal-title": "Blood"}, {"issue": "7", "key": "3_CR7", "doi-asserted-by": "crossref", "first-page": "2005", "DOI": "10.1158/1078-0432.CCR-06-2788", "volume": "13", "author": "J Kriangkum", "year": "2007", "unstructured": "Kriangkum J, Taylor BJ, Treon SP, Mant MJ, Reiman T, Belch AR, Pilarski LM. Molecular characterization of Waldenstrom\u2019s macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences. Clin Cancer Res. 2007;13(7):2005\u201313.", "journal-title": "Clin Cancer Res"}, {"key": "3_CR8", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1002/ajh.2830370106", "volume": "37", "author": "GS Jensen", "year": "1991", "unstructured": "Jensen GS, Andrews EJ, Mant MJ, Vergidis R, Ledbetter JA, Pilarski LM. Transitions in CD45 isoform expression indicate continuous differentiation of a monoclonal CD5+CD11b+ B lineage in Waldenstrom\u2019s macroglobulinemia. Am J Hematol. 1991;37:20\u201330.", "journal-title": "Am J Hematol"}, {"issue": "2", "key": "3_CR9", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.3109/10428194.2010.535183", "volume": "52", "author": "J Kirshner", "year": "2011", "unstructured": "Kirshner J, Thulien KJ, Kriangkum J, Motz S, Belch AR, Pilarski LM. In a patient with biclonal Waldenstrom macroglobulinemia only one clone expands in three-dimensional culture and includes putative cancer stem cells. Leuk Lymphoma. 2011;52(2):285\u20139.", "journal-title": "Leuk Lymphoma"}, {"issue": "4", "key": "3_CR10", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.3816/CLM.2005.n.002", "volume": "5", "author": "J Kriangkum", "year": "2005", "unstructured": "Kriangkum J, Taylor BJ, Reiman T, Belch AR, Pilarski LM. Origins of Waldenstrom\u2019s macroglobulinemia: does it arise from an unusual B-cell precursor? Clin Lymphoma. 2005;5(4):217\u20139.", "journal-title": "Clin Lymphoma"}, {"key": "3_CR11", "author": "J Kriangkum", "volume": "8", "year": "2013", "unstructured": "Kriangkum J, Motz S, Debes Marun CS, Lafarge ST, Gibson SB, Venner CP, Johnston JB, Belch AR, Pilarski LM. Frequent occurrence of highly expanded but unrelated B-cell clones in patients with multiple myeloma. PLoS One. 2013;8, e649927.", "journal-title": "PLoS One", "DOI": "10.1371/annotation/9984da27-0e7f-4c7f-bcd3-bef1a4c0be87", "doi-asserted-by": "crossref"}, {"issue": "5363", "key": "3_CR12", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1038/238339a0", "volume": "238", "author": "BA Askonas", "year": "1972", "unstructured": "Askonas BA, Williamson AR. Dominance of a cell clone forming antibody to DNP. Nature. 1972;238(5363):339\u201341.", "journal-title": "Nature"}, {"issue": "5363", "key": "3_CR13", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1038/238337a0", "volume": "238", "author": "AR Williamson", "year": "1972", "unstructured": "Williamson AR, Askonas BA. Senescence of an antibody-forming cell clone. Nature. 1972;238(5363):337\u20139.", "journal-title": "Nature"}, {"key": "3_CR14", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.13032/tjop.2052-5931.100005", "volume": "1", "author": "LM Pilarski", "year": "2013", "unstructured": "Pilarski LM, Debes-Marun CS, Martin LD, Venner CP, Pilarski PM, Belch AR. B lymphocytes as cancer stem cells in multiple myeloma. J Oncopathol. 2013;1:10\u201321.", "journal-title": "J Oncopathol"}, {"issue": "9", "key": "3_CR15", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pone.0137232", "volume": "10", "author": "J Kriangkum", "year": "2015", "unstructured": "Kriangkum J, Motz SN, Mack T, Beiggi S, Baigorri E, Kuppusamy H, Belch AR, Johnston JB, Pilarski LM. Single-cell analysis and next-generation immuno-sequencing show that multiple clones persist in patients with chronic lymphocytic leukemia. PLoS One. 2015;10(9), e0137232. doi:\n10.1371/journal.pone.0137232\n\n.", "journal-title": "PLoS One"}, {"issue": "2", "key": "3_CR16", "doi-asserted-by": "crossref", "first-page": "250", "DOI": "10.1200/JCO.2007.15.1530", "volume": "27", "author": "X Leleu", "year": "2009", "unstructured": "Leleu X, Soumerai J, Roccaro A, Hatjiharissi E, Hunter ZR, Manning R, Ciccarelli BT, Sacco A, Ioakimidis L, Adamia S, Moreau AS, Patterson CJ, Ghobrial IM, Treon SP. Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenstrom macroglobulinemia treated with nucleoside analogs. J Clin Oncol. 2009;27(2):250\u20135.", "journal-title": "J Clin Oncol"}, {"issue": "9", "key": "3_CR17", "doi-asserted-by": "crossref", "first-page": "2640", "DOI": "10.1182/blood.V98.9.2640", "volume": "98", "author": "V Leblond", "year": "2001", "unstructured": "Leblond V, Levy V, Maloisel F, Cazin B, Fermand JP, Harousseau JL, Remenieras L, Porcher R, Gardembas M, Marit G, Deconinck E, Desablens B, Guilhot F, Philippe G, Stamatoullas A, Guibon O. Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenstrom macroglobulinemia in first relapse or with primary refractory disease. Blood. 2001;98(9):2640\u20134.", "journal-title": "Blood"}, {"issue": "2", "key": "3_CR18", "doi-asserted-by": "crossref", "first-page": "542", "DOI": "10.1093/annonc/mdr537", "volume": "23", "author": "RP Ojha", "year": "2012", "unstructured": "Ojha RP, Thertulien R. Second malignancies among Waldenstrom macroglobulinemia patients: small samples and sparse data. Ann Oncol. 2012;23(2):542\u20133.", "journal-title": "Ann Oncol"}, {"issue": "6", "key": "3_CR19", "doi-asserted-by": "crossref", "first-page": "700", "DOI": "10.1016/j.clml.2013.05.008", "volume": "13", "author": "E Morra", "year": "2013", "unstructured": "Morra E, Varettoni M, Tedeschi A, Arcaini L, Ricci F, Pascutto C, Rattotti S, Vismara E, Paris L, Cazzola M. Associated cancers in Waldenstrom macroglobulinemia: clues for common genetic predisposition. Clin Lymphoma Myeloma Leuk. 2013;13(6):700\u20133.", "journal-title": "Clin Lymphoma Myeloma Leuk"}, {"issue": "3", "key": "3_CR20", "first-page": "268", "volume": "88", "author": "N Stavroyianni", "year": "2003", "unstructured": "Stavroyianni N, Belessi C, Stamatopoulos K, Kosmas C, Paterakis G, Abazis D, Pangalos C, Yataganas X. Expression of recombination activating genes-1 and-2 immunoglobulin heavy chain gene rearrangements in acute myeloid leukemia: evaluation of biological and clinical significance in a series of 76 uniformly treated patients and review of the literature. Haematologica. 2003;88(3):268\u201374.", "journal-title": "Haematologica"}, {"issue": "1", "key": "3_CR21", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.3816/CLM.2009.n.006", "volume": "9", "author": "S Adamia", "year": "2009", "unstructured": "Adamia S, Pilarski PM, Belch AR, Pilarski LM. Genetic abnormalities in Waldenstrom\u2019s macroglobulinemia. Clin Lymphoma Myeloma. 2009;9(1):30\u20132.", "journal-title": "Clin Lymphoma Myeloma"}, {"key": "3_CR22", "doi-asserted-by": "crossref", "first-page": "5111", "DOI": "10.1182/blood-2008-02-141770", "volume": "112", "author": "S Adamia", "year": "2008", "unstructured": "Adamia S, Reichert A, Kuppusamy H, Kriangkum J, Ghosh A, Hodges J, Pilarski PM, Treon SP, Mant MJ, Reiman T, Belch AR, Pilarski LM. Inherited and acquired mutations in the hyaluronan synthase-1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom\u2019s macroglobulinemia. Blood. 2008;112:5111\u201321.", "journal-title": "Blood"}, {"issue": "6", "key": "3_CR23", "doi-asserted-by": "crossref", "DOI": "10.1371/journal.pone.0100691", "volume": "9", "author": "H Kuppusamy", "year": "2014", "unstructured": "Kuppusamy H, Ogmundsdottir HM, Baigorri E, Warkentin A, Steingrimsdottir H, Haraldsdottir V, Mant MJ, Mackey J, Johnston JB, Adamia S, Belch AR, Pilarski LM. Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer. PLoS One. 2014;9(6), e100691.", "journal-title": "PLoS One"}, {"issue": "9", "key": "3_CR24", "doi-asserted-by": "crossref", "first-page": "826", "DOI": "10.1056/NEJMoa1200710", "volume": "367", "author": "SP Treon", "year": "2012", "unstructured": "Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR. MYD88 L265P somatic mutation in Waldenstrom\u2019s macroglobulinemia. N Engl J Med. 2012;367(9):826\u201333.", "journal-title": "N Engl J Med"}, {"issue": "1", "key": "3_CR25", "first-page": "66", "volume": "90", "author": "HM Ogmundsdottir", "year": "2005", "unstructured": "Ogmundsdottir HM, Haraldsdottirm V, Johannesson GM, Olafsdottir G, Bjarnadottir K, Sigvaldason H, Tulinius H. Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families. Haematologica. 2005;90(1):66\u201371.", "journal-title": "Haematologica"}, {"issue": "2", "key": "3_CR26", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1111/j.1365-3083.1994.tb03450.x", "volume": "40", "author": "HM Ogmundsdottir", "year": "1994", "unstructured": "Ogmundsdottir HM, Johannesson GM, Sveinsdottir S, Einarsdottir S, Hegeman A, Jensson O, Ogsmundsdottir HM. Familial macroglobulinaemia: hyperactive B-cells but normal natural killer function. Scand J Immunol. 1994;40(2):195\u2013200.", "journal-title": "Scand J Immunol"}, {"issue": "5", "key": "3_CR27", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.3324/haematol.2008.003632", "volume": "94", "author": "LR Goldin", "year": "2009", "unstructured": "Goldin LR, Bjorkholm M, Kristinsson SY, Turesson I, Landgren O. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin\u2019s lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica. 2009;94(5):647\u201353.", "journal-title": "Haematologica"}, {"issue": "2", "key": "3_CR28", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1053/sonc.2003.50042", "volume": "30", "author": "S Adamia", "year": "2003", "unstructured": "Adamia S, Crainie M, Kriangkum J, Mant MJ, Belch AR, Pilarski LM. Abnormal expression of hyaluronan synthases in patients with Waldenstrom\u2019s macroglobulinemia. Semin Oncol. 2003;30(2):165\u20138.", "journal-title": "Semin Oncol"}, {"issue": "4", "key": "3_CR29", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.2174/1568009611313040001", "volume": "13", "author": "S Adamia", "year": "2013", "unstructured": "Adamia S, Pilarski PM, Belch AR, Pilarski LM. Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targets. Curr Cancer Drug Targets. 2013;13(4):347\u201361.", "journal-title": "Curr Cancer Drug Targets"}, {"key": "3_CR30", "doi-asserted-by": "crossref", "first-page": "4836", "DOI": "10.1182/blood-2004-10-3825", "volume": "105", "author": "S Adamia", "year": "2005", "unstructured": "Adamia S, Reiman T, Crainie M, Mant MJ, Belch A, Pilarski LM. Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma. Blood. 2005;105:4836\u201344.", "journal-title": "Blood"}, {"issue": "28", "key": "3_CR31", "doi-asserted-by": "crossref", "first-page": "18840", "DOI": "10.1074/jbc.M109.013813", "volume": "284", "author": "A Ghosh", "year": "2009", "unstructured": "Ghosh A, Kuppusamy H, Pilarski LM. Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer. J Biol Chem. 2009;284(28):18840\u201350.", "journal-title": "J Biol Chem"}, {"key": "3_CR32", "first-page": "329", "volume-title": "Hyaluronan structure, metabolism, biological activities, therapeutic applications", "author": "LM Pilarski", "year": "2005", "unstructured": "Pilarski LM, Adamia S, Maxwell CA, Pilarski PM, Reiman T, Belch AR. Hyaluronan synthases and RHAMM as synergistic mediators of malignancy in B lineage cancers. In: Balazs EA, Hascall VC, editors. Hyaluronan structure, metabolism, biological activities, therapeutic applications. 1st ed. Edgewater, NJ: Matrix Biology Institute; 2005. p. 329\u201338.", "edition": "1"}, {"issue": "5", "key": "3_CR33", "first-page": "1891", "volume": "87", "author": "A Masellis-Smith", "year": "1996", "unstructured": "Masellis-Smith A, Belch AR, Mant MJ, Turley EA, Pilarski LM. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Blood. 1996;87(5):1891\u20139.", "journal-title": "Blood"}, {"key": "3_CR34", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.3816/CLM.2005.n.010", "volume": "5", "author": "S Adamia", "year": "2005", "unstructured": "Adamia S, Treon SP, Reiman T, Tournilhac O, McQuarrie C, Mant MJ, Belch AR, Pilarski LM. Single nucleotide polymorphism of hyaluronan synthase 1 gene and aberrant splicing in Waldenstroms macroglobulinemia. Clin Lymphoma. 2005;5:253\u20136.", "journal-title": "Clin Lymphoma"}, {"issue": "1", "key": "3_CR35", "doi-asserted-by": "crossref", "DOI": "10.1371/journal.pone.0053469", "volume": "8", "author": "J Kriangkum", "year": "2013", "unstructured": "Kriangkum J, Warkentin A, Belch AR, Pilarski LM. Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert pre-mRNA splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes. PLoS One. 2013;8(1), e53469.", "journal-title": "PLoS One"}, {"key": "3_CR36", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1158/1078-0432.CCR-13-0956", "volume": "20", "author": "S Adamia", "year": "2014", "unstructured": "Adamia S, Haibe-Kains B, Pilarski PM, Bar-Natan M, Pevzner S, vet-Loiseau H, Lode L, Verselis S, Fox EA, Burke J, Galinsky I, gogo-Jack I, Wadleigh M, Steensma DP, Motyckova G, Deangelo DJ, Quackenbush J, Stone R, Griffin JD. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets. Clin Cancer Res. 2014;20:1\u201311.", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "3_CR37", "doi-asserted-by": "crossref", "first-page": "260", "DOI": "10.1182/blood-2012-09-399725", "volume": "121", "author": "M Cazzola", "year": "2013", "unstructured": "Cazzola M, Rossi M, Malcovati L. Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms. Blood. 2013;121(2):260\u20139.", "journal-title": "Blood"}, {"issue": "23", "key": "3_CR38", "doi-asserted-by": "crossref", "first-page": "4627", "DOI": "10.1182/blood-2013-02-427641", "volume": "121", "author": "Y Wan", "year": "2013", "unstructured": "Wan Y, Wu CJ. SF3B1 mutations in chronic lymphocytic leukemia. Blood. 2013;121(23):4627\u201334.", "journal-title": "Blood"}, {"issue": "24", "key": "3_CR39", "doi-asserted-by": "crossref", "first-page": "4831", "DOI": "10.1093/hmg/ddr422", "volume": "20", "author": "K Wilkins", "year": "2011", "unstructured": "Wilkins K, LaFramboise T. Losing balance: Hardy-Weinberg disequilibrium as a marker for recurrent loss-of-heterozygosity in cancer. Hum Mol Genet. 2011;20(24):4831\u20139.", "journal-title": "Hum Mol Genet"}, {"key": "3_CR40", "first-page": "3930", "volume": "118", "author": "LM Pilarski", "year": "2011", "unstructured": "Pilarski LM, Kuppusamy H, Kriangkum J, Warkentin A, Ghosh S, Gibson S, Steingrimsdottir H, Haraldsdottir V, Johnston JB, Ogmundsdottir HM, Belch AR. Functional and familial risk of B lineage malignancies in patients carrying single nucleotide polymorphisms (SNPs) in the hyaluronan synthase 1 gene (HAS1). Blood. 2011;118:3930.", "journal-title": "Blood"}, {"key": "3_CR41", "doi-asserted-by": "crossref", "first-page": "2262", "DOI": "10.1091/mbc.E02-07-0377", "volume": "14", "author": "CA Maxwell", "year": "2003", "unstructured": "Maxwell CA, Keats JJ, Crainie M, Sun X, Yen T, Shibuya E, Hendzel M, Chan G, Pilarski LM. RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. Mol Biol Cell. 2003;14:2262\u201376.", "journal-title": "Mol Biol Cell"}, {"key": "3_CR42", "series-title": "Advances in cancer research", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1016/B978-0-12-800092-2.00003-4", "volume-title": "Hyaluronan signaling and turnover", "author": "S Adamia", "year": "2014", "unstructured": "Adamia S, Kriangkum J, Belch AR, Pilarski LM. Aberrant post-transcriptional processing of hyaluronan synthase 1 in malignant transformation and tumor progression. In: Simpson M, Heldin P, editors. Hyaluronan signaling and turnover, Advances in cancer research, vol. 123. 1st ed. New York, NY: Elsevier Academic Press; 2014. p. 67\u201394.", "edition": "1"}, {"issue": "5", "key": "3_CR43", "first-page": "1684", "volume": "93", "author": "M Crainie", "year": "1999", "unstructured": "Crainie M, Belch AR, Mant MJ, Pilarski LM. Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants. Blood. 1999;93(5):1684\u201396.", "journal-title": "Blood"}, {"key": "3_CR44", "doi-asserted-by": "crossref", "first-page": "1151", "DOI": "10.1182/blood-2003-11-4079", "volume": "104", "author": "CA Maxwell", "year": "2004", "unstructured": "Maxwell CA, Rasmussen E, Zhan F, Keats JJ, Adamia S, Strachan E, Crainie M, Belch AR, Pilarski LM, Shaugnessy J, Reiman T. RHAMM expression and isoform balance predicts aggressive disease and poor survival in multiple myeloma. Blood. 2004;104:1151\u20138.", "journal-title": "Blood"}], "container-title": ["Waldenstr\u00f6m\u2019s Macroglobulinemia"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-22584-5_3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 27]], "date-time": "2017-07-27T11:12:53Z", "timestamp": 1501153973000}, "score": 25.735172, "issued": {"date-parts": [[2016, 10, 7]]}, "ISBN": ["9783319225838", "9783319225845"], "references-count": 44, "URL": "http://dx.doi.org/10.1007/978-3-319-22584-5_3", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:43:54Z", "timestamp": 1574520234204}, "reference-count": 55, "publisher": "OMICS Publishing Group", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Investigation"], "published-print": {"date-parts": [[2011, 6]]}, "DOI": "10.4155/cli.11.60", "type": "journal-article", "created": {"date-parts": [[2011, 6, 22]], "date-time": "2011-06-22T15:28:52Z", "timestamp": 1308756532000}, "page": "815-824", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Novel agents in Waldenstr\u00f6m macroglobulinemia"], "prefix": "10.4172", "volume": "1", "author": [{"given": "Ghayas C", "family": "Issa", "sequence": "first", "affiliation": []}, {"given": "Irene M", "family": "Ghobrial", "sequence": "additional", "affiliation": []}, {"given": "Aldo M", "family": "Roccaro", "sequence": "additional", "affiliation": []}], "member": "2674", "container-title": ["Clinical Investigation"], "language": "en", "deposited": {"date-parts": [[2019, 6, 12]], "date-time": "2019-06-12T04:07:07Z", "timestamp": 1560312427000}, "score": 25.349699, "issued": {"date-parts": [[2011, 6]]}, "references-count": 55, "journal-issue": {"published-print": {"date-parts": [[2011, 6]]}, "issue": "6"}, "alternative-id": ["10.4155/cli.11.60"], "URL": "http://dx.doi.org/10.4155/cli.11.60", "ISSN": ["2041-6792", "2041-6806"], "issn-type": [{"value": "2041-6792", "type": "print"}, {"value": "2041-6806", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T10:09:12Z", "timestamp": 1574158152910}, "reference-count": 0, "publisher": "American Medical Association (AMA)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1992, 3, 1]]}, "DOI": "10.1001/archderm.128.3.372", "type": "journal-article", "created": {"date-parts": [[2003, 3, 18]], "date-time": "2003-03-18T21:22:40Z", "timestamp": 1048022560000}, "page": "372-376", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Waldenstrom macroglobulinemia with an IgM-kappa antiepidermal basement membrane zone antibody"], "prefix": "10.1001", "volume": "128", "author": [{"given": "M. W.", "family": "Cobb", "sequence": "first", "affiliation": []}], "member": "10", "container-title": ["Archives of Dermatology"], "deposited": {"date-parts": [[2011, 5, 25]], "date-time": "2011-05-25T14:00:04Z", "timestamp": 1306332004000}, "score": 25.315226, "issued": {"date-parts": [[1992, 3, 1]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1001/archderm.128.3.372", "ISSN": ["0003-987X"], "issn-type": [{"value": "0003-987X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T18:28:57Z", "timestamp": 1574706537236}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 6, 1]], "date-time": "2016-06-01T00:00:00Z", "timestamp": 1464739200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["bprch.com", "clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Best Practice & Research Clinical Haematology"], "published-print": {"date-parts": [[2016, 6]]}, "DOI": "10.1016/j.beha.2016.09.001", "type": "journal-article", "created": {"date-parts": [[2016, 10, 9]], "date-time": "2016-10-09T17:59:27Z", "timestamp": 1476035967000}, "page": "135", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Learning from Waldenstrom Macroglobulinemia"], "prefix": "10.1016", "volume": "29", "author": [{"given": "M. Lia", "family": "Palomba", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Best Practice & Research Clinical Haematology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1521692616300524?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1521692616300524?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 7]], "date-time": "2018-09-07T20:24:13Z", "timestamp": 1536351853000}, "score": 25.315226, "issued": {"date-parts": [[2016, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 6]]}, "issue": "2"}, "alternative-id": ["S1521692616300524"], "URL": "http://dx.doi.org/10.1016/j.beha.2016.09.001", "ISSN": ["1521-6926"], "issn-type": [{"value": "1521-6926", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Learning from Waldenstrom Macroglobulinemia", "name": "articletitle", "label": "Article Title"}, {"value": "Best Practice & Research Clinical Haematology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.beha.2016.09.001", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2016 Published by Elsevier Ltd.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T23:20:34Z", "timestamp": 1574551234844}, "reference-count": 9, "publisher": "Informa UK Limited", "issue": "4", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Leukemia & Lymphoma"], "published-print": {"date-parts": [[2015, 4, 3]]}, "DOI": "10.3109/10428194.2014.970551", "type": "journal-article", "created": {"date-parts": [[2014, 10, 6]], "date-time": "2014-10-06T10:34:59Z", "timestamp": 1412591699000}, "page": "845-846", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Waldenstr\u00f6m macroglobulinemia and autoimmunity: what's the connection?"], "prefix": "10.1080", "volume": "56", "author": [{"given": "Stephen M.", "family": "Ansell", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 11, 3]]}, "reference": [{"key": "CIT0001", "DOI": "10.1093/jnci/djq043", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.3109/10428194.2014.944520", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.1056/NEJMoa1200710", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1084/jem.20131424", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1196/annals.1443.012", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1007/s12026-012-8270-1", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1017/erm.2013.10", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1016/j.autrev.2013.03.010", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.2174/187152812803589994", "doi-asserted-by": "publisher"}], "container-title": ["Leukemia & Lymphoma"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.970551", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 15]], "date-time": "2016-12-15T17:47:30Z", "timestamp": 1481824050000}, "score": 25.315226, "issued": {"date-parts": [[2014, 11, 3]]}, "references-count": 9, "journal-issue": {"published-online": {"date-parts": [[2014, 10, 30]]}, "published-print": {"date-parts": [[2015, 4, 3]]}, "issue": "4"}, "alternative-id": ["10.3109/10428194.2014.970551"], "URL": "http://dx.doi.org/10.3109/10428194.2014.970551", "relation": {"cites": []}, "ISSN": ["1042-8194", "1029-2403"], "issn-type": [{"value": "1042-8194", "type": "print"}, {"value": "1029-2403", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ilal20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ilal20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T00:32:54Z", "timestamp": 1574814774128}, "reference-count": 12, "publisher": "Informa UK Limited", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Postgraduate Medicine"], "published-print": {"date-parts": [[1959, 12]]}, "DOI": "10.1080/00325481.1959.11712725", "type": "journal-article", "created": {"date-parts": [[2016, 7, 6]], "date-time": "2016-07-06T17:18:17Z", "timestamp": 1467825497000}, "page": "815-821", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Macroglobulinemia of Waldenstr\u00f6m"], "prefix": "10.1080", "volume": "26", "author": [{"given": "M. Richard", "family": "Pachter", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2016, 7, 6]]}, "reference": [{"key": "CIT0001", "DOI": "10.1111/j.0954-6820.1944.tb03955.x", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "author": "Glenchur H.", "volume": "40", "first-page": "1055", "year": "1958", "journal-title": "Ann. Int. Med."}, {"key": "CIT0003", "author": "Kappeler R.", "volume": "25", "first-page": "54", "year": "1958", "journal-title": "Helvet. med. acta"}, {"key": "CIT0004", "author": "Jahnke K.", "volume": "11", "first-page": "25", "year": "1956", "journal-title": "\u00c4rztl. Wchnschr."}, {"key": "CIT0005", "author": "Wanner J.", "volume": "87", "first-page": "1243", "year": "1957", "journal-title": "Schweiz, med. Wchnschr."}, {"key": "CIT0006", "DOI": "10.1016/0002-9343(56)90139-5", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "author": "Wilde H.", "volume": "9", "first-page": "875", "year": "1954", "journal-title": "Blood"}, {"key": "CIT0008", "author": "Layani F.", "volume": "63", "first-page": "44", "year": "1955", "journal-title": "Presse m\u00e9d."}, {"key": "CIT0009", "author": "Undritz E.", "volume": "87", "first-page": "1431", "year": "1957", "journal-title": "Schweiz, med. Wchnschr."}, {"key": "CIT0010", "DOI": "10.1093/ajcp/31.6.467", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1016/S0140-6736(57)90577-9", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "author": "Scheidegger J. J.", "volume": "25", "first-page": "25", "year": "1958", "journal-title": "Helvet. med. acta"}], "container-title": ["Postgraduate Medicine"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/00325481.1959.11712725", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 17]], "date-time": "2016-12-17T09:13:30Z", "timestamp": 1481966010000}, "score": 25.315226, "subtitle": ["Clinical, Laboratory and Anatomic Features"], "issued": {"date-parts": [[1959, 12]]}, "references-count": 12, "journal-issue": {"published-online": {"date-parts": [[2016, 7, 6]]}, "published-print": {"date-parts": [[1959, 12]]}, "issue": "6"}, "alternative-id": ["10.1080/00325481.1959.11712725"], "URL": "http://dx.doi.org/10.1080/00325481.1959.11712725", "relation": {"cites": []}, "ISSN": ["0032-5481", "1941-9260"], "issn-type": [{"value": "0032-5481", "type": "print"}, {"value": "1941-9260", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 9]], "date-time": "2019-12-09T03:10:12Z", "timestamp": 1575861012002}, "reference-count": 58, "publisher": "American Society of Hematology", "issue": "1", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2012, 12, 8]]}, "abstract": "<jats:title>Abstract</jats:title><jats:p>Waldenstr\u00f6m macroglobulinemia (WM) is a rare lymphoproliferative disorder characterized by the presence of lymphoplasmacytic cells in the BM and IgM monoclonal protein in the serum. The origin of the malignant clone is thought to be a B cell arrested after somatic hypermutation in the germinal center and before terminal differentiation to plasma cells. In this review, recent advances in the genetic and epigenetic regulators of tumor progression are discussed. Risk factors include IgM-monoclonal gammopathy of undermined significance, familial disease, and immunological factors. The clinical manifestations of the disease include those related to clonal infiltration of the BM, lymph nodes, and, rarely, other sites such as pulmonary or CNS infiltration (Bing-Neel syndrome). Other manifestations are related to the IgM monoclonal protein, including hyperviscosity, cryoglobulinemia, protein-protein interactions, Ab-mediated disorders such as neuropathy, hemolytic anemia, and Schnitzler syndrome. IgM deposition in organs can lead to amyloidogenic manifestations in WM. The diagnostic workup for a patient with WM and rare presentations of WM are described herein. Prognosis of WM depends on 5 major factors in the International Staging System, including age, anemia, thrombocytopenia, \u03b2-2 microglobulin, and IgM level. The differential diagnosis of WM includes IgM-multiple myeloma, marginal zone lymphoma, mantle cell lymphoma, and follicular lymphoma.</jats:p>", "DOI": "10.1182/asheducation.v2012.1.586.3798562", "type": "journal-article", "created": {"date-parts": [[2019, 10, 10]], "date-time": "2019-10-10T08:57:13Z", "timestamp": 1570697833000}, "page": "586-594", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Are you sure this is Waldenstr\u00f6m macroglobulinemia?"], "prefix": "10.1182", "volume": "2012", "author": [{"given": "Irene M.", "family": "Ghobrial", "sequence": "first", "affiliation": [{"name": "Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}]}], "member": "234", "reference": [{"issue": "1", "key": "2019111811400840400_B1", "doi-asserted-by": "crossref", "first-page": "214", "DOI": "10.1200/JCO.2000.18.1.214", "article-title": "Waldenstrom's macroglobulinemia: clinical features, complications, and management", "volume": "18", "author": "Dimopoulos", "year": "2000", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "2019111811400840400_B2", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1007/s11864-004-0015-5", "article-title": "Waldenstrom macroglobulinemia", "volume": "5", "author": "Ghobrial", "year": "2004", "journal-title": "Curr Treat Options Oncol"}, {"issue": "7", "key": "2019111811400840400_B3", "doi-asserted-by": "crossref", "first-page": "1564", "DOI": "10.1200/JCO.2005.03.144", "article-title": "Diagnosis and management of Waldenstrom's macroglobulinemia", "volume": "23", "author": "Dimopoulos", "year": "2005", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "2019111811400840400_B4", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1053/sonc.2003.50082", "article-title": "Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia", "volume": "30", "author": "Owen", "year": "2003", "journal-title": "Semin Oncol"}, {"issue": "1", "key": "2019111811400840400_B5", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.3322/canjclin.55.1.10", "article-title": "Cancer statistics, 2005", "volume": "55", "author": "Jemal", "year": "2005", "journal-title": "CA Cancer J Clin"}, {"key": "2019111811400840400_B6", "doi-asserted-by": "crossref", "first-page": "3148", "DOI": "10.1182/blood.V82.10.3148.3148", "article-title": "Incidence of Waldenstr\u00f6m's macroglobulinemia", "volume": "82", "author": "Herrinton", "year": "1993", "journal-title": "Blood"}, {"issue": "8", "key": "2019111811400840400_B7", "doi-asserted-by": "crossref", "first-page": "1422", "DOI": "10.1200/JCO.2009.25.3237", "article-title": "Phase II trial of weekly bortezomib in combination with rituximab in relapsed or relapsed and refractory Waldenstrom macroglobulinemia", "volume": "28", "author": "Ghobrial", "year": "2010", "journal-title": "J Clin Oncol"}, {"issue": "12", "key": "2019111811400840400_B8", "doi-asserted-by": "crossref", "first-page": "2375", "DOI": "10.1182/blood-2009-05-174359", "article-title": "How I treat Waldenstrom macroglobulinemia", "volume": "114", "author": "Treon", "year": "2009", "journal-title": "Blood"}, {"key": "2019111811400840400_B9", "doi-asserted-by": "crossref", "first-page": "1505", "DOI": "10.1182/blood.V100.4.1505.h81602001505_1505_1507", "article-title": "Typical Waldenstr\u00f6m macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events", "volume": "100", "author": "Sahota", "year": "2002", "journal-title": "Blood"}, {"issue": "8", "key": "2019111811400840400_B10", "doi-asserted-by": "crossref", "first-page": "2996", "DOI": "10.1182/blood.V100.8.2996", "article-title": "Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions", "volume": "100", "author": "Schop", "year": "2002", "journal-title": "Blood"}, {"key": "2019111811400840400_B11", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1016/0092-8674(94)90321-2", "article-title": "Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells", "volume": "77", "author": "Turner", "year": "1994", "journal-title": "Cell"}, {"issue": "8", "key": "2019111811400840400_B12", "doi-asserted-by": "crossref", "first-page": "3579", "DOI": "10.1158/0008-5472.CAN-08-3701", "article-title": "Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia", "volume": "69", "author": "Braggio", "year": "2009", "journal-title": "Cancer Res"}, {"issue": "21", "key": "2019111811400840400_B13", "first-page": "300", "article-title": "Whole genome sequencing reveals a widely expressed mutation (MYD88 L265P) with oncogenic activity in Waldenstrom's macroglobulinemia [abstract]", "volume": "118", "author": "Treon", "year": "2011", "journal-title": "Blood (ASH Annual Meeting Abstracts)"}, {"issue": "18", "key": "2019111811400840400_B14", "doi-asserted-by": "crossref", "first-page": "4391", "DOI": "10.1182/blood-2008-09-178228", "article-title": "microRNA expression in the biology, prognosis and therapy of Waldenstrom macroglobulinemia", "volume": "113", "author": "Roccaro", "year": "2009", "journal-title": "Blood"}, {"issue": "9", "key": "2019111811400840400_B15", "doi-asserted-by": "crossref", "first-page": "1506", "DOI": "10.1182/blood-2010-01-265686", "article-title": "microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia", "volume": "116", "author": "Roccaro", "year": "2010", "journal-title": "Blood"}, {"issue": "10", "key": "2019111811400840400_B16", "doi-asserted-by": "crossref", "first-page": "3759", "DOI": "10.1182/blood-2003-03-0801", "article-title": "Long-term follow-up of IgM monoclonal gammopathy of undetermined significance", "volume": "102", "author": "Kyle", "year": "2003", "journal-title": "Blood"}, {"issue": "6", "key": "2019111811400840400_B17", "doi-asserted-by": "crossref", "first-page": "1104", "DOI": "10.1080/10428190802074619", "article-title": "Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia", "volume": "49", "author": "Leleu", "year": "2008", "journal-title": "Leuk Lymphoma"}, {"issue": "2", "key": "2019111811400840400_B18", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1016/j.cancergencyto.2006.04.009", "article-title": "6q deletion discriminates Waldenstrom macroglobulinemia from IgM monoclonal gammopathy of undetermined significance", "volume": "169", "author": "Schop", "year": "2006", "journal-title": "Cancer Genet Cytogenet"}, {"key": "2019111811400840400_B19", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1053/sonc.2003.50063", "article-title": "Familial Waldenstr\u00f6m's macroglobulinemia", "volume": "30", "author": "McMaster", "year": "2003", "journal-title": "Semin Oncol"}, {"issue": "3", "key": "2019111811400840400_B20", "doi-asserted-by": "crossref", "first-page": "488", "DOI": "10.1093/annonc/mdj111", "article-title": "Characterization of familial Waldenstrom's macroglobulinemia", "volume": "17", "author": "Treon", "year": "2006", "journal-title": "Ann Oncol"}, {"issue": "8", "key": "2019111811400840400_B21", "doi-asserted-by": "crossref", "first-page": "3052", "DOI": "10.1182/blood-2008-06-162768", "article-title": "Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden", "volume": "112", "author": "Kristinsson", "year": "2008", "journal-title": "Blood"}, {"issue": "1", "key": "2019111811400840400_B22", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.3816/CLML.2011.n.015", "article-title": "What causes Waldenstrom's macroglobulinemia: genetic or immune-related factors, or a combination?", "volume": "11", "author": "Kristinsson", "year": "2011", "journal-title": "Clin Lymphoma Myeloma Leuk"}, {"issue": "3", "key": "2019111811400840400_B23", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1159/000335618", "article-title": "Familial aggregation of lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia with solid tumors and myeloid malignancies", "volume": "127", "author": "Kristinsson", "year": "2012", "journal-title": "Acta Haematol"}, {"key": "2019111811400840400_B24", "doi-asserted-by": "crossref", "first-page": "S91", "DOI": "10.1002/cyto.b.20550", "article-title": "Prevalence, clinical aspects, and natural history of IgM MGUS", "volume": "78", "author": "McMaster", "year": "2010", "journal-title": "Cytometry B Clin Cytom"}, {"key": "2019111811400840400_B25", "first-page": "363", "article-title": "Urticaire chronique, le\u2032sions osseuses, macroglobuline\u2032mie IgM: maladie de Waldenstrom? [article in French]", "volume": "81", "author": "Schnitzler", "year": "1974", "journal-title": "Bull Soc Fr Derm Syph"}, {"issue": "5", "key": "2019111811400840400_B26", "doi-asserted-by": "crossref", "first-page": "914", "DOI": "10.1200/JCO.1993.11.5.914", "article-title": "Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenstrom's macroglobulinemia", "volume": "11", "author": "Gertz", "year": "1993", "journal-title": "J Clin Oncol"}, {"issue": "11", "key": "2019111811400840400_B27", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1016/S1470-2045(03)01246-4", "article-title": "Waldenstrom macroglobulinaemia", "volume": "4", "author": "Ghobrial", "year": "2003", "journal-title": "Lancet Oncol"}, {"key": "2019111811400840400_B28", "doi-asserted-by": "crossref", "first-page": "S112", "DOI": "10.1179/102453312X13336169156212", "article-title": "Waldenstrom macroglobulinemia", "volume": "17", "author": "Gertz", "year": "2012", "journal-title": "Hematology"}, {"issue": "19", "key": "2019111811400840400_B29", "doi-asserted-by": "crossref", "first-page": "4462", "DOI": "10.1182/blood-2011-10-384768", "article-title": "Progression in smoldering Waldenstrom's macroglobulinemia: long-term results", "volume": "119", "author": "Kyle", "year": "2012", "journal-title": "Blood"}, {"issue": "6", "key": "2019111811400840400_B30", "first-page": "659", "article-title": "Monoclonal IgM interference with immunoturbidimetric determination of ferritin and transferrin [article in French]", "volume": "65", "author": "Roszyk", "year": "2007", "journal-title": "Ann Biol Clin (Paris)"}, {"issue": "2", "key": "2019111811400840400_B31", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1053/sonc.2003.50037", "article-title": "Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia", "volume": "30", "author": "Weber", "year": "2003", "journal-title": "Semin Oncol"}, {"issue": "5", "key": "2019111811400840400_B32", "doi-asserted-by": "crossref", "first-page": "380", "DOI": "10.3816/CLM.2006.n.013", "article-title": "Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia", "volume": "6", "author": "Kimby", "year": "2006", "journal-title": "Clin Lymphoma Myeloma"}, {"key": "2019111811400840400_B33", "doi-asserted-by": "crossref", "first-page": "669", "DOI": "10.1148/radiology.188.3.8351330", "article-title": "Waldenstrom macroglobulinemia: MR imaging of the spine and CT of the abdomen and pelvis", "volume": "188", "author": "Moulopoulos", "year": "1993", "journal-title": "Radiology"}, {"key": "2019111811400840400_B34", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1097/RLU.0b013e31817dea44", "article-title": "Scintigraphic pattern of skeletal involvement of Waldenstrom macroglobulinemia", "volume": "33", "author": "Elmonayeri", "year": "2008", "journal-title": "Clin Nucl Med"}, {"issue": "2", "key": "2019111811400840400_B35", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1111/j.1365-2141.2006.06003.x", "article-title": "Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia", "volume": "133", "author": "Ghobrial", "year": "2006", "journal-title": "Br J Haematol"}, {"issue": "9", "key": "2019111811400840400_B36", "doi-asserted-by": "crossref", "first-page": "3013", "DOI": "10.1158/1078-0432.CCR-10-2954", "article-title": "The role of serum immunoglobulin free light chain in response and progression in waldenstrom macroglobulinemia", "volume": "17", "author": "Leleu", "year": "2011", "journal-title": "Clin Cancer Res"}, {"issue": "12", "key": "2019111811400840400_B37", "doi-asserted-by": "crossref", "first-page": "5096", "DOI": "10.1182/blood-2006-11-055012", "article-title": "Waldenstrom macroglobulinemia", "volume": "109", "author": "Vijay", "year": "2007", "journal-title": "Blood"}, {"issue": "3", "key": "2019111811400840400_B38", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/j.semarthrit.2007.04.001", "article-title": "Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment", "volume": "37", "author": "de Koning", "year": "2007", "journal-title": "Semin Arthritis Rheum"}, {"issue": "3", "key": "2019111811400840400_B39", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1055/s-0038-1650099", "article-title": "Acquired von Willebrand's syndrome in the course of Waldenstrom's disease", "volume": "44", "author": "Mazurier", "year": "1980", "journal-title": "Thromb Haemost"}, {"issue": "4", "key": "2019111811400840400_B40", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1046/j.1035-6851.2001.00263.x", "article-title": "Angioedema in the emergency department: a presentation of lymphoma", "volume": "13", "author": "Wellwood", "year": "2001", "journal-title": "Emerg Med (Fremantle)"}, {"issue": "9", "key": "2019111811400840400_B41", "doi-asserted-by": "crossref", "first-page": "1691", "DOI": "10.1373/clinchem.2004.037499", "article-title": "Paraprotein interference in automated chemistry analyzers", "volume": "50", "author": "Smogorzewska", "year": "2004", "journal-title": "Clin Chem"}, {"issue": "1", "key": "2019111811400840400_B42", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1182/blood.V98.1.41", "article-title": "Prognostic factors and response to fludarabine therapy in patients with Waldenstrom macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003)", "volume": "98", "author": "Dhodapkar", "year": "2001", "journal-title": "Blood"}, {"issue": "8", "key": "2019111811400840400_B43", "doi-asserted-by": "crossref", "first-page": "1299", "DOI": "10.1093/annonc/mdg334", "article-title": "Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia", "volume": "14", "author": "Dimopoulos", "year": "2003", "journal-title": "Ann Oncol"}, {"issue": "2", "key": "2019111811400840400_B44", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1053/sonc.2003.50038", "article-title": "Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia", "volume": "30", "author": "Kyle", "year": "2003", "journal-title": "Semin Oncol"}, {"issue": "9", "key": "2019111811400840400_B45", "doi-asserted-by": "crossref", "first-page": "1809", "DOI": "10.1080/10428190410001687512", "article-title": "The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia", "volume": "45", "author": "Dimopoulos", "year": "2004", "journal-title": "Leuk Lymphoma"}, {"issue": "18", "key": "2019111811400840400_B46", "doi-asserted-by": "crossref", "first-page": "4163", "DOI": "10.1182/blood-2008-08-174961", "article-title": "International prognostic scoring system for Waldenstrom's macroglobulinemia", "volume": "113", "author": "Morel", "year": "2009", "journal-title": "Blood"}, {"issue": "11", "key": "2019111811400840400_B47", "doi-asserted-by": "crossref", "first-page": "853", "DOI": "10.1002/ajh.21845", "article-title": "IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia", "volume": "85", "author": "Schuster", "year": "2010", "journal-title": "Am J Hematol"}, {"issue": "1", "key": "2019111811400840400_B48", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1200/JCO.2008.17.7865", "article-title": "Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia", "volume": "27", "author": "Dimopoulos", "year": "2009", "journal-title": "J Clin Oncol"}, {"issue": "9", "key": "2019111811400840400_B49", "doi-asserted-by": "crossref", "first-page": "3442", "DOI": "10.1182/blood-2005-02-0833", "article-title": "Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia", "volume": "107", "author": "Treon", "year": "2006", "journal-title": "Blood"}, {"issue": "2", "key": "2019111811400840400_B50", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1007/s00415-004-0323-5", "article-title": "Immune mediated neuropathies\u2013an update on therapeutic strategies", "volume": "251", "author": "Czaplinski", "year": "2004", "journal-title": "J Neurol"}, {"issue": "2", "key": "2019111811400840400_B51", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1007/s11940-001-0050-5", "article-title": "Paraproteinemic neuropathy", "volume": "3", "author": "Wicklund", "year": "2001", "journal-title": "Curr Treat Options Neurol"}, {"issue": "8", "key": "2019111811400840400_B52", "doi-asserted-by": "crossref", "first-page": "1701", "DOI": "10.1212/WNL.52.8.1701", "article-title": "IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rituximab", "volume": "52", "author": "Levine", "year": "1999", "journal-title": "Neurology"}, {"issue": "9", "key": "2019111811400840400_B53", "doi-asserted-by": "crossref", "first-page": "1267", "DOI": "10.1586/14737175.6.9.1267", "article-title": "Rituximab in the treatment of peripheral neuropathy associated with monoclonal gammopathy", "volume": "6", "author": "Zivkovi\u0107", "year": "2006", "journal-title": "Expert Rev Neurother"}, {"issue": "5", "key": "2019111811400840400_B54", "doi-asserted-by": "crossref", "first-page": "859", "DOI": "10.1080/14786410500441664", "article-title": "Rituximab therapy in monoclonal IgM-related neuropathies", "volume": "47", "author": "Kilidireas", "year": "2006", "journal-title": "Leuk Lymphoma"}, {"issue": "4", "key": "2019111811400840400_B55", "doi-asserted-by": "crossref", "first-page": "510", "DOI": "10.1002/mus.20244", "article-title": "Rituximab treatment of an IgM monoclonal autonomic and sensory neuropathy", "volume": "31", "author": "Goldfarb", "year": "2005", "journal-title": "Muscle Nerve"}, {"issue": "11", "key": "2019111811400840400_B56", "first-page": "490", "article-title": "Phase II study of bortezomib in Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248 [abstract]", "volume": "106", "author": "Treon", "year": "2005", "journal-title": "Blood (ASH Annual Meeting Abstracts)"}, {"issue": "11", "key": "2019111811400840400_B57", "first-page": "2765", "article-title": "Bortezomib, dexamethasone and rituximab (BDR) is a highly active regimen in the primary therapy of Waldenstr\u00f6m's macroglobulinemia: planned interim results of WMCTG clinical trial 05-180 [abstract]", "volume": "108", "author": "Treon", "year": "2006", "journal-title": "Blood (ASH Annual Meeting Abstracts)"}, {"issue": "8", "key": "2019111811400840400_B58", "doi-asserted-by": "crossref", "first-page": "1408", "DOI": "10.1200/JCO.2009.24.0994", "article-title": "Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia", "volume": "28", "author": "Ghobrial", "year": "2010", "journal-title": "J Clin Oncol"}], "container-title": ["Hematology"], "language": "en", "link": [{"URL": "http://ashpublications.org/hematology/article-pdf/2012/1/586/1502000/bep00112000586.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/hematology/article-pdf/2012/1/586/1502000/bep00112000586.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 9]], "date-time": "2019-12-09T02:48:14Z", "timestamp": 1575859694000}, "score": 25.315226, "issued": {"date-parts": [[2012, 12, 8]]}, "references-count": 58, "journal-issue": {"published-print": {"date-parts": [[2012, 12, 8]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1182/asheducation.v2012.1.586.3798562", "relation": {"cites": []}, "ISSN": ["1520-4391", "1520-4383"], "issn-type": [{"value": "1520-4391", "type": "print"}, {"value": "1520-4383", "type": "electronic"}], "subject": ["Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:14:22Z", "timestamp": 1576797262324}, "reference-count": 42, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2013, 1, 20]]}, "DOI": "10.1200/jco.2012.46.6177", "type": "journal-article", "created": {"date-parts": [[2012, 12, 12]], "date-time": "2012-12-12T02:44:06Z", "timestamp": 1355280246000}, "page": "291-293", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Choice of Therapy for Patients With  Waldenstr\u00f6m Macroglobulinemia"], "prefix": "10.1200", "volume": "31", "author": [{"given": "Irene M.", "family": "Ghobrial", "sequence": "first", "affiliation": [{"name": "Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2012.46.6177", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:39:25Z", "timestamp": 1574887165000}, "score": 25.315226, "issued": {"date-parts": [[2013, 1, 20]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[2013, 1, 20]]}, "issue": "3"}, "alternative-id": ["10.1200/JCO.2012.46.6177"], "URL": "http://dx.doi.org/10.1200/jco.2012.46.6177", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T16:59:42Z", "timestamp": 1575305982384}, "reference-count": 35, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2005, 3, 1]], "date-time": "2005-03-01T00:00:00Z", "timestamp": 1109635200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Lymphoma"], "published-print": {"date-parts": [[2005, 3]]}, "DOI": "10.3816/clm.2005.n.005", "type": "journal-article", "created": {"date-parts": [[2008, 9, 11]], "date-time": "2008-09-11T01:10:14Z", "timestamp": 1221095414000}, "page": "230-234", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Cytogenetics of Familial Waldenstr\u00f6m's Macroglobulinemia: In Pursuit of an Understanding of Genetic Predisposition"], "prefix": "10.3816", "volume": "5", "author": [{"given": "Mary L.", "family": "McMaster", "sequence": "first", "affiliation": []}, {"given": "Therese", "family": "Giambarresi", "sequence": "additional", "affiliation": []}, {"given": "Linda", "family": "Vasquez", "sequence": "additional", "affiliation": []}, {"given": "Alisa M.", "family": "Goldstein", "sequence": "additional", "affiliation": []}, {"given": "Margaret A.", "family": "Tucker", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Lymphoma"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1526965511700884?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1526965511700884?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 25]], "date-time": "2018-12-25T22:59:30Z", "timestamp": 1545778770000}, "score": 25.121214, "issued": {"date-parts": [[2005, 3]]}, "references-count": 35, "journal-issue": {"published-print": {"date-parts": [[2005, 3]]}, "issue": "4"}, "alternative-id": ["S1526965511700884"], "URL": "http://dx.doi.org/10.3816/clm.2005.n.005", "ISSN": ["1526-9655"], "issn-type": [{"value": "1526-9655", "type": "print"}], "subject": ["Cancer Research"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:12:36Z", "timestamp": 1575529956070}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "21", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2012, 11, 16]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Abstract 2703</jats:p>\n               <jats:sec>\n                  <jats:title>Background and Significance:</jats:title>\n                  <jats:p>Lymphoplasmacytic lymphoma (LPL) is an indolent but incurable B cell lymphoproliferative characterized by the clonal expansion of plasmacytoid lymphocytes in the lymph nodes and bone marrow. The majority of cases are associated with an IgM isotype paraprotein, and when present, is termed Waldenstro\u0308m macroglobulinemia (WM). WM shows familial aggregation suggesting an inherited risk for disease, and also co-aggregates with CLL in families. In our previous work, we have shown that clonal populations of peripherally circulating B cells can be identified in 18% of unaffected family members from CLL kindreds. Most of these clonal populations have a typical CLL immunophenotype and have been termed CLL-like monoclonal B cell lymphocytosis (MBL). Because CLL and WM have related gene expression profiles and appear to have shared genetic risk, we hypothesized that unaffected family members of WM kindreds would have detectable circulating clonal B cell populations. Further, we undertook systematic flow cytometric screening of familial WM and IgM MGUS cases to determine the prevalence, immunphenotype, and biologic characteristics of circulating malignant B cells.</jats:p>\n               </jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:</jats:title>\n                  <jats:p>A diagnosis of LPL / WM or IgM MGUS was determined using standard WHO criteria. All patients and unaffected family members were ascertained at the National Cancer Institute and provided informed consent. Peripheral blood mononuclear cells were isolated using density centrifugation and viably frozen in DMSO containing media. We developed a two tube, nine color flow cytometric assay: the first tube allowed for detection of CLL-like clones based upon co-expression of CD5, CD20, and CD23; the second tube targeted WM populations based upon expression on CD19, CD20, CD25, CD38, and surface IgM. Cell populations were considered clonally restricted if the \u03ba: \u03bb was &gt; 3.0 or &lt; 0.3. Clonal populations were then isolated using fluorescence activated cell sorting (FACS). RNA and genomic DNA were extracted for genetic and genomic studies using phenol: chloroform purification.</jats:p>\n               </jats:sec>\n               <jats:sec>\n                  <jats:title>Results:</jats:title>\n                  <jats:p>A total of 155 individuals were analyzed: 54 WM / LPL, 17 IgM MGUS, 1 IgG MGUS, 1 IgA MGUS, 1 NHL, and 81 unaffected family members. Twenty of 54 WM patients had detectable peripherally circulating populations. Thirteen WM patients had no detectable B cells, of these, 11 patients had prior treatment. As such, among the 41 WM patients with a B cell compartment that was analyzable by flow cytometry, 49% (20 of 41) had peripherally circulating B cell clones detected. Four of these 20 cases showed two immunophenotypically distinct clonal B cell populations. The immunophenotype was somewhat heterogenenous: 18 cases expressed surface IgM, CD38 was variable but expressed in most cases, CD25 was not detected in any case, and 4 cases showed a CLL like (CD5+CD20dimCD23+) immunophenotype. Interestingly, we detected peripherally circulating B cell clones in 9 of 17 cases (53%) of IgM MGUS, a proportion nearly identical to that identified in WM / LPL. Three of 9 were \u201cCLL-like\u201d with co-expression of CD5 and CD23, while the majority of clones were CD5negIgM+CD38+. Among unaffected family members, we identified B cell clones in only 4 of 81 (5%). All 4 cases expressed CD5, and 3 showed a CLL-like phenotype, consistent with these individuals having MBL. Among all study subjects, 20 clonal B cell populations of &gt; 104 B cells were FACS purified from 18 different cases: 12 WM, 4 IgM MGUS, 1 IgA MGUS, and 1 unaffected family member.</jats:p>\n               </jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:</jats:title>\n                  <jats:p>Peripherally circulating B cell clones with an immunophenotype similar to that of LPL can be identified in approximately half of patients with WM / LPL. We observed for the first time that a similar proportion of patients with IgM MGUS have detectable clonal populations with an immunophenotype similar to that observed in WM patients. Genetic and genomic studies to determine the lineage of these populations are currently underway. The frequency of MBL among unaffected family members with WM is lower than that observed in CLL kindreds. CLL-like MBL can be detected at very low numbers because the cell population is immunophenotypically abnormal. The peripherally circulating clones identified in WM / LPL patients have an otherwise normal B cell immunophenotype and can only be detected by light chain restriction. This likely significantly limits the ability of flow cytometry to detect pre-clinical CD5neg IgM expressing clonal populations.</jats:p>\n               </jats:sec>\n               <jats:sec>\n                  <jats:title>Disclosures:</jats:title>\n                  <jats:p>No relevant conflicts of interest to declare.</jats:p>\n               </jats:sec>", "DOI": "10.1182/blood.v120.21.2703.2703", "type": "journal-article", "created": {"date-parts": [[2019, 10, 12]], "date-time": "2019-10-12T16:50:40Z", "timestamp": 1570899040000}, "page": "2703-2703", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Circulating B Cell Clones in Familial Waldenstro\u0308m Macroglobulinemia."], "prefix": "10.1182", "volume": "120", "author": [{"given": "Mark C.", "family": "Lanasa", "sequence": "first", "affiliation": [{"name": "Department of Medicine, Duke University Medical Center, Durham, NC, USA,"}]}, {"given": "Sallie D.", "family": "Allgood", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Duke University Medical Center, Durham, NC, USA,"}]}, {"given": "Lynn R.", "family": "Goldin", "sequence": "additional", "affiliation": [{"name": "Genetic Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA,"}]}, {"given": "Danielle M.", "family": "Brander", "sequence": "additional", "affiliation": [{"name": "Medicine, Duke University Medical Center, Durham, NC, USA"}]}, {"given": "Mary L.", "family": "McMaster", "sequence": "additional", "affiliation": [{"name": "Genetic Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA,"}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/120/21/2703/112800/Circulating-B-Cell-Clones-in-Familial-Waldenstrom", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/120/21/2703/112800/Circulating-B-Cell-Clones-in-Familial-Waldenstrom", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T19:23:24Z", "timestamp": 1574191404000}, "score": 25.121214, "issued": {"date-parts": [[2012, 11, 16]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012, 11, 16]]}, "issue": "21"}, "URL": "http://dx.doi.org/10.1182/blood.v120.21.2703.2703", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T00:49:45Z", "timestamp": 1575247785966}, "publisher-location": "Berlin, Heidelberg", "reference-count": 85, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642056437", "type": "print"}, {"value": "9783662088852", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2004]]}, "DOI": "10.1007/978-3-662-08885-2_9", "type": "book-chapter", "created": {"date-parts": [[2013, 7, 8]], "date-time": "2013-07-08T10:08:04Z", "timestamp": 1373278084000}, "page": "205-225", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Waldenstr\u00f6m Macroglobulinemia"], "prefix": "10.1007", "author": [{"given": "Jerry M.", "family": "Winkler", "sequence": "first", "affiliation": []}, {"given": "Rafael", "family": "Fonseca", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "9_CR1", "doi-asserted-by": "publisher", "first-page": "2580", "DOI": "10.1002/1097-0142(19820615)49:12<2580::AID-CNCR2820491228>3.0.CO;2-5", "volume": "49", "author": "M Abe", "year": "1982", "unstructured": "Abe M, Takahashi K, Mori N, Kojima M (1982) \u201cWaldenstr\u00f6m\u2019s macro-globulinemia\u201d terminating in immunoblastic sarcoma. A case report. Cancer 49:2580\u20132586", "journal-title": "Cancer"}, {"key": "9_CR2", "first-page": "1913", "volume": "85", "author": "H Aoki", "year": "1995", "unstructured": "Aoki H, Takishita M, Kosaka M, Saito S (1995) Frequent somatic mutations in D and/or JH segments of Ig gene in Waldenstr\u00f6m\u2019s macro-globulinemia and chronic lymphocytic leukemia (CLL) with Richter\u2019s syndrome but not in common CLL. Blood 85:1913\u20131919", "journal-title": "Blood"}, {"key": "9_CR3", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1111/j.0954-6820.1985.tb01646.x", "volume": "217", "author": "C Avnstorp", "year": "1985", "unstructured": "Avnstorp C, Nielsen H, Drachmann O, Hippe E (1985) Plasmapheresis in hyperviscosity syndrome. Acta Med Scand 217:133\u2013137", "journal-title": "Acta Med Scand"}, {"key": "9_CR4", "doi-asserted-by": "publisher", "first-page": "358", "DOI": "10.1046/j.1365-2141.1997.3923206.x", "volume": "99", "author": "DC Betticher", "year": "1997", "unstructured": "Betticher DC, Hsu Schmitz SF, Ratschiller D, von Rohr A, Egger T, Pugin P, Stalder M, Hess U, Fey MF, Cerny T, for the Swiss Group for Clinical Cancer Research (SAKK) (1997) Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenstr\u00f6m\u2019s macroglobulinaemia. Br J Haematol 99:358\u2013363", "journal-title": "Br J Haematol"}, {"key": "9_CR5", "doi-asserted-by": "publisher", "first-page": "830", "DOI": "10.7326/0003-4819-93-6-830", "volume": "93", "author": "WA Blattner", "year": "1980", "unstructured": "Blattner WA, Garber JE, Mann DL, McKeen EA, Henson R, McGuire DB, Fisher WB, Bauman AW, Goldin LR, Fraumeni JF Jr (1980) Waldenstr\u00f6m\u2019s macroglobulinemia and autoimmune disease in a family. Ann Intern Med 93:830\u2013832", "journal-title": "Ann Intern Med"}, {"key": "9_CR6", "first-page": "223", "volume": "53", "author": "C Bottura", "year": "1966", "unstructured": "Bottura C (1966) The genetic nature of Waldenstr\u00f6m\u2019s macroglobulinemia. [Spanish] Prensa Med Argent 53:223\u2013224", "journal-title": "Prensa Med Argent"}, {"key": "9_CR7", "doi-asserted-by": "publisher", "first-page": "408", "DOI": "10.1056/NEJM197902223000806", "volume": "300", "author": "J Brody", "year": "1979", "unstructured": "Brody Jl, Haidar ME, Rossman RE (1979) A hemorrhagic syndrome in Waldenstr\u00f6m\u2019s macroglobulinemia secondary to immunoadsorp-tion of factor VIII. Recovery after splenectomy. N Engl J Med 300:408\u2013410", "journal-title": "N Engl J Med"}, {"key": "9_CR8", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.1159/000209015", "volume": "38", "author": "AK Brown", "year": "1967", "unstructured": "Brown AK, Elves MW, Gunson HH, Pell-Ilderton R (1967) Waldenstr\u00f6m\u2019s macroglobulinaemia. A family study. Acta Haematol 38:184\u2013192", "journal-title": "Acta Haematol"}, {"key": "9_CR9", "doi-asserted-by": "publisher", "first-page": "872", "DOI": "10.2165/00003495-199346050-00007", "volume": "46", "author": "HM Bryson", "year": "1993", "unstructured": "Bryson HM, Sorkin EM (1993) Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies. Drugs 46:872\u2013894", "journal-title": "Drugs"}, {"key": "9_CR10", "doi-asserted-by": "publisher", "first-page": "1525", "DOI": "10.1023/A:1008350208019", "volume": "10", "author": "JC Byrd", "year": "1999", "unstructured": "Byrd JC, White CA, Link B, Lucas MS, Valasquez WS, Rosenberg J, Grillo-Lopez AJ (1999) Rituximab therapy in Waldenstr\u00f6m\u2019s macroglobulinemia: preliminary evidence of clinical activity. Ann Oncol 10:1525\u20131527", "journal-title": "Ann Oncol"}, {"key": "9_CR11", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.3109/07357909109032794", "volume": "9", "author": "DC Case Jr", "year": "1991", "unstructured": "Case DC Jr, Ervin TJ, Boyd MA, Redfield DL (1991) Waldenstr\u00f6m\u2019s macroglobulinemia: long-term results with the M-2 protocol. Cancer Invest 9:1\u20137", "journal-title": "Cancer Invest"}, {"key": "9_CR12", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1016/S0165-4608(97)00346-4", "volume": "103", "author": "YY Chong", "year": "1998", "unstructured": "Chong YY, Lau LC, Lui WO, Lim P, Lim E, Tan PH, Tan P, Ong YY (1998) A case of t(8;14) with total and partial trisomy 3 in Waldenstr\u00f6m macroglobulinemia. Cancer Genet Cytogenet 103:65\u201367", "journal-title": "Cancer Genet Cytogenet"}, {"key": "9_CR13", "doi-asserted-by": "publisher", "first-page": "370", "DOI": "10.1159/000130783", "volume": "18", "author": "G Contrafatto", "year": "1977", "unstructured": "Contrafatto G (1977) Marker chromosome of macroglobulinemia identified by G-banding. Cytogenet Cell Genet 18:370\u2013373", "journal-title": "Cytogenet Cell Genet"}, {"key": "9_CR14", "first-page": "317", "volume": "36", "author": "A Delannoy", "year": "1994", "unstructured": "Delannoy A, Ferrant A, Martiat P, Bosly A, Zenebergh A, Michaux JL (1994) 2-Chlorodeoxyadenosine therapy in Waldenstr\u00f6m\u2019s macroglobulinaemia. Nouv Rev Fr Hematol 36:317\u2013320", "journal-title": "Nouv Rev Fr Hematol"}, {"key": "9_CR15", "doi-asserted-by": "publisher", "first-page": "993", "DOI": "10.1046/j.1365-2141.1999.01461.x", "volume": "105", "author": "R Desikan", "year": "1999", "unstructured": "Desikan R, Dhodapkar M, Siegel D, Fassas A, Singh J, Singhal S, Mehta J, Vesole D, Tricot G, Jagannath S, Anaissie E, Barlogie B, Munshi NC (1999) High-dose therapy with autologous haemopoietic stem cell support for Waldenstr\u00f6m\u2019s macroglobulinaemia. Br J Haematol 105:993\u2013996", "journal-title": "Br J Haematol"}, {"key": "9_CR16", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1182/blood.V98.1.41", "volume": "98", "author": "MV Dhodapkar", "year": "2001", "unstructured": "Dhodapkar MV, Jacobson JL, Gertz MA, Rivkin SE, Roodman GD, Tuscano JM, Shurafa M, Kyle RA, Crowley JJ, Barlogie B (2001) Prognostic factors and response to fludarabine therapy in patients with Waldenstr\u00f6m macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003). Blood 98: 41\u201348", "journal-title": "Blood"}, {"key": "9_CR17", "doi-asserted-by": "publisher", "first-page": "195", "DOI": "10.7326/0003-4819-118-3-199302010-00007", "volume": "118", "author": "MA Dimopoulos", "year": "1993", "unstructured": "Dimopoulos MA, Kantarjian H, Estey E, O\u2019Brien S, Delasalle K, Keating MJ, Freireich EJ, Alexanian R (1993 a) Treatment of Waldenstr\u00f6m macroglobulinemia with 2-chlorodeoxyadenosine. Ann Intern Med 118:195\u2013198", "journal-title": "Ann Intern Med"}, {"key": "9_CR18", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1016/0002-9343(93)90231-D", "volume": "95", "author": "MA Dimopoulos", "year": "1993", "unstructured": "Dimopoulos MA, O\u2019Brien S, Kantarjian H, Pierce S, Delasalle K, Barlogie B, Alexanian R, Keating MJ (1993 b) Fludarabine therapy in Waldenstr\u00f6m\u2019s macroglobulinemia. Am J Med 95:49\u201352", "journal-title": "Am J Med"}, {"key": "9_CR19", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1093/oxfordjournals.annonc.a058811", "volume": "5", "author": "MA Dimopoulos", "year": "1994", "unstructured": "Dimopoulos MA, Weber DM, Kantarjian H, Keating M, Alexanian R (1994) 2-Chlorodeoxyadenosine therapy of patients with Waldenstr\u00f6m macroglobulinemia previously treated with fludarabine. Ann Oncol 5:288\u2013289", "journal-title": "Ann Oncol"}, {"key": "9_CR20", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1093/oxfordjournals.annonc.a059040", "volume": "6", "author": "MA Dimopoulos", "year": "1995", "unstructured": "Dimopoulos MA, Weber D, Delasalle KB, Keating M, Alexanian R (1995) Treatment of Waldenstr\u00f6m\u2019s macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors. Ann Oncol 6:49\u201352", "journal-title": "Ann Oncol"}, {"key": "9_CR21", "doi-asserted-by": "crossref", "first-page": "214", "DOI": "10.1200/JCO.2000.18.1.214", "volume": "18", "author": "MA Dimopoulos", "year": "2000", "unstructured": "Dimopoulos MA, Panayiotidis P, Moulopoulos LA, Sfikakis P, Dalakas M (2000) Waldenstr\u00f6m\u2019s macroglobulinemia: clinical features, complications, and management. J Clin Oncol 18:214\u2013226", "journal-title": "J Clin Oncol"}, {"key": "9_CR22", "doi-asserted-by": "crossref", "first-page": "3596", "DOI": "10.1200/JCO.2001.19.16.3596", "volume": "19", "author": "MA Dimopoulos", "year": "2001", "unstructured": "Dimopoulos MA, Zomas A, Viniou NA, Grigoraki V, Galani E, Matsouka C, Economou O, Anagnostopoulos N, Panayiotidis P (2001) Treatment of Waldenstr\u00f6m\u2019s macroglobulinemia with thalidomide. J Clin Oncol 19:3596\u20133601", "journal-title": "J Clin Oncol"}, {"key": "9_CR23", "doi-asserted-by": "publisher", "first-page": "2327", "DOI": "10.1200/JCO.2002.09.039", "volume": "20", "author": "MA Dimopoulos", "year": "2002", "unstructured": "Dimopoulos MA, Zervas C, Zomas A, Kiamouris C, Viniou NA, Grigoraki V, Karkantaris C, Mitsouli C, Gika D, Christakis J, Anagnostopoulos N (2002) Treatment of Waldenstr\u00f6m\u2019s macroglobulinemia with rituximab. J Clin Oncol 20:2327\u20132333", "journal-title": "J Clin Oncol"}, {"key": "9_CR24", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1046/j.1365-2141.1999.01493.x", "volume": "106", "author": "P Dreger", "year": "1999", "unstructured": "Dreger P, Glass B, Kuse R, Sonnen R, von Neuhoff N, Bolouri H, Kneba M, Schmitz N (1999) Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenstr\u00f6m\u2019s macroglobulinaemia. Br J Haematol 106:115\u2013118", "journal-title": "Br J Haematol"}, {"key": "9_CR25", "doi-asserted-by": "crossref", "first-page": "1553", "DOI": "10.1200/JCO.1993.11.8.1553", "volume": "11", "author": "T Facon", "year": "1993", "unstructured": "Facon T, Brouillard M, Duhamel A, Morel P, Simon M, Jouet JP, Bauters F, Fenaux P (1993) Prognostic factors in Waldenstr\u00f6m\u2019s macroglobulinemia: a report of 167 cases. J Clin Oncol 11:1553\u20131558", "journal-title": "J Clin Oncol"}, {"key": "9_CR26", "first-page": "348", "volume": "3", "author": "HD Feiner", "year": "1990", "unstructured": "Feiner HD, Rizk CC, Finfer MD, Bannan M, Gottesman SR, Chuba JV, Amorosi E (1990) IgM monoclonal gammopathy/Waldenstr\u00f6m\u2019s macroglobulinemia: a morphological and immunophenotypic study of the bone marrow. Mod Pathol 3:348\u2013356", "journal-title": "Mod Pathol"}, {"key": "9_CR27", "doi-asserted-by": "crossref", "first-page": "546", "DOI": "10.1200/JCO.1999.17.2.546", "volume": "17", "author": "JM Foran", "year": "1999", "unstructured": "Foran JM, Rohatiner AZ, Coiffier B, Barbui T, Johnson SA, Hiddemann W, Radford JA, Norton AJ, Tollerfield SM, Wilson MP, Lister TA (1999) Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstr\u00f6m\u2019s macroglobulinemia, and mantle-cell lymphoma. J Clin Oncol 17:546\u2013553", "journal-title": "J Clin Oncol"}, {"key": "9_CR28", "doi-asserted-by": "publisher", "first-page": "71", "DOI": "10.1046/j.1365-2141.2000.01971.x", "volume": "109", "author": "R Garand", "year": "2000", "unstructured": "Garand R, Sahota SS, Avet-Loiseau H, Talmant P, Robillard N, Moreau A, Gaillard F, Stevenson FK, Bataille R (2000) IgG-secreting lymphoplasmacytoid leukaemia: a B-cell disorder with extensively mutated VH genes undergoing Ig isotype-switching frequently associated with trisomy 12. Br J Haematol 109:71\u201380", "journal-title": "Br J Haematol"}, {"key": "9_CR29", "doi-asserted-by": "publisher", "first-page": "575", "DOI": "10.1046/j.1365-2141.2001.03144.x", "volume": "115", "author": "R Garcia-Sanz", "year": "2001", "unstructured": "Garcia-Sanz R, Montoto S, Torrequebrada A, de Coca AG, Petit J, Sureda A, Rodriguez-Garcia JA, Masso P, Perez-Aliaga A, Monteagudo MD, Navarro I, Moreno G, Toledo C, Alonso A, Besses C, Besalduch J, Jarque I, Salama P, Rivas JA, Navarro B, Blad\u00e9 J, Miguel JF (2001) Waldenstr\u00f6m macroglobulinaemia: presenting features and outcome in a series with 217 cases. Br J Haematol 115: 575\u2013582", "journal-title": "Br J Haematol"}, {"key": "9_CR30", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.1177/088506669501000304", "volume": "10", "author": "MA Gertz", "year": "1995", "unstructured": "Gertz MA, Kyle RA (1995) Hyperviscosity syndrome. J Intensive Care Med 10:128\u2013141", "journal-title": "J Intensive Care Med"}, {"key": "9_CR31", "doi-asserted-by": "crossref", "first-page": "490", "DOI": "10.1016/S0025-6196(11)65130-6", "volume": "74", "author": "MA Gertz", "year": "1999", "unstructured": "Gertz MA, Lacy MQ, Dispenzieri A (1999) Amyloidosis: recognition, confirmation, prognosis, and therapy. Mayo Clin Proc 74:490\u2013494", "journal-title": "Mayo Clin Proc"}, {"key": "9_CR32", "doi-asserted-by": "publisher", "first-page": "63", "DOI": "10.1634/theoncologist.5-1-63", "volume": "5", "author": "MA Gertz", "year": "2000", "unstructured": "Gertz MA, Fonseca R, Rajkumar SV (2000) Waldenstr\u00f6m\u2019s macroglobulinemia. Oncologist 5:63\u201367", "journal-title": "Oncologist"}, {"key": "9_CR33", "first-page": "2939", "volume": "83", "author": "PG Gobbi", "year": "1994", "unstructured": "Gobbi PG, Bettini R, Montecucco C, Cavanna L, Morandi S, Pieresca C, Merlini G, Bertoloni D, Grignani G, Pozzetti U, Caporali R, Ascari E (1994) Study of prognosis in Waldenstr\u00f6m\u2019s macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility. Blood 83:2939\u20132945", "journal-title": "Blood"}, {"key": "9_CR34", "first-page": "3382", "volume": "81", "author": "PR Greipp", "year": "1993", "unstructured": "Greipp PR, Lust JA, O\u2019Fallon WM, Katzmann JA, Witzig TE, Kyle RA (1993) Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood 81:3382\u20133387", "journal-title": "Blood"}, {"key": "9_CR35", "doi-asserted-by": "publisher", "first-page": "1078", "DOI": "10.1002/(SICI)1097-0142(19980315)82:6<1078::AID-CNCR10>3.0.CO;2-3", "volume": "82", "author": "FD Groves", "year": "1998", "unstructured": "Groves FD, Travis LB, Devesa SS, Ries LA, Fraumeni JF Jr (1998) Waldenstr\u00f6m\u2019s macroglobulinemia: incidence patterns in the United States, 1988\u20131994. Cancer 82:1078\u20131081", "journal-title": "Cancer"}, {"key": "9_CR36", "first-page": "1361", "volume": "84", "author": "NL Harris", "year": "1994", "unstructured": "Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, DeWolf-Peeters C, Falini B, Gatter KC (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361\u20131392", "journal-title": "Blood"}, {"key": "9_CR37", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1111/j.1600-0609.1999.tb01848.x", "volume": "63", "author": "A Hellmann", "year": "1999", "unstructured": "Hellmann A, Lewandowski K, Zaucha JM, Bieniaszewska M, Halaburda K, Robak T (1999) Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenstr\u00f6m\u2019s macroglobulinemia. Eur J Haematol 63:35\u201341", "journal-title": "Eur J Haematol"}, {"key": "9_CR38", "first-page": "3148", "volume": "82", "author": "U Herrinton", "year": "1993", "unstructured": "Herrinton U, Weiss NS (1993) Incidence of Waldenstr\u00f6m\u2019s macroglobulinemia. Blood 82:3148\u20133150", "journal-title": "Blood"}, {"key": "9_CR39", "first-page": "340", "volume": "37", "author": "N Hirase", "year": "1996", "unstructured": "Hirase N, Miyamura T, Ishikura H, Yufu Y, Nishimura J, Nawata H (1996) Primary macroglobulinemia with t(11;18)(q21;q21). [Japanese] Rinsho Ketsueki 37:340\u2013345", "journal-title": "Rinsho Ketsueki"}, {"key": "9_CR40", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1016/S0165-4608(99)00156-9", "volume": "117", "author": "N Hirase", "year": "2000", "unstructured": "Hirase N, Yufu Y, Abe Y, Muta K, Shiokawa S, Nawata H, Nishimura J (2000) Primary macroglobulinemia with t(11;18)(q21;q21). Cancer Genet Cytogenet 117:113\u2013117", "journal-title": "Cancer Genet Cytogenet"}, {"key": "9_CR41", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1002/ajh.2830150111", "volume": "15", "author": "DE Horsman", "year": "1983", "unstructured": "Horsman DE, Card RT, Skinnider LF (1983) Waldenstr\u00f6m macroglobulinemia terminating in acute leukemia: a report of three cases. Am J Hematol 15:97\u2013101", "journal-title": "Am J Hematol"}, {"key": "9_CR42", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1002/ajh.2830480411", "volume": "48", "author": "JS Humphrey", "year": "1995", "unstructured": "Humphrey JS, Conley CL (1995) Durable complete remission of macroglobulinemia after splenectomy: a report of two cases and review of the literature. Am J Hematol 48:262\u2013266", "journal-title": "Am J Hematol"}, {"key": "9_CR43", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.3109/10428199909083377", "volume": "34", "author": "S Iida", "year": "1999", "unstructured": "Iida S, Rao PH, Ueda R, Chaganti RS, Dalla-Favera R (1999) Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32). Leuk Lymphoma 34:25\u201333", "journal-title": "Leuk Lymphoma"}, {"key": "9_CR44", "first-page": "1928", "volume": "75", "author": "HM Kantarjian", "year": "1990", "unstructured": "Kantarjian HM, Alexanian R, Koller CA, Kurzrock R, Keating MJ (1990) Fludarabine therapy in macroglobulinemic lymphoma. Blood 75:1928\u20131931", "journal-title": "Blood"}, {"key": "9_CR45", "doi-asserted-by": "publisher", "first-page": "719", "DOI": "10.1016/S0025-6196(12)65225-2", "volume": "62", "author": "RA Kyle", "year": "1987", "unstructured": "Kyle RA, Garton JP (1987) The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 62:719\u2013731", "journal-title": "Mayo Clin Proc"}, {"key": "9_CR46", "doi-asserted-by": "publisher", "first-page": "1347", "DOI": "10.1056/NEJM198006123022405", "volume": "302", "author": "RA Kyle", "year": "1980", "unstructured": "Kyle RA, Greipp PR (1980) Smoldering multiple myeloma. N Engl J Med 302:1347\u20131349", "journal-title": "N Engl J Med"}, {"key": "9_CR47", "doi-asserted-by": "publisher", "first-page": "737", "DOI": "10.1046/j.1365-2141.2000.01918.x", "volume": "108", "author": "RA Kyle", "year": "2000", "unstructured": "Kyle RA, Greipp PR, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Therneau TM (2000) Waldenstr\u00f6m\u2019s macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil. Br J Haematol 108:737\u2013742", "journal-title": "Br J Haematol"}, {"key": "9_CR48", "doi-asserted-by": "publisher", "first-page": "564", "DOI": "10.1056/NEJMoa01133202", "volume": "346", "author": "RA Kyle", "year": "2002", "unstructured": "Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton U III (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346:564\u2013569", "journal-title": "N Engl J Med"}, {"key": "9_CR49", "doi-asserted-by": "publisher", "first-page": "722", "DOI": "10.1007/s00277-001-0385-8", "volume": "80", "author": "MC Kyrtsonis", "year": "2001", "unstructured": "Kyrtsonis MC, Vassilakopoulos TP, Angelopoulou MK, Siakantaris P, Kontopidou FN, Dimopoulou MN, Boussiotis V, Gribabis A, Konstantopoulos K, Vaiopoulos GA, Fessas P, Kittas C, Pangalis GA (2001) Waldenstr\u00f6m\u2019s macroglobulinemia: clinical course and prosnostic factors in 60 patients. Experience from a single hematology unit. Ann Hematol 80:722\u2013727", "journal-title": "Ann Hematol"}, {"key": "9_CR50", "doi-asserted-by": "publisher", "first-page": "1215", "DOI": "10.1038/sj.bjc.6690195", "volume": "79", "author": "FM Laurencet", "year": "1999", "unstructured": "Laurencet FM, Zulian GB, Guetty-Alberto M, Iten PA, Betticher DC, Alberto P (1999) Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies. Br J Cancer 79:1215\u20131219", "journal-title": "Br J Cancer"}, {"key": "9_CR51", "doi-asserted-by": "crossref", "first-page": "2060", "DOI": "10.1200/JCO.1998.16.6.2060", "volume": "16", "author": "V Leblond", "year": "1998", "unstructured": "Leblond V, Ben-Othman T, Deconinck E, Taksin AL, Harousseau JL, Delgado MA, Delmer A, Maloisel F, Manette X, Morel P, Clauvel JP, Duboisset P, Entezam S, Hermine O, Merlet M, Yakoub-Agha I, Guibon O, Caspard H, Fort N, for the Groupe Coop\u00e9ratif Macroglobulin\u00e9mie (1998) Activity of fludarabine in previously treated Waldenstr\u00f6m\u2019s macroglobulinemia: a report of 71 cases. J Clin Oncol 16:2060\u20132064", "journal-title": "J Clin Oncol"}, {"key": "9_CR52", "doi-asserted-by": "publisher", "first-page": "2640", "DOI": "10.1182/blood.V98.9.2640", "volume": "98", "author": "V Leblond", "year": "2001", "unstructured": "Leblond V, Levy V, Maloisel F, Cazin B, Fermand JP, Harousseau JL, Remenieras L, Porcher R, Gardembas M, Marit G, Deconinck E, Desablens B, Guilhot F, Philippe G, Stamatoullas A, Guibon O (2001) Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenstr\u00f6m macroglobulinemia in first relapse or with primary refractory disease. Blood 98:2640\u20132644", "journal-title": "Blood"}, {"key": "9_CR53", "first-page": "1363", "volume": "7", "author": "MS Linet", "year": "1993", "unstructured": "Linet MS, Humphrey RL, Mehl ES, Brown LM, Pottern LM, Bias WB, McCaffrey L (1993) A case-control and family study of Waldenstr\u00f6m\u2019s macroglobulinemia. Leukemia 7:1363\u20131369", "journal-title": "Leukemia"}, {"key": "9_CR54", "doi-asserted-by": "publisher", "first-page": "690", "DOI": "10.1046/j.1365-2141.1998.01069.x", "volume": "103", "author": "ES Liu", "year": "1998", "unstructured": "Liu ES, Burian C, Miller WE, Saven A (1998) Bolus administration of cladribine in the treatment of Waldenstr\u00f6m macroglobulinaemia. Br J Haematol 103:690\u2013695", "journal-title": "Br J Haematol"}, {"key": "9_CR55", "first-page": "184b", "volume": "92", "author": "I Louviaux", "year": "1998", "unstructured": "Louviaux I, Michaux L, Hagemeijer A, Criel A, Billiet J, Scheiff JM, Deneys V, Delannoy A, Ferrant A (1998) Cytogenetic abnormalities in Waldenstr\u00f6m\u2019s disease (WD): a single centre study on 45 cases (abstract). Blood 92 Suppl:184b", "journal-title": "Blood"}, {"key": "9_CR56", "doi-asserted-by": "publisher", "first-page": "543", "DOI": "10.1309/9DBY-FBUG-Y10A-AAXT", "volume": "116", "author": "A Mansoor", "year": "2001", "unstructured": "Mansoor A, Medeiros U, Weber DM, Alexanian R, Hayes K, Jones D, Lai R, Glassman A, Bueso-Ramos CE (2001) Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenstr\u00f6m macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol 116:543\u2013549", "journal-title": "Am J Clin Pathol"}, {"key": "9_CR57", "first-page": "852", "volume": "96", "author": "P Morel", "year": "2000", "unstructured": "Morel P, Monconduit M, Jacomy D, Lenain P, Grosbois B, Bateli C, Facon T, Dervite I, Bauters F, Najman A, deGramont A, Wattel E (2000) Patients with the description of a new scoring system and its validation on 253 other patients. Blood 96:852\u2013858", "journal-title": "Blood"}, {"key": "9_CR58", "doi-asserted-by": "publisher", "first-page": "140", "DOI": "10.1002/ajh.2830370221", "volume": "37", "author": "M Nagai", "year": "1991", "unstructured": "Nagai M, Ikeda K, Nakamura H, Ohnishi H, Amino Y, Irino S, Sato A, Uda H (1991) Splenectomy for a case with Waldenstr\u00f6m macroglobulinemia with giant splenomegaly (letter to the editor). Am J Hematol 37:140", "journal-title": "Am J Hematol"}, {"key": "9_CR59", "first-page": "1275", "volume": "49", "author": "K Nishida", "year": "1989", "unstructured": "Nishida K, Taniwaki M, Misawa S, Abe T (1989) Nonrandom rearrangement of chromosome 14 at band q32.33 in human lymphoid malignancies with mature B-cell phenotype. Cancer Res 49:1275\u20131281", "journal-title": "Cancer Res"}, {"key": "9_CR60", "first-page": "2594", "volume": "80", "author": "K Offit", "year": "1992", "unstructured": "Offit K, Parsa NZ, Filippa D, Jhanwar SC, Chaganti RS (1992) t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin\u2019s lymphoma with plasmacytoid differentiation. Blood 80:2594\u20132599", "journal-title": "Blood"}, {"key": "9_CR61", "doi-asserted-by": "publisher", "first-page": "252", "DOI": "10.1046/j.1365-2249.1999.00971.x", "volume": "117", "author": "HM Ogmundsdottir", "year": "1999", "unstructured": "Ogmundsdottir HM, Sveinsdottir S, Sigfusson A, Skaftadottir I, Jonasson JG, Agnarsson BA (1999) Enhanced B cell survival in familial macroglobulinaemia is associated with increased expression of Bcl-2. Clin Exp Immunol 117:252\u2013260", "journal-title": "Clin Exp Immunol"}, {"key": "9_CR62", "doi-asserted-by": "publisher", "first-page": "234", "DOI": "10.1001/archinte.1967.00300020106015", "volume": "120", "author": "RA O\u2019Reilly", "year": "1967", "unstructured": "O\u2019Reilly RA, MacKenzie MR(1967) Primary macrocryogelglobulinemia. Remission with adrenal corticosteroid therapy. Arch Intern Med 120:234\u2013238", "journal-title": "Arch Intern Med"}, {"key": "9_CR63", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1002/1099-1069(200006)18:2<41::AID-HON654>3.0.CO;2-W", "volume": "18", "author": "RG Owen", "year": "2000", "unstructured": "Owen RG, Johnson SA, Morgan GJ (2000) Waldenstr\u00f6m\u2019s macroglobulinaemia: laboratory diagnosis and treatment. Hematol Oncol 18:41\u201349", "journal-title": "Hematol Oncol"}, {"key": "9_CR64", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1002/1099-1069(200006)18:2<41::AID-HON654>3.0.CO;2-W", "volume": "18", "author": "RG Owen", "year": "2000", "unstructured": "Owen RG, Johnson SA, Morgan GJ (2000) Waldenstr\u00f6m\u2019s macroglobulinaemia: laboratory diagnosis and treatment. Hematol Oncol 18:41\u201349", "journal-title": "Hematol Oncol"}, {"key": "9_CR65", "first-page": "104", "volume": "36", "author": "GA Pangalis", "year": "1999", "unstructured": "Pangalis GA, Angelopoulou MK, Vassilakopoulos TP, Siakantaris MP, Kittas C (1999) B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenstr\u00f6m\u2019s macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders. Semin Hematol 36:104\u2013114", "journal-title": "Semin Hematol"}, {"key": "9_CR66", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1111/j.1365-2796.1989.tb01422.x", "volume": "226", "author": "MT Petrucci", "year": "1989", "unstructured": "Petrucci MT, Avvisati G, Tribalto M, Giovangrossi P, Mandelli F (1989) Waldenstr\u00f6m\u2019s macroglobulinaemia: results of a combined oral treatment in 34 newly diagnosed patients. J Intern Med 226:443\u2013447", "journal-title": "J Intern Med"}, {"key": "9_CR67", "doi-asserted-by": "publisher", "first-page": "1554", "DOI": "10.1002/1097-0142(19891001)64:7<1554::AID-CNCR2820640734>3.0.CO;2-3", "volume": "64", "author": "G Renier", "year": "1989", "unstructured": "Renier G, Ifrah N, Chevailler A, Saint-Andre JP, Boasson M, Hurez D (1989) Four brothers with Waldenstr\u00f6m\u2019s macroglobulinemia. Cancer 64:1554\u20131559", "journal-title": "Cancer"}, {"key": "9_CR68", "first-page": "2661", "volume": "45", "author": "MK Robinson", "year": "1992", "unstructured": "Robinson MK, Halpern Jl (1992) Retinal vein occlusion. Am Fam Physician 45:2661\u20132666", "journal-title": "Am Fam Physician"}, {"key": "9_CR69", "doi-asserted-by": "publisher", "first-page": "2996", "DOI": "10.1182/blood.V100.8.2996", "volume": "100", "author": "RF Schop", "year": "2002", "unstructured": "Schop RF, Kuehl WM, Van Wier SA, Ahmann GJ, Price-Troska T, Bailey RJ, Jalal SM, Qi Y, Kyle RA, Greipp PR, Fonseca R (2002) Waldenstr\u00f6m macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood 100:2996\u20133001", "journal-title": "Blood"}, {"key": "9_CR70", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1172/JCI116178", "volume": "91", "author": "A Singh", "year": "1993", "unstructured": "Singh A, Eckardt KU, Zimmermann A, Gotz KH, Hamann M, Ratcliffe PJ, Kurtz A, Reinhart WH (1993) Increased plasma viscosity as a reason for inappropriate erythropoietin formation. J Clin Invest 91:251\u2013256", "journal-title": "J Clin Invest"}, {"key": "9_CR71", "doi-asserted-by": "publisher", "first-page": "703", "DOI": "10.3109/02841869109092443", "volume": "30", "author": "N Taleb", "year": "1991", "unstructured": "Taleb N, Tohme A, Abi Jirgiss D, Kattan J, Salloum E (1991) Familial macroglobulinemia in a Lebanese family with two sisters presenting Waldenstr\u00f6m\u2019s disease. Acta Oncol 30:703\u2013705", "journal-title": "Acta Oncol"}, {"key": "9_CR72", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1097/00043764-199402000-00007", "volume": "36", "author": "A Tepper", "year": "1994", "unstructured": "Tepper A, Moss CE (1994) Waldenstr\u00f6m\u2019s macroglobulinemia: search for occupational exposure. J Occup Med 36:133\u2013136", "journal-title": "J Occup Med"}, {"key": "9_CR73", "doi-asserted-by": "publisher", "first-page": "125", "DOI": "10.3109/10428190009057635", "volume": "37", "author": "SA Tetreault", "year": "2000", "unstructured": "Tetreault SA, Saven A (2000) Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenstr\u00f6m macroglobulinemia. Leuk Lymphoma 37:125\u2013130", "journal-title": "Leuk Lymphoma"}, {"key": "9_CR74", "doi-asserted-by": "publisher", "first-page": "556", "DOI": "10.1007/s002770000185", "volume": "79", "author": "R Thalhammer-Scherrer", "year": "2000", "unstructured": "Thalhammer-Scherrer R, Geissler K, Schwarzinger I, Chott A, Gisslinger H, Knobl P, Lechner K, Jager U (2000) Fludarabine therapy in Waldenstr\u00f6m\u2019s macroglobulinemia. Ann Hematol 79:556\u2013559", "journal-title": "Ann Hematol"}, {"key": "9_CR75", "doi-asserted-by": "publisher", "first-page": "102", "DOI": "10.1136/bjo.67.2.102", "volume": "67", "author": "EL Thomas", "year": "1983", "unstructured": "Thomas EL, Olk RJ, Markman M, Braine H, Patz A (1983) Irreversible visual loss in Waldenstr\u00f6m\u2019s macroglobulinaemia. Br J Ophthalmol 67:102\u2013106", "journal-title": "Br J Ophthalmol"}, {"key": "9_CR76", "first-page": "79", "volume": "12", "author": "SP Treon", "year": "2000", "unstructured": "Treon SP, Anderson KC (2000) The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders. Semin Oncol 27 Suppl 12:79\u201385", "journal-title": "Semin Oncol 27 Suppl"}, {"key": "9_CR77", "first-page": "97", "volume": "14", "author": "SP Treon", "year": "1999", "unstructured": "Treon SP, Shima Y, Preffer Fl, Doss DS, Ellman L, Schlossman RL, Grossbard ML, Belch AR, Pilarski LM, Anderson KC (1999) Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy. Semin Oncol 26 Suppl 14:97\u2013106", "journal-title": "Semin Oncol 26 Suppl"}, {"key": "9_CR78", "doi-asserted-by": "publisher", "first-page": "272", "DOI": "10.1097/00002371-200105000-00012", "volume": "24", "author": "SP Treon", "year": "2001", "unstructured": "Treon SP, Agus DB, Link B, Rodrigues G, Molina A, Lacy MQ, Fisher DC, Emmanouilides C, Richards Al, Clark B, Lucas MS, Schlossman R, Schenkein D, Lin B, Kimby E, Anderson KC, Byrd JC (2001) CD20-Directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstr\u00f6m\u2019s macroglobulinemia. J Immunother 24:272\u2013279", "journal-title": "J Immunother"}, {"key": "9_CR79", "doi-asserted-by": "publisher", "first-page": "1136", "DOI": "10.1038/sj.leu.2401783", "volume": "14", "author": "E Neste Van Den", "year": "2000", "unstructured": "Van Den Neste E, Louviaux I, Michaux JL, Delannoy A, Michaux L, Sonet A, Bosly A, Doyen C, Mineur P, Andre M, Straetmans N, Coche E, Venet C, Duprez T, Ferrant A (2000) Phase I/II study of 2-chloro-2\u2032-deoxyadenosine with cyclophosphamide in patients with pre-treated B cell chronic lymphocytic leukemia and indolent non-Hodgkin\u2019s lymphoma. Leukemia 14:1136\u20131142", "journal-title": "Leukemia"}, {"key": "9_CR80", "first-page": "3647", "volume": "83", "author": "SD Wagner", "year": "1994", "unstructured": "Wagner SD, Martinelli V, Luzzatto L (1994) Similar patterns of V kappa gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstr\u00f6m\u2019s macroglobulinemia, and myeloma. Blood 83:3647 \u2013 3653", "journal-title": "Blood"}, {"key": "9_CR81", "doi-asserted-by": "publisher", "first-page": "216", "DOI": "10.1111/j.0954-6820.1944.tb03955.x", "volume": "117", "author": "J Waldenstr\u00f6m", "year": "1944", "unstructured": "Waldenstr\u00f6m J (1944) Incipient myelomatosis or \u201cessential\u201d hyperglobulinemia with fibrinogenopenia \u2014 a new syndrome? Acta Med Scand 117:216\u2013247", "journal-title": "Acta Med Scand"}, {"key": "9_CR82", "first-page": "927", "volume": "78", "author": "J Waldenstr\u00f6m", "year": "1948", "unstructured": "Waldenstr\u00f6m J (1948) Zwei interessante Syndrome mit Hyperglobulin\u00e4mie: Purpura hyperglobulinaemica und Makroglobulin\u00e4mie. Schweiz Med Wochenschr 78:927\u2013928", "journal-title": "Schweiz Med Wochenschr"}, {"key": "9_CR83", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1089/cbr.1999.14.241", "volume": "14", "author": "CA White", "year": "1999", "unstructured": "White CA (1999) Rituximab immunotherapy for non-Hodgkin\u2019s lymphoma. Cancer Biother Radiopharm 14:241\u2013250", "journal-title": "Cancer Biother Radiopharm"}, {"key": "9_CR84", "doi-asserted-by": "publisher", "first-page": "137", "DOI": "10.1016/S0165-4608(00)00334-4", "volume": "124", "author": "KF Wong", "year": "2001", "unstructured": "Wong KF, So CC (2001) Waldenstr\u00f6m macroglobulinemia with karyotypic aberrations involving both homologous 6q. Cancer Genet Cytogenet 124:137\u2013139", "journal-title": "Cancer Genet Cytogenet"}, {"key": "9_CR85", "doi-asserted-by": "publisher", "first-page": "120", "DOI": "10.1111/j.1600-0609.1995.tb01779.x", "volume": "54", "author": "PL Zinzani", "year": "1995", "unstructured": "Zinzani PL, Gherlinzoni F, Bendandi M, Zaccaria A, Aitini E, Salvucci M, Tura S (1995) Fludarabine treatment in resistant Waldenstr\u00f6m\u2019s macroglobulinemia. Eur J Haematol 54:120\u2013123", "journal-title": "Eur J Haematol"}], "container-title": ["Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-662-08885-2_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 15]], "date-time": "2019-05-15T13:32:47Z", "timestamp": 1557927167000}, "score": 25.117226, "issued": {"date-parts": [[2004]]}, "ISBN": ["9783642056437", "9783662088852"], "references-count": 85, "URL": "http://dx.doi.org/10.1007/978-3-662-08885-2_9", "relation": {"cites": []}}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}